Human	O
cytomegalovirus	O
binding	O
to	O
human	B-cell_type
monocytes	I-cell_type
induces	O
immunoregulatory	O
gene	O
expression	O
.	O

To	O
continue	O
our	O
investigation	O
of	O
the	O
cellular	O
events	O
that	O
occur	O
following	O
human	O
CMV	O
(	O
HCMV	O
)	O
infection	O
,	O
we	O
focused	O
on	O
the	O
regulation	O
of	O
cellular	O
activation	O
following	O
viral	O
binding	O
to	O
human	B-cell_type
monocytes	I-cell_type
.	O

First	O
,	O
we	O
showed	O
that	O
viral	O
binding	O
induced	O
a	O
number	O
of	O
immunoregulatory	B-cell_type
genes	I-cell_type
(	O
IL-1beta	B-protein
,	O
A20	B-protein
,	O
NF-kappaB-p105/p50	B-protein
,	O
and	O
IkappaBalpha	B-protein
)	O
in	O
unactivated	O
monocytes	B-cell_type
and	O
that	O
neutralizing	B-protein
Abs	I-protein
to	O
the	O
major	O
HCMV	B-protein
glycoproteins	I-protein
,	O
gB	B-protein
(	O
UL55	B-protein
)	O
and	O
gH	B-protein
(	O
UL75	B-protein
)	O
,	O
inhibited	O
the	O
induction	O
of	O
these	O
genes	O
.	O

Next	O
,	O
we	O
demonstrated	O
that	O
these	O
viral	O
ligands	O
directly	O
up-regulated	O
monocyte	O
gene	O
expression	O
upon	O
their	O
binding	O
to	O
their	O
appropriate	O
cellular	O
receptors	O
.	O

We	O
then	O
investigated	O
if	O
HCMV	O
binding	O
also	O
resulted	O
in	O
the	O
translation	O
and	O
secretion	O
of	O
cytokines	B-protein
.	O

Our	O
results	O
showed	O
that	O
HCMV	O
binding	O
to	O
monocytes	B-cell_type
resulted	O
in	O
the	O
production	O
and	O
release	O
of	O
IL-1beta	B-protein
protein	I-protein
.	O

Because	O
these	O
induced	O
gene	O
products	O
have	O
NF-kappaB	B-DNA
sites	I-DNA
in	O
their	O
promoter	B-DNA
regions	I-DNA
,	O
we	O
next	O
examined	O
whether	O
there	O
was	O
an	O
up-regulation	O
of	O
nuclear	O
NF-kappaB	B-protein
levels	O
.	O

These	O
experiments	O
showed	O
that	O
,	O
in	O
fact	O
,	O
NF-kappaB	B-protein
was	O
translocated	O
to	O
the	O
nucleus	O
following	O
viral	O
binding	O
or	O
purified	O
viral	O
ligand	O
binding	O
.	O

Changes	O
in	O
IkappaBalpha	B-protein
levels	O
correlated	O
with	O
the	O
changes	O
in	O
NF-kappaB	B-protein
translocation	O
.	O

Lastly	O
,	O
we	O
demonstrated	O
that	O
p38	B-protein
kinase	O
activity	O
played	O
a	O
central	O
role	O
in	O
IL-1beta	B-protein
production	O
and	O
that	O
it	O
was	O
rapidly	O
up-regulated	O
following	O
infection	O
.	O

These	O
results	O
support	O
our	O
hypothesis	O
that	O
HCMV	O
initiates	O
a	O
signal	O
transduction	O
pathway	O
that	O
leads	O
to	O
monocyte	O
activation	O
and	O
pinpoints	O
a	O
potential	O
mechanism	O
whereby	O
HCMV	O
infection	O
of	O
monocytes	B-cell_type
can	O
result	O
in	O
profound	O
pathogenesis	O
,	O
especially	O
in	O
chronic	O
inflammatory-type	O
conditions	O
.	O

X	NULL
Boldly	NULL
GolnVivo	NULL
``	NULL
``	NULL
BioLegend®	NULL
#	NULL
s	NULL
meJournal	NULL
of	NULL
Human	NULL
Cytomegalovirus	NULL
Binding	NULL
to	NULL
Human	NULL
4D	NULL
Imnmunolo	NULL
gy	NULL
Monocytes	NULL
Induces	NULL
Immunoregulatory	NULL
Gene	NULL
Expression	NULL
Andrew	NULL
D.	NULL
Yurochko	NULL
and	NULL
Eng-Shang	NULL
Huang	NULL
J	NULL
Immunol	NULL
1999	NULL
;	NULL
162:4806-4816	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/8/4806	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
64	NULL
articles	NULL
,	NULL
42	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/8/4806.full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
Human	NULL
Cytomegalovirus	NULL
Binding	NULL
to	NULL
Human	NULL
Monocytes	NULL
Induces	NULL
Immunoregulatory	NULL
Gene	NULL
Expression	NULL
'	NULL
Andrew	NULL
D.	NULL
Yurochko**	NULL
and	NULL
Eng-Shang	NULL
Huang*	NULL
``	NULL
*	NULL
``	NULL
To	NULL
continue	NULL
our	NULL
investigation	NULL
of	NULL
the	NULL
cellular	NULL
events	NULL
that	NULL
occur	NULL
following	NULL
human	NULL
CMV	NULL
(	NULL
HCMV	NULL
)	NULL
infection	NULL
,	NULL
we	NULL
focused	NULL
on	NULL
the	NULL
regulation	NULL
of	NULL
cellular	NULL
activation	NULL
following	NULL
viral	NULL
binding	NULL
to	NULL
human	NULL
monocytes	NULL
.	NULL

First	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
viral	NULL
binding	NULL
induced	NULL
a	NULL
number	NULL
of	NULL
immunoregulatory	NULL
genes	NULL
(	NULL
IL-1	NULL
,	NULL
A20	NULL
,	NULL
NF-sB-p105/p50	NULL
,	NULL
and	NULL
IxBa	NULL
)	NULL
in	NULL
unactivated	NULL
monocytes	NULL
and	NULL
that	NULL
neutralizing	NULL
Abs	NULL
to	NULL
the	NULL
major	NULL
HCMV	NULL
glycoproteins	NULL
,	NULL
gB	NULL
(	NULL
UL55	NULL
)	NULL
and	NULL
gH	NULL
(	NULL
UL75	NULL
)	NULL
,	NULL
inhibited	NULL
the	NULL
induction	NULL
of	NULL
these	NULL
genes	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
these	NULL
viral	NULL
ligands	NULL
directly	NULL
up-regulated	NULL
monocyte	NULL
gene	NULL
expression	NULL
upon	NULL
their	NULL
binding	NULL
to	NULL
their	NULL
appropriate	NULL
cellular	NULL
receptors	NULL
.	NULL

We	NULL
then	NULL
investigated	NULL
if	NULL
HCMV	NULL
binding	NULL
also	NULL
resulted	NULL
in	NULL
the	NULL
translation	NULL
and	NULL
secretion	NULL
of	NULL
cytokines	NULL
.	NULL

Our	NULL
results	NULL
showed	NULL
that	NULL
HCMV	NULL
binding	NULL
to	NULL
monocytes	NULL
resulted	NULL
in	NULL
the	NULL
production	NULL
and	NULL
release	NULL
of	NULL
IL-1§	NULL
protein	NULL
.	NULL

Because	NULL
these	NULL
induced	NULL
gene	NULL
products	NULL
have	NULL
NF-KB	NULL
sites	NULL
in	NULL
their	NULL
promoter	NULL
regions	NULL
,	NULL
we	NULL
next	NULL
examined	NULL
whether	NULL
there	NULL
was	NULL
an	NULL
up-regulation	NULL
of	NULL
nuclear	NULL
NF-KB	NULL
levels	NULL
.	NULL

These	NULL
experiments	NULL
showed	NULL
that	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
NF-xB	NULL
was	NULL
translocated	NULL
to	NULL
the	NULL
nucleus	NULL
following	NULL
viral	NULL
binding	NULL
or	NULL
purified	NULL
viral	NULL
ligand	NULL
binding	NULL
.	NULL

Changes	NULL
in	NULL
IxBa	NULL
levels	NULL
correlated	NULL
with	NULL
the	NULL
changes	NULL
in	NULL
NF-B	NULL
translocation	NULL
.	NULL

Lastly	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
p38	NULL
kinase	NULL
activity	NULL
played	NULL
a	NULL
central	NULL
role	NULL
in	NULL
IL-1	NULL
production	NULL
and	NULL
that	NULL
it	NULL
was	NULL
rapidly	NULL
up-regulated	NULL
following	NULL
infection	NULL
.	NULL

These	NULL
results	NULL
support	NULL
our	NULL
hypothesis	NULL
that	NULL
HCMV	NULL
initiates	NULL
a	NULL
signal	NULL
transduction	NULL
pathway	NULL
that	NULL
leads	NULL
to	NULL
monocyte	NULL
activation	NULL
and	NULL
pinpoints	NULL
a	NULL
potential	NULL
mechanism	NULL
whereby	NULL
HCMV	NULL
infection	NULL
of	NULL
monocytes	NULL
can	NULL
result	NULL
in	NULL
profound	NULL
pathogenesis	NULL
,	NULL
especially	NULL
in	NULL
chronic	NULL
inflammatory-type	NULL
conditions	NULL
.	NULL

1999	NULL
,	NULL
162	NULL
:	NULL
4806-4816.	NULL
onocytes	NULL
are	NULL
vital	NULL
effector	NULL
cells	NULL
responsible	NULL
for	NULL
proM	NULL
tecting	NULL
the	NULL
body	NULL
from	NULL
infections	NULL
and	NULL
tumors	NULL
through	NULL
their	NULL
release	NULL
of	NULL
soluble	NULL
factors	NULL
or	NULL
cytokines	NULL
,	NULL
direct	NULL
action	NULL
toward	NULL
invaders	NULL
or	NULL
aberrant	NULL
cells	NULL
,	NULL
and	NULL
interaction	NULL
with	NULL
T	NULL
lymphocytes	NULL
(	NULL
1	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
many	NULL
disease	NULL
states	NULL
these	NULL
cells	NULL
are	NULL
dys-regulated	NULL
or	NULL
are	NULL
the	NULL
target	NULL
of	NULL
invading	NULL
pathogens	NULL
,	NULL
resulting	NULL
in	NULL
an	NULL
aberrant	NULL
immune	NULL
response	NULL
(	NULL
2-5	NULL
)	NULL
.	NULL

Of	NULL
particular	NULL
interest	NULL
to	NULL
our	NULL
laboratory	NULL
is	NULL
the	NULL
common	NULL
theme	NULL
that	NULL
viruses	NULL
often	NULL
target	NULL
these	NULL
cells	NULL
during	NULL
viral	NULL
infection	NULL
.	NULL

HIV	NULL
and	NULL
human	NULL
CMV	NULL
(	NULL
HCMV	NULL
)	NULL
are	NULL
two	NULL
examples	NULL
of	NULL
viruses	NULL
that	NULL
target	NULL
these	NULL
cells	NULL
.	NULL

During	NULL
HCMV	NULL
infection	NULL
,	NULL
for	NULL
instance	NULL
,	NULL
monocytes	NULL
are	NULL
one	NULL
of	NULL
the	NULL
primary	NULL
targets	NULL
in	NULL
vivo	NULL
(	NULL
4	NULL
,	NULL
6-11	NULL
)	NULL
.	NULL

Understanding	NULL
the	NULL
results	NULL
of	NULL
this	NULL
infection	NULL
is	NULL
important	NULL
because	NULL
1	NULL
)	NULL
monocytes	NULL
appear	NULL
to	NULL
be	NULL
a	NULL
site	NULL
of	NULL
latency	NULL
or	NULL
persistent	NULL
infection	NULL
for	NULL
HCMV	NULL
(	NULL
7	NULL
,	NULL
8	NULL
,	NULL
11-13	NULL
)	NULL
;	NULL
2	NULL
)	NULL
they	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
dissemination	NULL
of	NULL
the	NULL
virus	NULL
throughout	NULL
the	NULL
body	NULL
(	NULL
4	NULL
,	NULL
7	NULL
,	NULL
10	NULL
,	NULL
12	NULL
)	NULL
;	NULL
and	NULL
3	NULL
)	NULL
their	NULL
infection	NULL
has	NULL
been	NULL
hypothesized	NULL
to	NULL
be	NULL
important	NULL
in	NULL
the	NULL
manifestation	NULL
of	NULL
many	NULL
HCMV-associated	NULL
diseases	NULL
(	NULL
2	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
14-	NULL
*Lineberger	NULL
Comprehensive	NULL
Cancer	NULL
Center	NULL
,	NULL
*Department	NULL
of	NULL
Medicine	NULL
,	NULL
*Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
and	NULL
``	NULL
Curriculum	NULL
in	NULL
Genetics	NULL
and	NULL
Molecular	NULL
Bi-ology	NULL
,	NULL
University	NULL
of	NULL
North	NULL
Carolina	NULL
,	NULL
Chapel	NULL
Hill	NULL
,	NULL
NC	NULL
27599	NULL
Received	NULL
for	NULL
publication	NULL
September	NULL
24	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
January	NULL
19	NULL
,	NULL
1999	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Grants	NULL
Al-12717	NULL
and	NULL
CA-10914	NULL
(	NULL
E.S.H	NULL
.	NULL
)	NULL

from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
.	NULL

A.D.Y	NULL
.	NULL

is	NULL
a	NULL
Hulda	NULL
Irene	NULL
Duggan	NULL
Arthritis	NULL
Investigator	NULL
(	NULL
AF	NULL
5-40974	NULL
)	NULL
.	NULL

2	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Andrew	NULL
D.	NULL
Yurochko	NULL
,	NULL
Rm	NULL
.	NULL

32-026	NULL
Lineberger	NULL
Comprehensive	NULL
Cancer	NULL
Center	NULL
,	NULL
University	NULL
of	NULL
North	NULL
Carolina	NULL
,	NULL
CB	NULL
7295	NULL
,	NULL
Chapel	NULL
Hill	NULL
,	NULL
NC	NULL
27599-7295	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
yurochko	NULL
@	NULL
med.unc.edu	NULL
3	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
HCMV	NULL
,	NULL
human	NULL
CMV	NULL
;	NULL
IE	NULL
,	NULL
immediate-early	NULL
;	NULL
MIEP	NULL
,	NULL
major	NULL
immediate-early	NULL
promoter	NULL
;	NULL
MAPK	NULL
,	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
;	NULL
M.O.L	NULL
,	NULL
multiplicity	NULL
of	NULL
infection	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
NAD	NULL
,	NULL
nonad-herent	NULL
;	NULL
ADH	NULL
,	NULL
adherent	NULL
;	NULL
ald	NULL
,	NULL
anti-idiotypic	NULL
;	NULL
PSA	NULL
,	NULL
prostate-specific	NULL
Ag	NULL
;	NULL
aPSA	NULL
,	NULL
anti-prostate-specific	NULL
Ag	NULL
;	NULL
ATF	NULL
,	NULL
activation	NULL
transcription	NULL
factor	NULL
;	NULL
CREB	NULL
,	NULL
cAMP-response-element-binding	NULL
protein	NULL
;	NULL
TO	NULL
'	NULL
,	NULL
time	NULL
zero	NULL
.	NULL

Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
16	NULL
)	NULL
.	NULL

Previously	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
HCMV	NULL
infection	NULL
of	NULL
adherent	NULL
monocytes	NULL
caused	NULL
a	NULL
sustained	NULL
expression	NULL
of	NULL
IL-1B	NULL
message	NULL
and	NULL
intracellular	NULL
protein	NULL
levels	NULL
(	NULL
6	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
using	NULL
monocytes	NULL
or	NULL
monocytic	NULL
cell	NULL
lines	NULL
that	NULL
HCMV	NULL
infection	NULL
or	NULL
its	NULL
immediate-early	NULL
(	NULL
IE	NULL
)	NULL
gene	NULL
products	NULL
can	NULL
stimulate	NULL
the	NULL
expression	NULL
of	NULL
various	NULL
monocyte-mediator	NULL
gene	NULL
products	NULL
and	NULL
transactivate	NULL
the	NULL
promoters	NULL
of	NULL
these	NULL
genes	NULL
(	NULL
6	NULL
,	NULL
16-22	NULL
)	NULL
.	NULL

These	NULL
results	NULL
taken	NULL
together	NULL
suggest	NULL
that	NULL
HCMV	NULL
infection	NULL
of	NULL
monocytes	NULL
could	NULL
be	NULL
associated	NULL
with	NULL
the	NULL
immune	NULL
dysregulation	NULL
seen	NULL
in	NULL
HCMV	NULL
-infected	NULL
individuals	NULL
,	NULL
whether	NULL
it	NULL
be	NULL
immunosuppression	NULL
(	NULL
4	NULL
,	NULL
23-25	NULL
)	NULL
or	NULL
hyperactivation	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
(	NULL
2	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
16	NULL
,	NULL
19	NULL
,	NULL
24	NULL
)	NULL
.	NULL

Previously	NULL
,	NULL
we	NULL
hypothesized	NULL
that	NULL
the	NULL
hallmark	NULL
of	NULL
HCMV	NULL
infec-tion-the	NULL
induction	NULL
and	NULL
dysregulation	NULL
of	NULL
the	NULL
tightly	NULL
regulated	NULL
cellular	NULL
transcription	NULL
factor	NULL
system	NULL
(	NULL
4	NULL
,	NULL
26-32	NULL
)	NULL
-was	NULL
responsible	NULL
for	NULL
the	NULL
wide	NULL
range	NULL
of	NULL
clinical	NULL
symptoms	NULL
and	NULL
viral	NULL
pathogenesis	NULL
observed	NULL
in	NULL
HCMV	NULL
-infected	NULL
individuals	NULL
(	NULL
4	NULL
,	NULL
14	NULL
,	NULL
32	NULL
)	NULL
.	NULL

We	NULL
and	NULL
others	NULL
have	NULL
demonstrated	NULL
that	NULL
infection	NULL
results	NULL
in	NULL
the	NULL
rapid	NULL
mobilization	NULL
of	NULL
NF-KB	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
increases	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
,	NULL
p105/p50	NULL
and	NULL
p65	NULL
,	NULL
in	NULL
human	NULL
fibroblasts	NULL
(	NULL
27	NULL
,	NULL
29	NULL
,	NULL
32	NULL
,	NULL
33	NULL
)	NULL
and	NULL
that	NULL
these	NULL
changes	NULL
were	NULL
mediated	NULL
initially	NULL
by	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
major	NULL
HCMV	NULL
envelope	NULL
glycoproteins	NULL
,	NULL
gB	NULL
(	NULL
UL55	NULL
)	NULL
and	NULL
gH	NULL
(	NULL
UL75	NULL
)	NULL
,	NULL
to	NULL
their	NULL
cognate	NULL
cellular	NULL
receptors	NULL
(	NULL
32	NULL
)	NULL
.	NULL

This	NULL
initial	NULL
cellular	NULL
activation	NULL
occurred	NULL
in	NULL
a	NULL
protein	NULL
synthesis-independent	NULL
manner	NULL
(	NULL
27	NULL
,	NULL
29	NULL
,	NULL
32	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
beginning	NULL
at	NULL
early	NULL
times	NULL
after	NULL
infection	NULL
the	NULL
promoters	NULL
for	NULL
p105/p50	NULL
and	NULL
p65	NULL
were	NULL
transactivated	NULL
in	NULL
a	NULL
protein	NULL
synthesis-dependent	NULL
manner	NULL
and	NULL
that	NULL
the	NULL
major	NULL
viral	NULL
IE	NULL
gene	NULL
products	NULL
along	NULL
with	NULL
the	NULL
induced	NULL
cellular	NULL
factors	NULL
(	NULL
such	NULL
as	NULL
Sp1	NULL
)	NULL
played	NULL
a	NULL
role	NULL
in	NULL
this	NULL
transactivation	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
the	NULL
induction	NULL
of	NULL
these	NULL
host	NULL
cell	NULL
factors	NULL
for	NULL
the	NULL
virus	NULL
stems	NULL
from	NULL
their	NULL
critical	NULL
role	NULL
during	NULL
infection	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
major	NULL
IE	NULL
promoter	NULL
(	NULL
MIEP	NULL
)	NULL
,	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
IE	NULL
genes	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
regulation	NULL
of	NULL
vital	NULL
cellular	NULL
genes	NULL
,	NULL
and	NULL
,	NULL
con-sequently	NULL
,	NULL
the	NULL
entire	NULL
gene	NULL
cascade	NULL
(	NULL
26	NULL
,	NULL
27	NULL
,	NULL
30	NULL
,	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

Specifically	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
binds	NULL
to	NULL
and	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
transactivation	NULL
of	NULL
the	NULL
MIEP	NULL
(	NULL
30	NULL
,	NULL
35	NULL
)	NULL
.	NULL

The	NULL
essential	NULL
role	NULL
for	NULL
NF-KB	NULL
in	NULL
the	NULL
viral	NULL
life	NULL
cycle	NULL
is	NULL
0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
further	NULL
underscored	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
,	NULL
to	NULL
date	NULL
,	NULL
no	NULL
other	NULL
documented	NULL
stimulus	NULL
induces	NULL
the	NULL
normally	NULL
constitutively	NULL
expressed	NULL
p65	NULL
gene	NULL
product	NULL
(	NULL
27	NULL
,	NULL
33	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
up-regulation	NULL
of	NULL
the	NULL
viral	NULL
life	NULL
cycle	NULL
,	NULL
these	NULL
documented	NULL
viral-mediated	NULL
changes	NULL
in	NULL
cellular	NULL
factors	NULL
would	NULL
have	NULL
profound	NULL
effects	NULL
on	NULL
the	NULL
infected	NULL
host	NULL
,	NULL
because	NULL
the	NULL
induced	NULL
transcription	NULL
factors	NULL
would	NULL
up-regulate	NULL
a	NULL
wide	NULL
array	NULL
of	NULL
important	NULL
cellular	NULL
genes	NULL
(	NULL
not	NULL
only	NULL
the	NULL
ones	NULL
needed	NULL
by	NULL
the	NULL
virus	NULL
)	NULL
.	NULL

This	NULL
might	NULL
be	NULL
particularly	NULL
important	NULL
during	NULL
infection	NULL
of	NULL
nonpermissive	NULL
cells	NULL
,	NULL
such	NULL
as	NULL
monocytes	NULL
where	NULL
all	NULL
cells	NULL
can	NULL
be	NULL
infected	NULL
(	NULL
9	NULL
)	NULL
,	NULL
but	NULL
where	NULL
viral	NULL
gene	NULL
expression	NULL
is	NULL
usually	NULL
limited	NULL
to	NULL
only	NULL
the	NULL
IE	NULL
genes	NULL
(	NULL
10	NULL
,	NULL
12	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
importance	NULL
of	NULL
understanding	NULL
the	NULL
up-regulation	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
and	NULL
their	NULL
ultimate	NULL
downstream	NULL
targets	NULL
not	NULL
only	NULL
would	NULL
reveal	NULL
the	NULL
overall	NULL
regulation	NULL
of	NULL
the	NULL
viral	NULL
life	NULL
cycle	NULL
,	NULL
but	NULL
also	NULL
their	NULL
potential	NULL
role	NULL
in	NULL
viral	NULL
pathogenicity	NULL
.	NULL

As	NULL
mentioned	NULL
,	NULL
we	NULL
hypothesized	NULL
that	NULL
the	NULL
induction	NULL
of	NULL
host	NULL
cell	NULL
factors	NULL
may	NULL
be	NULL
central	NULL
to	NULL
disease	NULL
progression	NULL
in	NULL
HCMV	NULL
individuals	NULL
,	NULL
and	NULL
that	NULL
this	NULL
would	NULL
be	NULL
especially	NULL
true	NULL
of	NULL
immune	NULL
cells	NULL
.	NULL

Therefore	NULL
,	NULL
in	NULL
our	NULL
next	NULL
line	NULL
of	NULL
study	NULL
we	NULL
wanted	NULL
to	NULL
determine	NULL
the	NULL
effect	NULL
of	NULL
viral	NULL
infection	NULL
on	NULL
monocytes	NULL
because	NULL
of	NULL
the	NULL
physiological	NULL
role	NULL
infection	NULL
of	NULL
these	NULL
cells	NULL
plays	NULL
in	NULL
HCMV-associated	NULL
diseases	NULL
(	NULL
4	NULL
,	NULL
6	NULL
,	NULL
14	NULL
)	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
we	NULL
wanted	NULL
to	NULL
address	NULL
the	NULL
regulation	NULL
of	NULL
monocyte	NULL
activation	NULL
following	NULL
viral	NULL
binding	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
chose	NULL
to	NULL
examine	NULL
the	NULL
possibility	NULL
that	NULL
viral	NULL
binding	NULL
to	NULL
these	NULL
cells	NULL
through	NULL
the	NULL
major	NULL
HCMV	NULL
glycoproteins	NULL
,	NULL
gB	NULL
and	NULL
gH	NULL
,	NULL
could	NULL
up-regulate	NULL
the	NULL
activity	NULL
of	NULL
these	NULL
cells	NULL
,	NULL
a	NULL
scenario	NULL
that	NULL
could	NULL
be	NULL
envisioned	NULL
to	NULL
occur	NULL
in	NULL
vivo	NULL
during	NULL
cases	NULL
of	NULL
active	NULL
HCMV	NULL
viremia	NULL
or	NULL
perhaps	NULL
in	NULL
a	NULL
localized	NULL
environment	NULL
in	NULL
a	NULL
persistently	NULL
infected	NULL
individual	NULL
.	NULL

This	NULL
possibility	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
studies	NULL
that	NULL
show	NULL
that	NULL
the	NULL
IE	NULL
events	NULL
that	NULL
take	NULL
place	NULL
following	NULL
HCMV	NULL
infection	NULL
including	NULL
Ca**	NULL
flux	NULL
,	NULL
phospho-lipid	NULL
turnover	NULL
,	NULL
induction	NULL
of	NULL
second	NULL
messengers	NULL
,	NULL
up-regulation	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
and	NULL
induction	NULL
of	NULL
the	NULL
protooncogenes	NULL
are	NULL
similar	NULL
to	NULL
the	NULL
events	NULL
that	NULL
occur	NULL
during	NULL
known	NULL
receptor/ligand	NULL
interactions	NULL
(	NULL
27-29	NULL
,	NULL
32	NULL
,	NULL
36-38	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
that	NULL
HCMV	NULL
binding	NULL
up-regulates	NULL
the	NULL
steady-state	NULL
message	NULL
levels	NULL
of	NULL
a	NULL
number	NULL
of	NULL
important	NULL
monocyte	NULL
mediator	NULL
genes	NULL
(	NULL
IL-1	NULL
,	NULL
A20	NULL
,	NULL
NF-	NULL
«	NULL
B-p105/p50	NULL
,	NULL
and	NULL
IxBa	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
show	NULL
that	NULL
viral	NULL
binding	NULL
activates	NULL
the	NULL
monocyte	NULL
because	NULL
neutralizing	NULL
Abs	NULL
block	NULL
viral-mediated	NULL
message	NULL
induction	NULL
,	NULL
and	NULL
,	NULL
more	NULL
importantly	NULL
,	NULL
purified	NULL
viral	NULL
glycoprotein	NULL
ligands	NULL
(	NULL
gB	NULL
and	NULL
gH	NULL
)	NULL
also	NULL
increase	NULL
monocyte	NULL
mediator	NULL
mRNA	NULL
.	NULL

We	NULL
also	NULL
show	NULL
that	NULL
the	NULL
increase	NULL
in	NULL
cytokine	NULL
message	NULL
expression	NULL
correlates	NULL
with	NULL
an	NULL
increase	NULL
in	NULL
cytokine	NULL
secretion	NULL
.	NULL

We	NULL
went	NULL
on	NULL
to	NULL
investigate	NULL
the	NULL
signaling	NULL
cascade	NULL
and	NULL
demonstrated	NULL
that	NULL
this	NULL
transcriptional	NULL
up-regulation	NULL
is	NULL
probably	NULL
due	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
cellular	NULL
transcription	NULL
factors	NULL
as	NULL
viral	NULL
binding	NULL
also	NULL
induces	NULL
the	NULL
nuclear	NULL
mobilization	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
which	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
up-regulate	NULL
many	NULL
of	NULL
these	NULL
induced	NULL
monocyte-mediator	NULL
genes	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Lastly	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
p38	NULL
,	NULL
a	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
MAPK	NULL
)	NULL
family	NULL
member	NULL
(	NULL
40	NULL
)	NULL
,	NULL
is	NULL
activated	NULL
by	NULL
viral	NULL
binding	NULL
and	NULL
is	NULL
an	NULL
important	NULL
player	NULL
in	NULL
viral-mediated	NULL
IL-1B	NULL
message	NULL
expression	NULL
.	NULL

This	NULL
viral	NULL
binding-mediated	NULL
p38	NULL
induction	NULL
appears	NULL
to	NULL
be	NULL
unique	NULL
to	NULL
monocytes	NULL
,	NULL
as	NULL
our	NULL
concomitant	NULL
study	NULL
in	NULL
fibroblasts	NULL
showed	NULL
no	NULL
induction	NULL
of	NULL
p38	NULL
at	NULL
IE	NULL
times	NULL
postinfection	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
studies	NULL
support	NULL
our	NULL
hypothesis	NULL
that	NULL
viral	NULL
binding	NULL
through	NULL
at	NULL
least	NULL
the	NULL
gB	NULL
and	NULL
gH	NULL
glycoproteins	NULL
is	NULL
a	NULL
bona	NULL
fide	NULL
mechanism	NULL
used	NULL
by	NULL
the	NULL
virus	NULL
to	NULL
activate	NULL
monocytes	NULL
.	NULL

Furthermore	NULL
,	NULL
a	NULL
distinct	NULL
HCMV-induced	NULL
pathobiology	NULL
could	NULL
be	NULL
mediated	NULL
at	NULL
least	NULL
in	NULL
part	NULL
by	NULL
this	NULL
interaction	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Monocyte	NULL
isolation	NULL
Fresh	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
from	NULL
random	NULL
donors	NULL
were	NULL
purified	NULL
by	NULL
double	NULL
density	NULL
gradient	NULL
centrifugation	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
42	NULL
)	NULL
.	NULL

The	NULL
donors	NULL
used	NULL
were	NULL
HCMV	NULL
seronegative	NULL
as	NULL
determined	NULL
by	NULL
ELISA	NULL
;	NULL
although	NULL
4807	NULL
under	NULL
our	NULL
conditions	NULL
tested	NULL
,	NULL
the	NULL
HCMV	NULL
status	NULL
of	NULL
the	NULL
donor	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
parameters	NULL
we	NULL
measured	NULL
.	NULL

Briefly	NULL
,	NULL
whole	NULL
blood	NULL
was	NULL
collected	NULL
by	NULL
veni-puncture	NULL
,	NULL
diluted	NULL
in	NULL
RPMI	NULL
1640	NULL
,	NULL
and	NULL
the	NULL
mononuclear	NULL
cells	NULL
separated	NULL
from	NULL
the	NULL
RBCs	NULL
and	NULL
neutrophils	NULL
by	NULL
centrifugation	NULL
through	NULL
a	NULL
Ficoll	NULL
Histopaque	NULL
1077	NULL
(	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
gradient	NULL
.	NULL

The	NULL
monocytes	NULL
were	NULL
then	NULL
repeatedly	NULL
washed	NULL
with	NULL
ice-cold	NULL
isotonic	NULL
saline	NULL
to	NULL
remove	NULL
platelets	NULL
.	NULL

Monocytes	NULL
were	NULL
further	NULL
purified	NULL
from	NULL
the	NULL
contaminating	NULL
lymphocytes	NULL
by	NULL
centrifugation	NULL
through	NULL
a	NULL
Percoll	NULL
(	NULL
Pharmacia	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
gradient	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
counted	NULL
and	NULL
treated	NULL
as	NULL
described	NULL
in	NULL
the	NULL
experimental	NULL
results	NULL
section	NULL
.	NULL

HCMV	NULL
infection	NULL
Methods	NULL
for	NULL
the	NULL
culturing	NULL
of	NULL
our	NULL
HCMV	NULL
Towne	NULL
strain	NULL
(	NULL
passage	NULL
43-44	NULL
)	NULL
in	NULL
human	NULL
fibroblasts	NULL
have	NULL
been	NULL
described	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Monocytes	NULL
were	NULL
infected	NULL
with	NULL
only	NULL
gradient-purified	NULL
virus	NULL
at	NULL
a	NULL
multiplicity	NULL
of	NULL
infection	NULL
(	NULL
M.O.1	NULL
.	NULL
)	NULL

of	NULL
2-3	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
in	NULL
1	NULL
%	NULL
human	NULL
serum	NULL
in	NULL
endotoxin-free	NULL
RPMI	NULL
1640	NULL
in	NULL
6	NULL
%	NULL
CO	NULL
,	NULL
incubators	NULL
for	NULL
the	NULL
lengths	NULL
of	NULL
time	NULL
described	NULL
.	NULL

HCMV	NULL
was	NULL
gradient	NULL
purified	NULL
and	NULL
used	NULL
to	NULL
infect	NULL
cells	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
32	NULL
)	NULL
.	NULL

UV-inactivated	NULL
virus	NULL
was	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
and	NULL
was	NULL
used	NULL
in	NULL
the	NULL
same	NULL
manner	NULL
as	NULL
``	NULL
live	NULL
``	NULL
virus	NULL
.	NULL

The	NULL
UV-inactivated	NULL
virus	NULL
did	NULL
not	NULL
replicate	NULL
or	NULL
produce	NULL
any	NULL
detectable	NULL
levels	NULL
of	NULL
IE	NULL
gene	NULL
products	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

For	NULL
the	NULL
studies	NULL
in	NULL
which	NULL
inhibitors	NULL
of	NULL
the	NULL
various	NULL
kinases	NULL
were	NULL
used	NULL
,	NULL
monocytes	NULL
were	NULL
pretreated	NULL
for	NULL
1	NULL
h	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
virus	NULL
.	NULL

The	NULL
inhibitors	NULL
used	NULL
were	NULL
$	NULL
B203580	NULL
(	NULL
Calbiochem	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
which	NULL
has	NULL
been	NULL
previously	NULL
shown	NULL
to	NULL
inhibit	NULL
p38	NULL
activation	NULL
(	NULL
40	NULL
)	NULL
and	NULL
to	NULL
block	NULL
HCMV	NULL
(	NULL
41	NULL
)	NULL
and	NULL
HIV	NULL
(	NULL
43	NULL
)	NULL
replication	NULL
,	NULL
and	NULL
PD98059	NULL
(	NULL
Calbiochem	NULL
)	NULL
,	NULL
which	NULL
has	NULL
been	NULL
previously	NULL
shown	NULL
to	NULL
inhibit	NULL
MAP	NULL
kinase	NULL
kinase	NULL
(	NULL
MEK	NULL
)	NULL
activity	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Abs	NULL
and	NULL
cellular	NULL
activation	NULL
We	NULL
used	NULL
the	NULL
same	NULL
protocol	NULL
for	NULL
the	NULL
use	NULL
of	NULL
the	NULL
various	NULL
Abs	NULL
or	NULL
purified	NULL
ligands	NULL
in	NULL
this	NULL
manuscript	NULL
as	NULL
we	NULL
previously	NULL
described	NULL
(	NULL
32	NULL
)	NULL
.	NULL

For	NULL
the	NULL
various	NULL
experiments	NULL
involving	NULL
neutralizing	NULL
Abs	NULL
,	NULL
virus	NULL
(	NULL
gradient-purified	NULL
``	NULL
live	NULL
``	NULL
or	NULL
UV-irradiated	NULL
virus	NULL
)	NULL
was	NULL
preincubated	NULL
with	NULL
a	NULL
protein	NULL
G	NULL
affinity-purified	NULL
murine	NULL
monoclonal	NULL
anti-gB	NULL
(	NULL
4	NULL
ug	NULL
of	NULL
15D8	NULL
(	NULL
45	NULL
)	NULL
of	NULL
the	NULL
IgG	NULL
;	NULL
,	NULL
isotype	NULL
)	NULL
and	NULL
anti-gH	NULL
Ab	NULL
(	NULL
4	NULL
ug	NULL
of	NULL
1G6	NULL
(	NULL
46	NULL
)	NULL
of	NULL
the	NULL
IgG	NULL
;	NULL
,	NULL
isotype	NULL
)	NULL
or	NULL
a	NULL
protein	NULL
G	NULL
affinity-purified	NULL
murine	NULL
monoclonal	NULL
control	NULL
Ab	NULL
(	NULL
4	NULL
pug	NULL
of	NULL
an	NULL
anti-human	NULL
prostate-specific	NULL
Ag	NULL
(	NULL
PSA	NULL
)	NULL
Ab	NULL
(	NULL
anti-PSA	NULL
or	NULL
aPSA	NULL
(	NULL
of	NULL
the	NULL
IgG	NULL
;	NULL
,	NULL
isotype	NULL
)	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
15D8	NULL
and	NULL
1G6	NULL
Abs	NULL
were	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
Dr.	NULL
L.	NULL
Rasmussen	NULL
(	NULL
Division	NULL
of	NULL
Infectious	NULL
Diseases	NULL
,	NULL
Stanford	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Stan-ford	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

For	NULL
neutralization	NULL
with	NULL
the	NULL
1G6	NULL
monoclonal	NULL
Ab	NULL
,	NULL
2	NULL
%	NULL
guinea	NULL
pig	NULL
complement	NULL
(	NULL
Accurate	NULL
Scientific	NULL
,	NULL
Westbury	NULL
,	NULL
NY	NULL
)	NULL
was	NULL
also	NULL
added	NULL
.	NULL

Complement	NULL
alone	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
monocytes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
neutralizing	NULL
Abs	NULL
used	NULL
in	NULL
the	NULL
experiments	NULL
prevented	NULL
viral-mediated	NULL
cytopathic	NULL
effects	NULL
and	NULL
viral	NULL
gene	NULL
expression	NULL
in	NULL
fibroblasts	NULL
as	NULL
confirmed	NULL
by	NULL
side-by-side	NULL
experiments	NULL
in	NULL
which	NULL
these	NULL
variables	NULL
were	NULL
assessed	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
purified	NULL
viral	NULL
gB	NULL
(	NULL
1	NULL
,	NULL
20	NULL
,	NULL
and	NULL
100	NULL
ng/ml	NULL
(	NULL
32	NULL
)	NULL
)	NULL
or	NULL
purified	NULL
viral	NULL
gB	NULL
blocked	NULL
with	NULL
Abs	NULL
(	NULL
4	NULL
ug	NULL
of	NULL
15D8	NULL
or	NULL
the	NULL
control	NULL
Ab	NULL
)	NULL
were	NULL
used	NULL
in	NULL
some	NULL
studies	NULL
to	NULL
stimulate	NULL
cells	NULL
.	NULL

In	NULL
other	NULL
studies	NULL
,	NULL
15	NULL
pug	NULL
of	NULL
the	NULL
4-3-5	NULL
affinity	NULL
,	NULL
purified	NULL
murine	NULL
anti-idiotypic	NULL
(	NULL
«	NULL
ld	NULL
)	NULL
IgM	NULL
Ab	NULL
(	NULL
47	NULL
,	NULL
48	NULL
)	NULL
,	NULL
which	NULL
mimics	NULL
the	NULL
HCMV	NULL
viral	NULL
gH	NULL
glycoprotein	NULL
and	NULL
is	NULL
thus	NULL
specific	NULL
for	NULL
the	NULL
92.5-kDa	NULL
cellular	NULL
gH	NULL
receptor	NULL
(	NULL
49	NULL
)	NULL
,	NULL
or	NULL
15	NULL
ug	NULL
of	NULL
an	NULL
IgM	NULL
control	NULL
Ab	NULL
(	NULL
affinity-purified	NULL
mouse	NULL
IgM	NULL
(	NULL
Southern	NULL
Biotechnology	NULL
Associates	NULL
,	NULL
Birmingham	NULL
,	NULL
AL	NULL
)	NULL
)	NULL
plus	NULL
3	NULL
ug	NULL
of	NULL
an	NULL
appropriate	NULL
cross-linking	NULL
Ab	NULL
(	NULL
goat	NULL
anti-mouse	NULL
IgM	NULL
Ab	NULL
(	NULL
Southern	NULL
Biotechnology	NULL
Associates	NULL
)	NULL
)	NULL
was	NULL
used	NULL
to	NULL
stimulate	NULL
cells	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
32	NULL
,	NULL
38	NULL
,	NULL
50	NULL
)	NULL
.	NULL

The	NULL
4-3-5	NULL
Ab	NULL
and	NULL
the	NULL
appropriate	NULL
control	NULL
anti-serum	NULL
were	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
Dr.	NULL
S.	NULL
Keay	NULL
(	NULL
Research	NULL
Services	NULL
,	NULL
The	NULL
Department	NULL
of	NULL
Veteran	NULL
Affairs	NULL
Medical	NULL
Center	NULL
,	NULL
University	NULL
of	NULL
Maryland	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Baltimore	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
of	NULL
cellular	NULL
stimulation	NULL
(	NULL
purified	NULL
virus	NULL
,	NULL
purified	NULL
gB	NULL
,	NULL
ald	NULL
Ab	NULL
,	NULL
or	NULL
the	NULL
various	NULL
control	NULL
products	NULL
)	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
treated	NULL
the	NULL
same	NULL
(	NULL
washed	NULL
identically	NULL
,	NULL
incubated	NULL
in	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
product	NULL
and	NULL
media	NULL
,	NULL
incubated	NULL
for	NULL
the	NULL
same	NULL
length	NULL
of	NULL
time	NULL
,	NULL
and	NULL
harvested	NULL
in	NULL
the	NULL
same	NULL
manner	NULL
)	NULL
to	NULL
allow	NULL
for	NULL
comparisons	NULL
between	NULL
groups	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
,	NULL
samples	NULL
labeled	NULL
``	NULL
Mock	NULL
``	NULL
were	NULL
treated	NULL
in	NULL
a	NULL
similar	NULL
manner	NULL
to	NULL
the	NULL
test	NULL
samples	NULL
(	NULL
except	NULL
no	NULL
virus	NULL
,	NULL
purified	NULL
viral	NULL
ligands	NULL
,	NULL
etc	NULL
.	NULL

were	NULL
added	NULL
)	NULL
,	NULL
and	NULL
they	NULL
were	NULL
incubated	NULL
for	NULL
the	NULL
length	NULL
of	NULL
the	NULL
stated	NULL
experiment	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
in	NULL
some	NULL
experiments	NULL
monocytes	NULL
were	NULL
treated	NULL
with	NULL
10	NULL
ng/ml	NULL
of	NULL
PMA	NULL
or	NULL
1	NULL
pg/ml	NULL
LPS	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
(	NULL
42	NULL
,	NULL
51	NULL
)	NULL
.	NULL

All	NULL
experiments	NULL
were	NULL
repeated	NULL
.	NULL

RNA	NULL
isolation	NULL
and	NULL
Northern	NULL
blot	NULL
analysis	NULL
Total	NULL
cellular	NULL
RNA	NULL
was	NULL
collected	NULL
in	NULL
guanidinium	NULL
isothiocyanate	NULL
and	NULL
isolated	NULL
by	NULL
cesium	NULL
chloride	NULL
centrifugation	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Then	NULL
,	NULL
5	NULL
pg	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
was	NULL
electrophoresed	NULL
on	NULL
a	NULL
1	NULL
%	NULL
denaturing	NULL
formaldehyde	NULL
agarose	NULL
gel	NULL
and	NULL
transferred	NULL
overnight	NULL
to	NULL
nitrocellulose	NULL
(	NULL
Immobilon-NC	NULL
;	NULL
Millipore	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
specific	NULL
messages	NULL
were	NULL
detected	NULL
by	NULL
Northern	NULL
blot	NULL
hybridization	NULL
.	NULL

RNA	NULL
levels	NULL
were	NULL
equivalent	NULL
based	NULL
on	NULL
188	NULL
and	NULL
28S	NULL
rRNA	NULL
levels	NULL
.	NULL

All	NULL
data	NULL
presented	NULL
in	NULL
this	NULL
manuscript	NULL
are	NULL
from	NULL
multiple	NULL
probes	NULL
of	NULL
the	NULL
same	NULL
blot	NULL
;	NULL
however	NULL
,	NULL
all	NULL
experiments	NULL
were	NULL
repeated	NULL
two	NULL
to	NULL
five	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
4808	NULL
times	NULL
.	NULL

Nitrocellulose	NULL
blots	NULL
were	NULL
probed	NULL
with	NULL
nick-translated	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
*°P-labeled	NULL
cDNA	NULL
sequences	NULL
specific	NULL
for	NULL
p105/p50	NULL
(	NULL
52	NULL
)	NULL
,	NULL
p65	NULL
(	NULL
53	NULL
)	NULL
,	NULL
I	NULL
«	NULL
Ba	NULL
(	NULL
54	NULL
)	NULL
,	NULL
IL-1	NULL
(	NULL
42	NULL
)	NULL
,	NULL
and	NULL
A20	NULL
(	NULL
42	NULL
)	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
hybridized	NULL
overnight	NULL
in	NULL
a	NULL
50	NULL
%	NULL
formamide	NULL
solution	NULL
at	NULL
42°C	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
then	NULL
washed	NULL
to	NULL
a	NULL
stringency	NULL
of	NULL
0.2	NULL
%	NULL
SSC	NULL
at	NULL
56°C	NULL
and	NULL
developed	NULL
for	NULL
1-6	NULL
days	NULL
with	NULL
intensifier	NULL
screens	NULL
at	NULL
-70°C	NULL
.	NULL

ELISA	NULL
Monocyte	NULL
supernatant	NULL
was	NULL
harvested	NULL
following	NULL
the	NULL
treatment	NULL
of	NULL
cells	NULL
as	NULL
stated	NULL
in	NULL
the	NULL
results	NULL
section	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
centrifuged	NULL
three	NULL
times	NULL
to	NULL
remove	NULL
any	NULL
cellular	NULL
debris	NULL
and	NULL
then	NULL
frozen	NULL
at	NULL
-70°C	NULL
until	NULL
needed	NULL
.	NULL

The	NULL
ELISA	NULL
was	NULL
then	NULL
performed	NULL
using	NULL
the	NULL
manufacturers	NULL
protocol	NULL
(	NULL
Endogen	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
run	NULL
in	NULL
duplicate	NULL
along	NULL
with	NULL
the	NULL
appropriate	NULL
IL-1	NULL
standards	NULL
.	NULL

Experiments	NULL
were	NULL
repeated	NULL
and	NULL
the	NULL
data	NULL
shown	NULL
is	NULL
from	NULL
representative	NULL
experiments	NULL
.	NULL

Cytoplasmic	NULL
and	NULL
nuclear	NULL
extract	NULL
isolation	NULL
Isolation	NULL
of	NULL
nuclear	NULL
extracts	NULL
have	NULL
been	NULL
described	NULL
elsewhere	NULL
(	NULL
27	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
collected	NULL
cell	NULL
pellets	NULL
were	NULL
incubated	NULL
for	NULL
4	NULL
min	NULL
on	NULL
ice	NULL
with	NULL
a	NULL
cytoplasmic	NULL
isolation	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
60	NULL
mM	NULL
KCI	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
PMSF	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
phenanthroline	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
250	NULL
M	NULL
dichloroisocoumarin	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
100	NULL
M	NULL
E-64	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
and	NULL
10	NULL
pM	NULL
pepstatin	NULL
A	NULL
(	NULL
Sigma	NULL
)	NULL
)	NULL
.	NULL

After	NULL
collection	NULL
by	NULL
cen-trifugation	NULL
,	NULL
the	NULL
nuclear	NULL
pellets	NULL
(	NULL
the	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
clarified	NULL
by	NULL
centrifugation	NULL
and	NULL
stored	NULL
at	NULL
-70°C	NULL
and	NULL
then	NULL
used	NULL
in	NULL
Western	NULL
blot	NULL
analyses	NULL
)	NULL
were	NULL
washed	NULL
in	NULL
a	NULL
cytoplasmic	NULL
isolation	NULL
buffer	NULL
without	NULL
Nonidet	NULL
P-40	NULL
,	NULL
spun	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
for	NULL
10	NULL
min	NULL
on	NULL
ice	NULL
with	NULL
a	NULL
nuclear	NULL
isolation	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
420	NULL
mM	NULL
NaCl	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
2	NULL
mM	NULL
phenanthroline	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
250	NULL
uM	NULL
dichloroisocoumarin	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
100	NULL
uM	NULL
E-64	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
and	NULL
10	NULL
M	NULL
pepstatin	NULL
A	NULL
(	NULL
Sigma	NULL
)	NULL
)	NULL
.	NULL

Supernatants	NULL
containing	NULL
the	NULL
nuclear	NULL
extracts	NULL
were	NULL
collected	NULL
and	NULL
stored	NULL
at	NULL
-70°C	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
Collected	NULL
nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
in	NULL
an	NULL
EMSA	NULL
buffer	NULL
containing	NULL
:	NULL
a	NULL
binding	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris-HCI	NULL
]	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
50	NULL
mM	NULL
NaCI	NULL
,	NULL
0.5	NULL
mM	NULL
EDTA	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
DTT	NULL
)	NULL
;	NULL
7.5	NULL
mM	NULL
MgC	NULL
)	NULL
,	NULL
;	NULL
0.1	NULL
ug	NULL
polydeoxyinosinic-deoxycytidylic	NULL
acid	NULL
(	NULL
dIdC	NULL
)	NULL
;	NULL
and	NULL
a	NULL
P-labeled	NULL
double-stranded	NULL
oligonucleotide	NULL
probe	NULL
containing	NULL
a	NULL
wild-type	NULL
MHC	NULL
class	NULL
I	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
or	NULL
a	NULL
wild-type	NULL
activation	NULL
transcription	NULL
factor	NULL
(	NULL
ATF	NULL
)	NULL
/cAMPresponse-element-binding	NULL
protein	NULL
(	NULL
CREB	NULL
)	NULL
binding	NULL
site	NULL
(	NULL
5-AGAGATTGCCTGACGTCAGAGAGCT	NULL
AG-3	NULL
'	NULL
)	NULL
for	NULL
experiments	NULL
examining	NULL
NF-KB	NULL
activity	NULL
and	NULL
ATE/CREB	NULL
activity	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
annealed	NULL
double	NULL
stranded	NULL
oligo	NULL
probes	NULL
with	NULL
``	NULL
I	NULL
``	NULL
overhangs	NULL
and	NULL
``	NULL
C	NULL
``	NULL
ends	NULL
were	NULL
labeled	NULL
by	NULL
filling	NULL
in	NULL
the	NULL
recessed	NULL
3	NULL
'	NULL
ends	NULL
of	NULL
the	NULL
oligo	NULL
with	NULL
[	NULL
a-P	NULL
]	NULL
dATP	NULL
(	NULL
ICN	NULL
,	NULL
Irvine	NULL
,	NULL
California	NULL
)	NULL
using	NULL
Klenow	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
chase	NULL
with	NULL
cold	NULL
dATP	NULL
and	NULL
dGTP	NULL
,	NULL
and	NULL
then	NULL
finally	NULL
G-25	NULL
Sephadex	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
column	NULL
purified	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
electrophoresed	NULL
on	NULL
a	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
developed	NULL
with	NULL
intensifier	NULL
screens	NULL
at	NULL
-70°C	NULL
.	NULL

Abs	NULL
were	NULL
used	NULL
to	NULL
supershift	NULL
the	NULL
specific	NULL
complexes	NULL
of	NULL
interest	NULL
by	NULL
pretreating	NULL
the	NULL
extracts	NULL
for	NULL
15	NULL
min	NULL
to	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
Ab	NULL
before	NULL
their	NULL
addition	NULL
to	NULL
the	NULL
binding	NULL
buffer	NULL
,	NULL
MgCl	NULL
,	NULL
,	NULL
dIdC	NULL
,	NULL
and	NULL
labeled	NULL
probes	NULL
.	NULL

Specific	NULL
Ab	NULL
to	NULL
p50	NULL
and	NULL
p65	NULL
,	NULL
as	NULL
well	NULL
as	NULL
preimmune	NULL
serum	NULL
,	NULL
and	NULL
their	NULL
appropriate	NULL
blocking	NULL
peptides	NULL
(	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
Dr.	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
,	NULL
Lineberger	NULL
Cancer	NULL
Center	NULL
,	NULL
University	NULL
of	NULL
North	NULL
Carolina	NULL
,	NULL
Chapel	NULL
Hill	NULL
,	NULL
NC	NULL
)	NULL
were	NULL
used	NULL
in	NULL
the	NULL
supershift	NULL
experiments	NULL
.	NULL

Preimmune	NULL
serum	NULL
and	NULL
blocking	NULL
peptides	NULL
were	NULL
used	NULL
to	NULL
show	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
super	NULL
shifts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
For	NULL
the	NULL
IxBa	NULL
and	NULL
B	NULL
Western	NULL
blot	NULL
analyses	NULL
,	NULL
cytoplasmic	NULL
proteins	NULL
were	NULL
used	NULL
and	NULL
were	NULL
harvested	NULL
as	NULL
stated	NULL
above	NULL
.	NULL

For	NULL
the	NULL
p38	NULL
Western	NULL
blot	NULL
analyses	NULL
,	NULL
whole	NULL
cell	NULL
extract	NULL
was	NULL
used	NULL
.	NULL

The	NULL
various	NULL
harvested	NULL
proteins	NULL
were	NULL
collected	NULL
and	NULL
added	NULL
to	NULL
an	NULL
SDS-PAGE	NULL
sample	NULL
buffer	NULL
,	NULL
boiled	NULL
,	NULL
and	NULL
then	NULL
stored	NULL
at	NULL
-70°C	NULL
.	NULL

Equal	NULL
protein	NULL
amounts	NULL
were	NULL
added	NULL
to	NULL
each	NULL
lane	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
run	NULL
on	NULL
a	NULL
12	NULL
%	NULL
SDS-PAGE	NULL
gel	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
(	NULL
Immo-bilon-P	NULL
;	NULL
Millipore	NULL
)	NULL
overnight	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
blocked	NULL
for	NULL
1	NULL
h	NULL
in	NULL
a	NULL
5	NULL
%	NULL
skim	NULL
milk	NULL
,	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
,	NULL
PBS	NULL
solution	NULL
for	NULL
1	NULL
h	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
the	NULL
primary	NULL
Ab	NULL
(	NULL
1:2000	NULL
dilution	NULL
of	NULL
the	NULL
anti-IxBa	NULL
and	NULL
anti-IxBB	NULL
Abs	NULL
;	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
;	NULL
or	NULL
1:1000	NULL
dilution	NULL
of	NULL
the	NULL
phospho-specific	NULL
anti-p38	NULL
MAPK	NULL
Ab	NULL
;	NULL
New	NULL
England	NULL
Biolabs	NULL
,	NULL
Beverly	NULL
,	NULL
MA	NULL
)	NULL
for	NULL
1	NULL
h	NULL
in	NULL
the	NULL
same	NULL
blocking	NULL
solution	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
washed	NULL
,	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
a	NULL
1:2500	NULL
dilution	NULL
of	NULL
goat	NULL
anti-rabbit-horseradish	NULL
peroxidase-conju-gated	NULL
secondary	NULL
Ab	NULL
in	NULL
the	NULL
same	NULL
blocking	NULL
solution	NULL
,	NULL
washed	NULL
again	NULL
,	NULL
and	NULL
finally	NULL
incubated	NULL
with	NULL
the	NULL
developing	NULL
agents	NULL
and	NULL
developed	NULL
as	NULL
per	NULL
the	NULL
en-	NULL
HCMV	NULL
ACTIVATES	NULL
MONOCYTES	NULL
ager	NULL
nab	NULL
p105/p50	NULL
-	NULL
|	NULL
.	NULL

|	NULL
pés	NULL
IkBo	NULL
FIGURE	NULL
1	NULL
.	NULL

HCMV	NULL
infection	NULL
results	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
monocyte	NULL
mediator	NULL
genes	NULL
.	NULL

A	NULL
Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
on	NULL
total	NULL
RNA	NULL
harvested	NULL
from	NULL
monocytes	NULL
treated	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
ways	NULL
.	NULL

The	NULL
experiment	NULL
was	NULL
repeated	NULL
and	NULL
a	NULL
representative	NULL
experiment	NULL
is	NULL
shown	NULL
.	NULL

All	NULL
the	NULL
blots	NULL
shown	NULL
are	NULL
from	NULL
multiple	NULL
probings	NULL
of	NULL
the	NULL
same	NULL
blot	NULL
.	NULL

Monocytes	NULL
were	NULL
treated	NULL
for	NULL
4	NULL
h	NULL
in	NULL
the	NULL
following	NULL
manner	NULL
before	NULL
harvesting	NULL
:	NULL
1	NULL
)	NULL
NAD	NULL
monocytes	NULL
were	NULL
untreated	NULL
or	NULL
mock	NULL
infected	NULL
;	NULL
2	NULL
)	NULL
and	NULL
3	NULL
)	NULL
NAD	NULL
monocytes	NULL
were	NULL
treated	NULL
with	NULL
10	NULL
ng/ml	NULL
of	NULL
PMA	NULL
or	NULL
1	NULL
pg/ml	NULL
of	NULL
LPS	NULL
;	NULL
4	NULL
)	NULL
NAD	NULL
monocytes	NULL
were	NULL
incubated	NULL
with	NULL
gradient-purified	NULL
HCMV	NULL
(	NULL
M.O.I	NULL
.	NULL

=	NULL
2-3	NULL
)	NULL
;	NULL
5	NULL
)	NULL
monocytes	NULL
were	NULL
adhered	NULL
to	NULL
tissue	NULL
culture	NULL
plastic	NULL
(	NULL
``	NULL
ADH	NULL
``	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
virus	NULL
or	NULL
other	NULL
stimuli	NULL
;	NULL
or	NULL
6	NULL
)	NULL
ADH	NULL
monocytes	NULL
were	NULL
incubated	NULL
with	NULL
gradient-purified	NULL
HCMV	NULL
(	NULL
M.O.L	NULL
.	NULL

=	NULL
2-3	NULL
)	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
probed	NULL
with	NULL
*°P-labeled	NULL
cDNA	NULL
probes	NULL
specific	NULL
for	NULL
IL-1	NULL
,	NULL
A20	NULL
,	NULL
p105/p50	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
IxBa	NULL
.	NULL

288	NULL
ribosome	NULL
levels	NULL
are	NULL
shown	NULL
as	NULL
a	NULL
control	NULL
.	NULL

hanced	NULL
chemiluminescence	NULL
protocol	NULL
(	NULL
Amersham	NULL
Life	NULL
Sciences	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
or	NULL
New	NULL
England	NULL
Biolabs	NULL
)	NULL
.	NULL

Results	NULL
HCMV	NULL
infection	NULL
and	NULL
virus	NULL
binding	NULL
up-regulate	NULL
monocyte	NULL
gene	NULL
expression	NULL
To	NULL
examine	NULL
the	NULL
role	NULL
of	NULL
HCMV	NULL
binding	NULL
and	NULL
infection	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
monocytes	NULL
,	NULL
we	NULL
initially	NULL
determined	NULL
whether	NULL
there	NULL
was	NULL
an	NULL
up-regulation	NULL
of	NULL
monocyte	NULL
mediators	NULL
following	NULL
infection	NULL
of	NULL
monocytes	NULL
with	NULL
HCMV	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
isolated	NULL
nonadherent	NULL
(	NULL
NAD	NULL
)	NULL
monocytes	NULL
showed	NULL
a	NULL
dramatic	NULL
increase	NULL
in	NULL
the	NULL
steady-state	NULL
mRNA	NULL
expression	NULL
of	NULL
various	NULL
monocyte	NULL
effectors	NULL
(	NULL
IL-1	NULL
,	NULL
A20	NULL
,	NULL
p105/p50	NULL
,	NULL
and	NULL
IxBa	NULL
)	NULL
following	NULL
a	NULL
4-h	NULL
viral	NULL
infection	NULL
(	NULL
with	NULL
gradient-purified	NULL
virus	NULL
)	NULL
or	NULL
incubation	NULL
with	NULL
known	NULL
activating	NULL
agents	NULL
(	NULL
10	NULL
ng/ml	NULL
of	NULL
PMA	NULL
or	NULL
1	NULL
ug/ml	NULL
of	NULL
LPS	NULL
)	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
unstimulated	NULL
control	NULL
(	NULL
``	NULL
NAD	NULL
``	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
p65	NULL
,	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
subunit	NULL
,	NULL
appeared	NULL
to	NULL
change	NULL
only	NULL
slightly	NULL
during	NULL
the	NULL
treatments	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

This	NULL
was	NULL
the	NULL
only	NULL
gene	NULL
product	NULL
tested	NULL
that	NULL
showed	NULL
donor	NULL
variability	NULL
;	NULL
some	NULL
donors	NULL
showed	NULL
no	NULL
effect	NULL
and	NULL
some	NULL
donors	NULL
showed	NULL
a	NULL
small	NULL
change	NULL
in	NULL
expression	NULL
.	NULL

This	NULL
in	NULL
itself	NULL
is	NULL
not	NULL
surprising	NULL
,	NULL
as	NULL
p65	NULL
message	NULL
expression	NULL
is	NULL
not	NULL
induced	NULL
by	NULL
any	NULL
known	NULL
stimulus	NULL
except	NULL
HCMV	NULL
infection	NULL
and	NULL
usually	NULL
only	NULL
occurs	NULL
at	NULL
later	NULL
times	NULL
postinfection	NULL
(	NULL
27	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
also	NULL
examined	NULL
if	NULL
monocyte	NULL
adhesion	NULL
(	NULL
a	NULL
known	NULL
activating	NULL
stimuli	NULL
(	NULL
37	NULL
,	NULL
51	NULL
)	NULL
,	NULL
a	NULL
process	NULL
that	NULL
occurs	NULL
during	NULL
extravasation	NULL
of	NULL
monocytes	NULL
from	NULL
the	NULL
blood	NULL
to	NULL
an	NULL
inflammatory	NULL
site	NULL
(	NULL
37	NULL
,	NULL
51	NULL
,	NULL
55	NULL
,	NULL
56	NULL
)	NULL
,	NULL
and	NULL
a	NULL
process	NULL
that	NULL
has	NULL
hypothesized	NULL
to	NULL
be	NULL
affected	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
a-	NULL
<	NULL
-|	NULL
pes	NULL
®	NULL
»	NULL
ap	NULL
a	NULL
»	NULL
ap|	NULL
FIGURE	NULL
2	NULL
.	NULL

Neutralizing	NULL
Abs	NULL
to	NULL
gB	NULL
and	NULL
gH	NULL
block	NULL
the	NULL
induction	NULL
of	NULL
monocyte	NULL
message	NULL
expression	NULL
.	NULL

A	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
total	NULL
RNA	NULL
harvested	NULL
from	NULL
NAD	NULL
monocytes	NULL
infected	NULL
for	NULL
4	NULL
h	NULL
with	NULL
gradient-purified	NULL
HCMV	NULL
(	NULL
M.O.I	NULL
.	NULL

=	NULL
2-3	NULL
)	NULL
or	NULL
HCMV	NULL
pretreated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
neutralizing	NULL
Ab	NULL
(	NULL
4	NULL
pg	NULL
of	NULL
anti-gB	NULL
[	NULL
15D8	NULL
(	NULL
45	NULL
)	NULL
]	NULL
and	NULL
-gH	NULL
[	NULL
1G6	NULL
(	NULL
46	NULL
)	NULL
]	NULL
,	NULL
labeled	NULL
``	NULL
agBgH	NULL
``	NULL
)	NULL
or	NULL
an	NULL
appropriate	NULL
control	NULL
Ab	NULL
(	NULL
4	NULL
ug	NULL
of	NULL
anti-PSA	NULL
,	NULL
labeled	NULL
``	NULL
@	NULL
PSA	NULL
``	NULL
,	NULL
isotype	NULL
and	NULL
species	NULL
matched	NULL
(	NULL
32	NULL
)	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
UV-irradiated	NULL
HCMV	NULL
is	NULL
also	NULL
shown	NULL
(	NULL
``	NULL
UV-HCMV	NULL
``	NULL
)	NULL
.	NULL

The	NULL
lane	NULL
labeled	NULL
only	NULL
``	NULL
NAD	NULL
``	NULL
is	NULL
the	NULL
untreated	NULL
or	NULL
mock-infected	NULL
control	NULL
.	NULL

A	NULL
representative	NULL
experiment	NULL
is	NULL
shown	NULL
and	NULL
the	NULL
experiment	NULL
was	NULL
repeated	NULL
.	NULL

All	NULL
the	NULL
blots	NULL
shown	NULL
are	NULL
from	NULL
multiple	NULL
probings	NULL
of	NULL
the	NULL
same	NULL
blot	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
probed	NULL
with	NULL
*°P-labeled	NULL
cDNA	NULL
probes	NULL
specific	NULL
for	NULL
IL-1	NULL
,	NULL
A20	NULL
,	NULL
p105/p50	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
IxBa	NULL
.	NULL

288	NULL
ribosome	NULL
levels	NULL
are	NULL
shown	NULL
as	NULL
a	NULL
control	NULL
.	NULL

by	NULL
HCMV	NULL
infection	NULL
(	NULL
57-59	NULL
)	NULL
)	NULL
was	NULL
affected	NULL
by	NULL
HCMV	NULL
infection	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
monocyte	NULL
adhesion	NULL
(	NULL
``	NULL
ADH	NULL
``	NULL
)	NULL
caused	NULL
an	NULL
increase	NULL
in	NULL
message	NULL
expression	NULL
and	NULL
HCMV	NULL
infection	NULL
further	NULL
enhanced	NULL
the	NULL
signal	NULL
(	NULL
``	NULL
ADH+HCMV	NULL
``	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
it	NULL
was	NULL
shown	NULL
that	NULL
viral	NULL
infection	NULL
can	NULL
up-regulate	NULL
at	NULL
least	NULL
IL-1	NULL
expression	NULL
as	NULL
early	NULL
as	NULL
30	NULL
min	NULL
to	NULL
1	NULL
h	NULL
postinfection	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
this	NULL
time	NULL
frame	NULL
is	NULL
similar	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
IL-1	NULL
and	NULL
other	NULL
monocyte	NULL
regulatory	NULL
products	NULL
following	NULL
adhesion	NULL
to	NULL
extracellular	NULL
matrix	NULL
components	NULL
or	NULL
treatment	NULL
of	NULL
monocytes	NULL
with	NULL
Abs	NULL
to	NULL
various	NULL
adhesion	NULL
receptors	NULL
(	NULL
42	NULL
,	NULL
60	NULL
,	NULL
61	NULL
)	NULL
.	NULL

Neutralizing	NULL
Abs	NULL
to	NULL
the	NULL
major	NULL
HCMV	NULL
viral	NULL
glycoproteins	NULL
prevent	NULL
monocyte	NULL
gene	NULL
induction	NULL
Next	NULL
,	NULL
we	NULL
wanted	NULL
to	NULL
narrow	NULL
down	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
viral-mediated	NULL
induction	NULL
of	NULL
monocyte	NULL
gene	NULL
products	NULL
.	NULL

Previously	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
a	NULL
receptor/ligand-mediated	NULL
process	NULL
was	NULL
responsible	NULL
for	NULL
transcription	NULL
factor	NULL
induction	NULL
in	NULL
human	NULL
fibroblasts	NULL
following	NULL
viral	NULL
binding	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
decided	NULL
to	NULL
test	NULL
if	NULL
this	NULL
type	NULL
of	NULL
process-a	NULL
receptor/ligand-mediated	NULL
event-was	NULL
responsible	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
monocytes	NULL
as	NULL
measured	NULL
by	NULL
an	NULL
increase	NULL
in	NULL
mRNA	NULL
expression	NULL
.	NULL

To	NULL
demonstrate	NULL
that	NULL
viral	NULL
binding	NULL
mediated	NULL
cellular	NULL
activation	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
role	NULL
of	NULL
the	NULL
two	NULL
major	NULL
HCMV	NULL
glycoproteins	NULL
,	NULL
gB	NULL
and	NULL
gH	NULL
,	NULL
by	NULL
preincubating	NULL
the	NULL
gradient-purified	NULL
virus	NULL
with	NULL
neutralizing	NULL
monoclonal	NULL
Abs	NULL
(	NULL
4	NULL
ug	NULL
of	NULL
anti-gB	NULL
[	NULL
15D8	NULL
(	NULL
45	NULL
)	NULL
]	NULL
and	NULL
anti-gH	NULL
[	NULL
1G6	NULL
(	NULL
46	NULL
)	NULL
]	NULL
)	NULL
or	NULL
a	NULL
species-	NULL
and	NULL
isotype-matched	NULL
control	NULL
Ab	NULL
(	NULL
4	NULL
ug	NULL
of	NULL
anti-PSA	NULL
(	NULL
32	NULL
)	NULL
)	NULL
for	NULL
60	NULL
min	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
virus	NULL
to	NULL
the	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
an	NULL
increase	NULL
in	NULL
message	NULL
expression	NULL
following	NULL
4809	NULL
p105/p50	NULL
4	NULL
”	NULL
ﬁn	NULL
p65	NULL
.	NULL
'	NULL

.	NULL

UW	NULL
a	NULL
»	NULL
|	NULL
IxBo	NULL
FIGURE	NULL
3	NULL
.	NULL

Incubation	NULL
of	NULL
monocytes	NULL
with	NULL
purified	NULL
viral	NULL
gB	NULL
increases	NULL
the	NULL
steady-state	NULL
levels	NULL
of	NULL
monocyte	NULL
mediator	NULL
mRNAs	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
total	NULL
RNA	NULL
harvested	NULL
from	NULL
monocytes	NULL
treated	NULL
with	NULL
purified	NULL
gB	NULL
(	NULL
labeled	NULL
``	NULL
+gB	NULL
``	NULL
)	NULL
and	NULL
a	NULL
series	NULL
of	NULL
controls	NULL
.	NULL

A	NULL
representative	NULL
experiment	NULL
is	NULL
shown	NULL
.	NULL

All	NULL
the	NULL
blots	NULL
shown	NULL
are	NULL
from	NULL
multiple	NULL
probings	NULL
of	NULL
the	NULL
same	NULL
blot	NULL
.	NULL

NAD	NULL
monocytes	NULL
were	NULL
incubated	NULL
for	NULL
4	NULL
h	NULL
with	NULL
purified	NULL
gB	NULL
(	NULL
1	NULL
,	NULL
20	NULL
,	NULL
and	NULL
100	NULL
ng/ml	NULL
)	NULL
,	NULL
100	NULL
ng/ml	NULL
of	NULL
a	NULL
flow-through	NULL
control	NULL
lysate	NULL
treated	NULL
in	NULL
the	NULL
same	NULL
manner	NULL
as	NULL
the	NULL
purified	NULL
gB	NULL
(	NULL
``	NULL
Control	NULL
``	NULL
)	NULL
,	NULL
100	NULL
ng/ml	NULL
of	NULL
gB	NULL
that	NULL
had	NULL
been	NULL
pretreated	NULL
with	NULL
4	NULL
ug	NULL
of	NULL
anti-gB	NULL
(	NULL
15D8	NULL
;	NULL
labeled	NULL
``	NULL
agB	NULL
``	NULL
)	NULL
,	NULL
or	NULL
a	NULL
control	NULL
Ab	NULL
(	NULL
``	NULL
aPSA	NULL
``	NULL
)	NULL
for	NULL
1	NULL
h	NULL
before	NULL
incubation	NULL
,	NULL
or	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
labeled	NULL
only	NULL
as	NULL
``	NULL
NAD	NULL
``	NULL
)	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
probed	NULL
with	NULL
*°P-labeled	NULL
cDNA	NULL
probes	NULL
specific	NULL
for	NULL
IL-1	NULL
,	NULL
A20	NULL
,	NULL
p105/p50	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
IxBa	NULL
.	NULL

288	NULL
ribosome	NULL
levels	NULL
are	NULL
shown	NULL
as	NULL
a	NULL
control	NULL
.	NULL

the	NULL
4-h	NULL
incubation	NULL
of	NULL
cells	NULL
with	NULL
virus	NULL
was	NULL
observed	NULL
(	NULL
compare	NULL
the	NULL
untreated	NULL
lanes	NULL
``	NULL
NAD	NULL
``	NULL
to	NULL
the	NULL
infected	NULL
lanes	NULL
``	NULL
NAD+HCMV	NULL
``	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
when	NULL
the	NULL
virus	NULL
was	NULL
preincubated	NULL
with	NULL
neutralizing	NULL
Abs	NULL
,	NULL
the	NULL
increase	NULL
in	NULL
IL-1	NULL
,	NULL
A20	NULL
,	NULL
p105/p50	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
IxBa	NULL
expression	NULL
was	NULL
blocked	NULL
(	NULL
the	NULL
``	NULL
NAD	NULL
+HCMV/agBgH	NULL
``	NULL
lane	NULL
)	NULL
,	NULL
while	NULL
the	NULL
control	NULL
Ab	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
signaling	NULL
(	NULL
the	NULL
``	NULL
NAD+HCMV/aPSA	NULL
``	NULL
lane	NULL
)	NULL
.	NULL

In	NULL
comparison	NULL
experiments	NULL
,	NULL
the	NULL
neutralizing	NULL
function	NULL
of	NULL
these	NULL
Abs	NULL
was	NULL
shown	NULL
to	NULL
prevent	NULL
cytopathic	NULL
effects	NULL
and	NULL
viral	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
fibroblasts	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

It	NULL
is	NULL
important	NULL
to	NULL
note	NULL
that	NULL
neutralizing	NULL
Abs	NULL
to	NULL
gB	NULL
or	NULL
gH	NULL
alone	NULL
can	NULL
block	NULL
viral-mediated	NULL
signaling	NULL
in	NULL
human	NULL
fibroblasts	NULL
,	NULL
while	NULL
nonneutralizing	NULL
Abs	NULL
have	NULL
no	NULL
effect	NULL
(	NULL
32	NULL
)	NULL
.	NULL

We	NULL
also	NULL
wanted	NULL
to	NULL
show	NULL
that	NULL
UV-irradiated	NULL
virus	NULL
,	NULL
which	NULL
can	NULL
bind	NULL
to	NULL
cells	NULL
but	NULL
can	NULL
not	NULL
replicate	NULL
,	NULL
could	NULL
activate	NULL
monocytes	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
irradiated	NULL
virus	NULL
also	NULL
increased	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
examined	NULL
gene	NULL
products	NULL
(	NULL
the	NULL
``	NULL
NAD+	NULL
UV-HCMV	NULL
``	NULL
lane	NULL
)	NULL
.	NULL

This	NULL
signaling	NULL
was	NULL
also	NULL
blocked	NULL
by	NULL
the	NULL
anti-gB	NULL
and	NULL
-gH	NULL
neutralizing	NULL
Abs	NULL
in	NULL
the	NULL
same	NULL
manner	NULL
as	NULL
was	NULL
seen	NULL
with	NULL
``	NULL
live	NULL
``	NULL
virus	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
results	NULL
support	NULL
the	NULL
hypothesis	NULL
that	NULL
viral	NULL
binding	NULL
itself	NULL
is	NULL
sufficient	NULL
to	NULL
activate	NULL
monocyte	NULL
gene	NULL
expression	NULL
.	NULL

Purified	NULL
HCMV	NULL
gB	NULL
up-regulated	NULL
message	NULL
expression	NULL
The	NULL
results	NULL
from	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
,	NULL
as	NULL
well	NULL
as	NULL
our	NULL
previous	NULL
results	NULL
(	NULL
32	NULL
)	NULL
,	NULL
present	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
initial	NULL
HCMV-mediated	NULL
cellular	NULL
activation	NULL
involves	NULL
a	NULL
viral-ligand/receptor	NULL
interaction	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
next	NULL
addressed	NULL
whether	NULL
our	NULL
purified	NULL
HCMV	NULL
gB	NULL
(	NULL
32	NULL
)	NULL
also	NULL
up-regulated	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
different	NULL
monocyte	NULL
gene	NULL
products	NULL
.	NULL

Purified	NULL
HCMV	NULL
gB	NULL
was	NULL
incubated	NULL
under	NULL
similar	NULL
conditions	NULL
to	NULL
that	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
4810	NULL
A20	NULL
p105/p50	NULL
g	NULL
p6S	NULL
#	NULL
-	NULL
IkBo	NULL
FIGURE	NULL
4	NULL
.	NULL

Treatment	NULL
of	NULL
monocytes	NULL
with	NULL
an	NULL
ald	NULL
Ab	NULL
that	NULL
mimics	NULL
the	NULL
HCMV	NULL
gH	NULL
glycoprotein	NULL
also	NULL
up-regulates	NULL
monocyte	NULL
mRNA	NULL
expression	NULL
.	NULL

Northern	NULL
blot	NULL
analyses	NULL
were	NULL
performed	NULL
on	NULL
total	NULL
RNA	NULL
harvested	NULL
from	NULL
NAD	NULL
monocytes	NULL
that	NULL
were	NULL
left	NULL
untreated	NULL
or	NULL
that	NULL
were	NULL
treated	NULL
with	NULL
an	NULL
ald	NULL
Ab	NULL
(	NULL
``	NULL
ald+X-L	NULL
``	NULL
)	NULL
or	NULL
its	NULL
appropriate	NULL
controls	NULL
(	NULL
``	NULL
eIgM+X-L	NULL
or	NULL
X-L	NULL
alone	NULL
``	NULL
)	NULL
.	NULL

The	NULL
experiment	NULL
was	NULL
repeated	NULL
and	NULL
a	NULL
representative	NULL
experiment	NULL
is	NULL
shown	NULL
.	NULL

All	NULL
the	NULL
blots	NULL
shown	NULL
are	NULL
from	NULL
multiple	NULL
probings	NULL
of	NULL
the	NULL
same	NULL
blot	NULL
.	NULL

Monocytes	NULL
were	NULL
incubated	NULL
for	NULL
4	NULL
h	NULL
with	NULL
either	NULL
15	NULL
pg	NULL
of	NULL
the	NULL
specific	NULL
ald	NULL
Ab	NULL
(	NULL
4-3-5	NULL
(	NULL
47	NULL
,	NULL
48	NULL
)	NULL
;	NULL
an	NULL
IgM	NULL
)	NULL
plus	NULL
3	NULL
ug	NULL
of	NULL
the	NULL
appropriate	NULL
anti-IgM	NULL
cross-linking	NULL
Ab	NULL
(	NULL
repre-sented	NULL
as	NULL
``	NULL
old+X-L	NULL
``	NULL
)	NULL
,	NULL
15	NULL
ug	NULL
of	NULL
a	NULL
nonspecific	NULL
IgM	NULL
anti-serum	NULL
plus	NULL
3	NULL
ug	NULL
of	NULL
the	NULL
cross-linking	NULL
Ab	NULL
(	NULL
labeled	NULL
as	NULL
``	NULL
«	NULL
IgM	NULL
Control+X-L	NULL
``	NULL
)	NULL
,	NULL
or	NULL
3	NULL
ug	NULL
of	NULL
the	NULL
cross-linking	NULL
Ab	NULL
alone	NULL
(	NULL
``	NULL
X-L	NULL
``	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
NAD	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
1	NULL
pg/ml	NULL
of	NULL
LPS	NULL
.	NULL

The	NULL
blots	NULL
shown	NULL
were	NULL
probed	NULL
with	NULL
P-labeled	NULL
cDNA	NULL
probes	NULL
specific	NULL
for	NULL
IL-1	NULL
,	NULL
A20	NULL
,	NULL
p105/p50	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
IxBa	NULL
.	NULL

The	NULL
288	NULL
ribosome	NULL
levels	NULL
are	NULL
shown	NULL
as	NULL
a	NULL
control	NULL
.	NULL

used	NULL
for	NULL
viral	NULL
infections	NULL
.	NULL

A	NULL
4-h	NULL
incubation	NULL
of	NULL
various	NULL
concentrations	NULL
of	NULL
purified	NULL
HCMV	NULL
gB	NULL
(	NULL
1	NULL
,	NULL
20	NULL
,	NULL
and	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

with	NULL
the	NULL
isolated	NULL
monocytes	NULL
(	NULL
lanes	NULL
marked	NULL
``	NULL
NAD+gB	NULL
``	NULL
)	NULL
induced	NULL
IL-1	NULL
$	NULL
,	NULL
A20	NULL
,	NULL
p105/p50	NULL
,	NULL
and	NULL
IxBa	NULL
expression	NULL
activity	NULL
above	NULL
that	NULL
seen	NULL
in	NULL
the	NULL
control	NULL
untreated	NULL
``	NULL
NAD	NULL
``	NULL
monocytes	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
20-ng/ml	NULL
concentration	NULL
of	NULL
purified	NULL
gB	NULL
showed	NULL
the	NULL
largest	NULL
increase	NULL
in	NULL
message	NULL
expression	NULL
.	NULL

However	NULL
,	NULL
this	NULL
amount	NULL
of	NULL
gB	NULL
did	NULL
not	NULL
show	NULL
the	NULL
largest	NULL
increase	NULL
in	NULL
IL-1	NULL
$	NULL
3	NULL
protein	NULL
secretion	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

As	NULL
with	NULL
the	NULL
use	NULL
of	NULL
all	NULL
human	NULL
donors	NULL
,	NULL
there	NULL
is	NULL
variability	NULL
,	NULL
and	NULL
we	NULL
attribute	NULL
these	NULL
sort	NULL
of	NULL
subtle	NULL
differences	NULL
to	NULL
donor	NULL
variability	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
used	NULL
a	NULL
control	NULL
lysate	NULL
(	NULL
labeled	NULL
as	NULL
``	NULL
Control	NULL
``	NULL
)	NULL
,	NULL
which	NULL
was	NULL
isolated	NULL
from	NULL
extracts	NULL
from	NULL
the	NULL
parental	NULL
293T	NULL
cells	NULL
(	NULL
no	NULL
transfected	NULL
gB	NULL
)	NULL
by	NULL
the	NULL
same	NULL
procedure	NULL
used	NULL
to	NULL
purify	NULL
the	NULL
gB	NULL
.	NULL

This	NULL
control	NULL
lysate	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

showed	NULL
no	NULL
ability	NULL
to	NULL
activate	NULL
cellular	NULL
transcription	NULL
factors	NULL
,	NULL
thus	NULL
demonstrating	NULL
that	NULL
the	NULL
protocol	NULL
used	NULL
to	NULL
purify	NULL
gB	NULL
did	NULL
not	NULL
in	NULL
itself	NULL
have	NULL
a	NULL
mitogenic	NULL
effect	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
effects	NULL
mediated	NULL
by	NULL
the	NULL
purified	NULL
gB	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

could	NULL
be	NULL
blocked	NULL
by	NULL
pretreatment	NULL
with	NULL
anti-gB	NULL
Ab	NULL
(	NULL
15D8	NULL
;	NULL
compare	NULL
lanes	NULL
treated	NULL
with	NULL
Ab	NULL
,	NULL
``	NULL
agB	NULL
``	NULL
,	NULL
to	NULL
those	NULL
without	NULL
)	NULL
,	NULL
but	NULL
not	NULL
by	NULL
pretreatment	NULL
with	NULL
an	NULL
isotype-matched	NULL
control	NULL
Ab	NULL
(	NULL
``	NULL
@	NULL
PSA	NULL
``	NULL
)	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
monocytes	NULL
following	NULL
incubation	NULL
with	NULL
purified	NULL
gB	NULL
and	NULL
its	NULL
inhibition	NULL
by	NULL
an	NULL
anti-gB	NULL
Ab	NULL
demonstrates	NULL
that	NULL
the	NULL
specific	NULL
gB/receptor	NULL
interaction	NULL
directly	NULL
initiates	NULL
the	NULL
signaling	NULL
process	NULL
.	NULL

HCMV	NULL
ACTIVATES	NULL
MONOCYTES	NULL
t=	NULL
a	NULL
>	NULL
§120	NULL
280	NULL
]	NULL
m	NULL
90	NULL
260	NULL
$	NULL
60	NULL
-4	NULL
0	NULL
on	NULL
.	NULL

col	NULL
<	NULL
30	NULL
v	NULL
20	NULL
-	NULL
1	NULL
0	NULL
433	NULL
oni	NULL
0	NULL
42°C	NULL
ITT	NULL
o	NULL
>	NULL
omm	NULL
op	NULL
o	NULL
<	NULL
Ooo	NULL
~	NULL
``	NULL
3+	NULL
+	NULL
~o0=s	NULL
1	NULL
22	NULL
5A	NULL
%	NULL
<	NULL
G	NULL
<	NULL
<	NULL
2mm	NULL
=	NULL
&	NULL
&	NULL
>	NULL
>	NULL
<	NULL
«	NULL
@	NULL
o	NULL
U	NULL
«	NULL
-	NULL
;	NULL
>	NULL
ZC	NULL
C	NULL
D	NULL
a	NULL
a	NULL
E40	NULL
£400	NULL
&	NULL
&	NULL
£20	NULL
2100	NULL
on	NULL
.	NULL

on	NULL
``	NULL
3	NULL
*L.	NULL
_	NULL
]	NULL
I	NULL
_I	NULL
-	NULL
0	NULL
40	NULL
2	NULL
2	NULL
S2	NULL
*~*	NULL
oqzhhnwhh	NULL
C	NULL
p	NULL
e	NULL
a	NULL
op-	NULL
3	NULL
~	NULL
co	NULL
c	NULL
o	NULL
S	NULL
L	NULL
``	NULL
Up	NULL
pos	NULL
.	NULL

22.	NULL
lle	NULL
»	NULL
o	NULL
m	NULL
Ln	NULL
+	NULL
ICICI	NULL
I	NULL
O+	NULL
*	NULL
~O+	NULL
o	NULL
I	NULL
T	NULL
a=	NULL
O	NULL
O	NULL
<	NULL
3	NULL
2	NULL
<	NULL
_	NULL
<	NULL
FIGURE	NULL
5	NULL
.	NULL

Secreted	NULL
IL-1§	NULL
protein	NULL
is	NULL
induced	NULL
following	NULL
viral	NULL
attachment	NULL
via	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
HCMV	NULL
gB	NULL
and	NULL
gH	NULL
glycoproteins	NULL
to	NULL
their	NULL
appropriate	NULL
cellular	NULL
receptors	NULL
.	NULL

An	NULL
ELISA	NULL
was	NULL
performed	NULL
on	NULL
supernatants	NULL
harvested	NULL
from	NULL
monocytes	NULL
treated	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
different	NULL
ways	NULL
.	NULL

All	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
4	NULL
h	NULL
unless	NULL
stated	NULL
(	NULL
the	NULL
experiment	NULL
shown	NULL
in	NULL
D	NULL
runs	NULL
through	NULL
48	NULL
h	NULL
)	NULL
.	NULL

Following	NULL
incubation	NULL
,	NULL
culture	NULL
supernatant	NULL
was	NULL
harvested	NULL
and	NULL
the	NULL
ELISAs	NULL
performed	NULL
.	NULL

Duplicate	NULL
samples	NULL
were	NULL
run	NULL
in	NULL
all	NULL
cases	NULL
and	NULL
representative	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

A	NULL
,	NULL
NAD	NULL
monocytes	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
mock	NULL
infected	NULL
)	NULL
,	NULL
infected	NULL
with	NULL
gradient-purified	NULL
HCMV	NULL
(	NULL
M.O.I	NULL
.	NULL

=	NULL
2-3	NULL
)	NULL
,	NULL
UV-irradiated	NULL
HCMV	NULL
,	NULL
or	NULL
preincubated	NULL
(	NULL
with	NULL
4	NULL
ug	NULL
of	NULL
neutralizing	NULL
Ab	NULL
[	NULL
``	NULL
«	NULL
gBgH	NULL
``	NULL
,	NULL
1508	NULL
and	NULL
1G6	NULL
]	NULL
or	NULL
an	NULL
isotype	NULL
and	NULL
species	NULL
matched	NULL
control	NULL
Ab	NULL
[	NULL
aPSA	NULL
]	NULL
)	NULL
HCMV	NULL
.	NULL

B	NULL
,	NULL
NAD	NULL
monocytes	NULL
were	NULL
left	NULL
untreated	NULL
or	NULL
were	NULL
treated	NULL
with	NULL
an	NULL
increasing	NULL
concentration	NULL
of	NULL
purified	NULL
gB	NULL
(	NULL
1	NULL
,	NULL
20	NULL
,	NULL
and	NULL
100	NULL
ng/ml	NULL
)	NULL
,	NULL
a	NULL
control	NULL
lysate	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
,	NULL
or	NULL
100	NULL
ng/m	NULL
!	NULL

of	NULL
purified	NULL
gB	NULL
pretreated	NULL
with	NULL
4	NULL
ug	NULL
of	NULL
an	NULL
anti-gB	NULL
Ab	NULL
or	NULL
its	NULL
control	NULL
.	NULL

C	NULL
,	NULL
NAD	NULL
monocytes	NULL
were	NULL
left	NULL
untreated	NULL
or	NULL
were	NULL
treated	NULL
with	NULL
an	NULL
ald	NULL
Ab	NULL
(	NULL
``	NULL
ald+X-L	NULL
``	NULL
)	NULL
or	NULL
its	NULL
control	NULL
Ab	NULL
(	NULL
``	NULL
eIgM+X-L	NULL
``	NULL
)	NULL
.	NULL

D	NULL
,	NULL
ADH	NULL
monocytes	NULL
were	NULL
incubated	NULL
with	NULL
or	NULL
without	NULL
gradient-purified	NULL
virus	NULL
for	NULL
various	NULL
times	NULL
(	NULL
4	NULL
,	NULL
24	NULL
,	NULL
and	NULL
48	NULL
h	NULL
)	NULL
.	NULL

Time	NULL
zero	NULL
(	NULL
TO	NULL
'	NULL
)	NULL
in	NULL
these	NULL
experiments	NULL
represents	NULL
the	NULL
supernatant	NULL
collected	NULL
from	NULL
the	NULL
incubated	NULL
cells	NULL
at	NULL
the	NULL
start	NULL
of	NULL
the	NULL
incubation	NULL
time	NULL
.	NULL

Incubation	NULL
of	NULL
monocytes	NULL
with	NULL
an	NULL
ald	NULL
Ab	NULL
,	NULL
which	NULL
mimics	NULL
the	NULL
HCMV	NULL
gH	NULL
glycoprotein	NULL
activated	NULL
monocytes	NULL
To	NULL
show	NULL
that	NULL
the	NULL
viral	NULL
gH	NULL
product	NULL
also	NULL
played	NULL
a	NULL
role	NULL
in	NULL
monocyte	NULL
activation	NULL
,	NULL
we	NULL
used	NULL
a	NULL
well-characterized	NULL
affinity-purified	NULL
monoclonal	NULL
ald	NULL
Ab	NULL
(	NULL
38	NULL
,	NULL
47-50	NULL
)	NULL
,	NULL
which	NULL
mimics	NULL
the	NULL
HCMV	NULL
gH	NULL
glycoprotein	NULL
and	NULL
binds	NULL
to	NULL
the	NULL
same	NULL
92.5-kDa	NULL
cell	NULL
membrane	NULL
protein	NULL
as	NULL
affinity-purified	NULL
gH	NULL
(	NULL
49	NULL
)	NULL
,	NULL
to	NULL
stimulate	NULL
our	NULL
purified	NULL
monocytes	NULL
.	NULL

We	NULL
incubated	NULL
the	NULL
cells	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
as	NULL
with	NULL
purified	NULL
gB	NULL
or	NULL
``	NULL
live	NULL
``	NULL
or	NULL
UV-irradiated	NULL
virus	NULL
.	NULL

The	NULL
ald	NULL
Ab	NULL
(	NULL
4-3-5	NULL
)	NULL
or	NULL
the	NULL
appropriate	NULL
control	NULL
(	NULL
a	NULL
nonspecific	NULL
IgM	NULL
)	NULL
were	NULL
preincubated	NULL
for	NULL
60	NULL
min	NULL
with	NULL
a	NULL
cross-linking	NULL
(	NULL
X-L	NULL
)	NULL
secondary	NULL
Ab	NULL
before	NULL
their	NULL
4-h	NULL
incubation	NULL
with	NULL
monocytes	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
gH	NULL
receptor	NULL
engagement	NULL
(	NULL
lanes	NULL
marked	NULL
with	NULL
``	NULL
NAD/ald+X-L	NULL
``	NULL
)	NULL
could	NULL
up-regulate	NULL
IL-1	NULL
3	NULL
,	NULL
A20	NULL
,	NULL
p105/p50	NULL
,	NULL
and	NULL
IxBa	NULL
expression	NULL
,	NULL
while	NULL
the	NULL
control	NULL
Abs	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
``	NULL
NAD/aIgM+X-L	NULL
``	NULL
or	NULL
``	NULL
X-L	NULL
``	NULL
alone	NULL
)	NULL
,	NULL
thus	NULL
demonstrating	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
gH-mediated	NULL
activation	NULL
via	NULL
the	NULL
ald	NULL
Ab	NULL
.	NULL

The	NULL
positive	NULL
control	NULL
,	NULL
monocytes	NULL
treated	NULL
with	NULL
LPS	NULL
,	NULL
also	NULL
demonstrated	NULL
an	NULL
induction	NULL
of	NULL
monocyte	NULL
gene	NULL
products	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
4811	NULL
8	NULL
2	NULL
x	NULL
``	NULL
#	NULL
$	NULL
3	NULL
C	NULL
$	NULL
&	NULL
&	NULL
P	NULL
$	NULL
$	NULL
NF-xB-p50/p65	NULL
*	NULL
NF—KB—ESWEES	NULL
¥*	NULL
#	NULL
bf	NULL
1°	NULL
20	NULL
3	NULL
4	NULL
5	NULL
moog	NULL
p50/p50	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
ATF/CREB	NULL
--	NULL
-	NULL
1°	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
FIGURE	NULL
6	NULL
.	NULL

HCMV	NULL
infection	NULL
of	NULL
monocytes	NULL
along	NULL
with	NULL
purified	NULL
gB	NULL
or	NULL
an	NULL
anti-gH	NULL
idiotypic	NULL
Ab	NULL
increases	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
.	NULL

EMSAs	NULL
of	NULL
harvested	NULL
nuclear	NULL
lysate	NULL
from	NULL
nonadherent	NULL
monocytes	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
in	NULL
the	NULL
following	NULL
manner	NULL
:	NULL
1	NULL
)	NULL
mock	NULL
infected	NULL
or	NULL
untreated	NULL
cells	NULL
(	NULL
``	NULL
NAD	NULL
``	NULL
)	NULL
;	NULL
2	NULL
)	NULL
cells	NULL
incubated	NULL
with	NULL
gradient-purified	NULL
HCMV	NULL
(	NULL
M.O.I	NULL
.	NULL

=	NULL
2-3	NULL
;	NULL
``	NULL
+HCMV	NULL
``	NULL
)	NULL
;	NULL
3	NULL
)	NULL
cells	NULL
incubated	NULL
with	NULL
UV-inactivated	NULL
virus	NULL
(	NULL
``	NULL
+	NULL
UV-HCMV	NULL
``	NULL
)	NULL
;	NULL
4	NULL
)	NULL
cells	NULL
treated	NULL
with	NULL
100	NULL
ng/ml	NULL
of	NULL
purified	NULL
gB	NULL
(	NULL
``	NULL
+gB	NULL
``	NULL
)	NULL
;	NULL
5	NULL
)	NULL
cells	NULL
treated	NULL
with	NULL
100	NULL
ng/ml	NULL
of	NULL
the	NULL
control	NULL
lysate	NULL
(	NULL
``	NULL
+	NULL
Control	NULL
``	NULL
)	NULL
;	NULL
or	NULL
in	NULL
the	NULL
other	NULL
experiment	NULL
6	NULL
)	NULL
untreated	NULL
cells	NULL
(	NULL
``	NULL
NAD	NULL
``	NULL
)	NULL
;	NULL
7	NULL
)	NULL
cells	NULL
incubated	NULL
with	NULL
gradient-purified	NULL
HCMV	NULL
(	NULL
``	NULL
+HCMV	NULL
``	NULL
)	NULL
;	NULL
8	NULL
)	NULL
and	NULL
9	NULL
)	NULL
cells	NULL
incubated	NULL
with	NULL
gradient-purified	NULL
HCMV	NULL
preincubated	NULL
with	NULL
4	NULL
ug	NULL
of	NULL
neutralizing	NULL
Abs	NULL
(	NULL
anti-gB	NULL
and	NULL
-gH	NULL
(	NULL
``	NULL
+HCMV+agBgH	NULL
``	NULL
)	NULL
)	NULL
or	NULL
a	NULL
control	NULL
Ab	NULL
(	NULL
``	NULL
HCMV+aPSA	NULL
``	NULL
)	NULL
;	NULL
10	NULL
)	NULL
and	NULL
11	NULL
)	NULL
cells	NULL
treated	NULL
with	NULL
15	NULL
ug	NULL
of	NULL
an	NULL
ald	NULL
Ab	NULL
plus	NULL
3	NULL
g	NULL
of	NULL
its	NULL
appropriate	NULL
cross-linking	NULL
Ab	NULL
(	NULL
``	NULL
+	NULL
ald+X-L	NULL
``	NULL
)	NULL
or	NULL
15	NULL
ug	NULL
of	NULL
a	NULL
control	NULL
Ab	NULL
plus	NULL
3	NULL
ug	NULL
of	NULL
the	NULL
cross-linking	NULL
Ab	NULL
(	NULL
``	NULL
+	NULL
«	NULL
Ig	NULL
M+X-L	NULL
``	NULL
)	NULL
.	NULL

A	NULL
,	NULL
EMSA	NULL
representing	NULL
NF-kB	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

B	NULL
,	NULL
EMSA	NULL
representing	NULL
ATF/CREB	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

C	NULL
,	NULL
EMSA	NULL
confirming	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
induced	NULL
NF-KB	NULL
products	NULL
via	NULL
supershift	NULL
experiments	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
harvested	NULL
nuclear	NULL
extracts	NULL
to	NULL
a	NULL
consensus	NULL
MHC	NULL
binding	NULL
site	NULL
(	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
,	NULL
5-CCTTTTTTIT	NULL
TGGGGATTCCCCA-3	NULL
'	NULL
)	NULL
and	NULL
a	NULL
consensus	NULL
ATF/CREB	NULL
site	NULL
(	NULL
for	NULL
ATF	NULL
activity	NULL
,	NULL
was	NULL
assessed	NULL
.	NULL

The	NULL
specific	NULL
ATF/CREB	NULL
and	NULL
p50/p65	NULL
and	NULL
the	NULL
supershifted	NULL
p50®*	NULL
and	NULL
p65*	NULL
complexes	NULL
are	NULL
labeled	NULL
.	NULL

Specific	NULL
anti-p50	NULL
and	NULL
-p65	NULL
Abs	NULL
(	NULL
lanes	NULL
marked	NULL
``	NULL
ap50	NULL
``	NULL
and	NULL
``	NULL
p65	NULL
``	NULL
)	NULL
were	NULL
used	NULL
in	NULL
the	NULL
supershift	NULL
experiments	NULL
.	NULL

Preiimmune	NULL
serum	NULL
and	NULL
blocking	NULL
peptides	NULL
were	NULL
also	NULL
used	NULL
to	NULL
show	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
bound	NULL
products	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

A	NULL
representative	NULL
experiment	NULL
is	NULL
shown	NULL
.	NULL

IL-1	NULL
$	NULL
B	NULL
protein	NULL
secretion	NULL
is	NULL
induced	NULL
by	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
virus	NULL
or	NULL
of	NULL
the	NULL
viral	NULL
glycoproteins	NULL
to	NULL
their	NULL
appropriate	NULL
cell	NULL
surface	NULL
receptors	NULL
Next	NULL
,	NULL
we	NULL
wanted	NULL
to	NULL
examine	NULL
if	NULL
the	NULL
increase	NULL
in	NULL
steady-state	NULL
mRNA	NULL
of	NULL
the	NULL
monocyte	NULL
mediators	NULL
(	NULL
specifically	NULL
IL-1	NULL
)	NULL
correlated	NULL
with	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
production	NULL
and	NULL
secretion	NULL
of	NULL
proteins	NULL
.	NULL

To	NULL
accomplish	NULL
this	NULL
goal	NULL
,	NULL
supernatants	NULL
were	NULL
harvested	NULL
from	NULL
monocytes	NULL
following	NULL
their	NULL
treatment	NULL
for	NULL
4	NULL
h	NULL
with	NULL
the	NULL
various	NULL
stimulatory	NULL
products	NULL
(	NULL
``	NULL
live	NULL
``	NULL
or	NULL
UV-inactivated	NULL
virus	NULL
or	NULL
the	NULL
purified	NULL
viral	NULL
ligands	NULL
)	NULL
and	NULL
then	NULL
examined	NULL
by	NULL
ELISA	NULL
for	NULL
IL-1	NULL
levels	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
HCMV	NULL
infection	NULL
as	NULL
well	NULL
as	NULL
treatment	NULL
with	NULL
UV-irradiated	NULL
virus	NULL
significantly	NULL
increased	NULL
IL-1	NULL
3	NULL
protein	NULL
levels	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
neutralizing	NULL
Abs	NULL
blocked	NULL
this	NULL
increase	NULL
(	NULL
``	NULL
«	NULL
agBgH	NULL
``	NULL
)	NULL
,	NULL
while	NULL
the	NULL
isotype-	NULL
and	NULL
species-matched	NULL
control	NULL
Ab	NULL
(	NULL
``	NULL
w	NULL
«	NULL
PSA	NULL
``	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
.	NULL

Treatment	NULL
of	NULL
monocytes	NULL
with	NULL
our	NULL
purified	NULL
gB	NULL
(	NULL
32	NULL
)	NULL
increased	NULL
IL-1	NULL
levels	NULL
in	NULL
a	NULL
dose-dependent	NULL
fashion	NULL
(	NULL
1	NULL
,	NULL
20	NULL
,	NULL
and	NULL
100	NULL
ng/ml	NULL
;	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
the	NULL
control	NULL
lysate	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

or	NULL
purified	NULL
gB	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

pretreated	NULL
with	NULL
an	NULL
anti-gB	NULL
Ab	NULL
did	NULL
not	NULL
cause	NULL
an	NULL
increase	NULL
in	NULL
secreted	NULL
IL-1	NULL
levels	NULL
.	NULL

The	NULL
control	NULL
Ab	NULL
(	NULL
``	NULL
a	NULL
@	NULL
PSA	NULL
``	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
.	NULL

Treatment	NULL
of	NULL
monocytes	NULL
with	NULL
an	NULL
ald	NULL
Ab	NULL
(	NULL
``	NULL
eId+X-L	NULL
``	NULL
)	NULL
,	NULL
which	NULL
mimics	NULL
gH	NULL
,	NULL
also	NULL
could	NULL
increase	NULL
the	NULL
secretion	NULL
of	NULL
IL-1	NULL
in	NULL
treated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
,	NULL
while	NULL
the	NULL
control	NULL
Ab	NULL
(	NULL
``	NULL
a	NULL
«	NULL
IgM+X-L	NULL
``	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
.	NULL

Viral	NULL
infection	NULL
of	NULL
adherent	NULL
monocytes	NULL
also	NULL
resulted	NULL
in	NULL
an	NULL
increase	NULL
in	NULL
IL-1	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
)	NULL
.	NULL

Monocytes	NULL
were	NULL
infected	NULL
at	NULL
the	NULL
time	NULL
of	NULL
adherence	NULL
to	NULL
tissue	NULL
culture	NULL
plates	NULL
.	NULL

It	NULL
can	NULL
be	NULL
seen	NULL
that	NULL
there	NULL
is	NULL
a	NULL
large	NULL
increase	NULL
in	NULL
IL-1	NULL
levels	NULL
in	NULL
24-h	NULL
and	NULL
48-h	NULL
infected	NULL
cells	NULL
,	NULL
with	NULL
no	NULL
activity	NULL
seen	NULL
in	NULL
4-h	NULL
infected	NULL
cells	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
in	NULL
at	NULL
least	NULL
one	NULL
donor	NULL
there	NULL
was	NULL
an	NULL
increase	NULL
in	NULL
IL-1f3	NULL
protein	NULL
secreted	NULL
at	NULL
4	NULL
h	NULL
after	NULL
virus	NULL
addition	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
difference	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
protein	NULL
secretion	NULL
in	NULL
adherent	NULL
vs	NULL
nonadherent	NULL
cells	NULL
is	NULL
not	NULL
surprising	NULL
as	NULL
it	NULL
has	NULL
been	NULL
previously	NULL
documented	NULL
to	NULL
be	NULL
differences	NULL
in	NULL
the	NULL
signaling	NULL
in	NULL
these	NULL
cells	NULL
under	NULL
these	NULL
different	NULL
conditions	NULL
(	NULL
42	NULL
,	NULL
51	NULL
)	NULL
.	NULL

HCMV	NULL
binding	NULL
up-regulates	NULL
NF-KB	NULL
activity	NULL
in	NULL
monocytes	NULL
Because	NULL
many	NULL
of	NULL
the	NULL
gene	NULL
products	NULL
(	NULL
IL-1	NULL
$	NULL
,	NULL
A20	NULL
,	NULL
p105/p50	NULL
,	NULL
and	NULL
that	NULL
we	NULL
examined	NULL
contain	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
in	NULL
their	NULL
promoter	NULL
regions	NULL
and	NULL
we	NULL
are	NULL
very	NULL
interested	NULL
in	NULL
viral-mediated	NULL
signal	NULL
transduction	NULL
,	NULL
we	NULL
next	NULL
addressed	NULL
if	NULL
NF-KB	NULL
activity	NULL
was	NULL
also	NULL
up-regulated	NULL
in	NULL
monocytes	NULL
following	NULL
viral	NULL
binding	NULL
.	NULL

We	NULL
examined	NULL
by	NULL
EMSA	NULL
the	NULL
induction	NULL
of	NULL
monocyte	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
following	NULL
HCMV	NULL
infection	NULL
(	NULL
gradient-purified	NULL
``	NULL
live	NULL
``	NULL
or	NULL
UV	NULL
-inactivated	NULL
virus	NULL
)	NULL
or	NULL
incubation	NULL
with	NULL
purified	NULL
viral	NULL
ligands	NULL
for	NULL
1	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

64	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
this	NULL
study	NULL
showed	NULL
that	NULL
there	NULL
was	NULL
an	NULL
increase	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
activity	NULL
following	NULL
HCMV	NULL
infection	NULL
(	NULL
compare	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
and	NULL
following	NULL
the	NULL
incubation	NULL
of	NULL
monocytes	NULL
with	NULL
our	NULL
purified	NULL
gB	NULL
(	NULL
compare	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
control	NULL
lysate	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
NF-KB	NULL
activity	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

UV-inactivated	NULL
virus	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
4812	NULL
3	NULL
y	NULL
&	NULL
o	NULL
3	NULL
“	NULL
;	NULL
&	NULL
~	NULL
$	NULL
g	NULL
yw	NULL
43	NULL
(	NULL
€	NULL
0	NULL
xt	NULL
at	NULL
at	NULL
PP	NULL
S2	NULL
¢	NULL
F	NULL
Ff	NULL
Ff	NULL
¢	NULL
P	NULL
€	NULL
y	NULL
_x_	NULL
x_x	NULL
€_¢	NULL
®	NULL
___	NULL
_	NULL
«	NULL
37kDay	NULL
[	NULL
__	NULL
_	NULL
-	NULL
-	NULL
]	NULL
[	NULL
-=	NULL
Ntk	NULL
=	NULL
--	NULL
}	NULL
IxBo	NULL
:	NULL
B	NULL
$	NULL
:	NULL
1.0	NULL
-	NULL
g	NULL
i	NULL
Q	NULL
N	NULL
Q	NULL
N	NULL
``	NULL
5041	NULL
ha	NULL
55031	NULL
M	NULL
M_M	NULL
am	NULL
hed	NULL
Ka	NULL
o~	NULL
~*	NULL
10	NULL
20	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
3	NULL
x	NULL
&	NULL
o	NULL
lés	NULL
@	NULL
>	NULL
é	NULL
»	NULL
gw	NULL
A	NULL
?	NULL

a	NULL
G	NULL
8	NULL
a	NULL
y	NULL
x	NULL
C	NULL
$	NULL
£	NULL
4	NULL
$	NULL
S	NULL
¢	NULL
6.9	NULL
¢	NULL
s	NULL
4£¢	NULL
JF	NULL
¢	NULL
F	NULL
¢	NULL
?	NULL

p	NULL
$	NULL
%	NULL
P	NULL
-	NULL
$	NULL
¢	NULL
¢	NULL
¢	NULL
%	NULL
kDa	NULL
|	NULL
C	NULL
x	NULL
a	NULL
ak	NULL
__	NULL
”	NULL
s	NULL
“	NULL
leBB	NULL
D	NULL
E	NULL
:	NULL
$	NULL
i	NULL
!	NULL

$	NULL
Sos	NULL
118	NULL
8,0.012345	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
FIGURE	NULL
7	NULL
.	NULL

IxBa	NULL
,	NULL
but	NULL
not	NULL
I	NULL
«	NULL
BB	NULL
,	NULL
levels	NULL
decrease	NULL
during	NULL
NF-	NULL
«	NULL
B	NULL
mobi-	NULL
lization	NULL
to	NULL
the	NULL
nucleus	NULL
following	NULL
HCMV-mediated	NULL
activation	NULL
of	NULL
monocytes	NULL
.	NULL

Western	NULL
blot	NULL
analyses	NULL
of	NULL
cytoplasmic	NULL
extracts	NULL
from	NULL
monocytes	NULL
following	NULL
activation	NULL
.	NULL

Monocytes	NULL
were	NULL
treated	NULL
by	NULL
incubating	NULL
the	NULL
cells	NULL
for	NULL
1	NULL
h	NULL
nonadherently	NULL
under	NULL
different	NULL
conditions	NULL
:	NULL
1	NULL
)	NULL
mock	NULL
infected	NULL
or	NULL
untreated	NULL
cells	NULL
(	NULL
``	NULL
NAD	NULL
``	NULL
)	NULL
;	NULL
2	NULL
)	NULL
cells	NULL
incubated	NULL
with	NULL
gradient-purified	NULL
HCMV	NULL
(	NULL
M.O.I	NULL
.	NULL

=	NULL
2-3	NULL
;	NULL
``	NULL
+HCMV	NULL
``	NULL
)	NULL
;	NULL
3	NULL
)	NULL
cells	NULL
incubated	NULL
with	NULL
UV-inactivated	NULL
virus	NULL
(	NULL
``	NULL
+	NULL
UV-HCMV	NULL
``	NULL
)	NULL
;	NULL
4	NULL
)	NULL
cells	NULL
treated	NULL
with	NULL
100	NULL
ng/m	NULL
!	NULL

of	NULL
purified	NULL
gB	NULL
(	NULL
``	NULL
+gB	NULL
``	NULL
)	NULL
;	NULL
5	NULL
)	NULL
cells	NULL
treated	NULL
with	NULL
100	NULL
ng/ml	NULL
of	NULL
the	NULL
control	NULL
lysate	NULL
(	NULL
+Control	NULL
)	NULL
;	NULL
or	NULL
in	NULL
the	NULL
other	NULL
experiment	NULL
6	NULL
)	NULL
untreated	NULL
cells	NULL
(	NULL
NAD	NULL
)	NULL
;	NULL
7	NULL
)	NULL
cells	NULL
incubated	NULL
with	NULL
gradient-purified	NULL
HCMV	NULL
(	NULL
``	NULL
+HCMV	NULL
``	NULL
)	NULL
;	NULL
8	NULL
)	NULL
and	NULL
9	NULL
)	NULL
cells	NULL
incubated	NULL
with	NULL
gradient-purified	NULL
HCMV	NULL
preincubated	NULL
with	NULL
4	NULL
pug	NULL
of	NULL
neutralizing	NULL
Abs	NULL
(	NULL
anti-gB	NULL
and	NULL
-gH	NULL
(	NULL
``	NULL
+HCMV	NULL
+	NULL
agBgH	NULL
``	NULL
)	NULL
)	NULL
or	NULL
a	NULL
control	NULL
Ab	NULL
(	NULL
``	NULL
+HCMV+aPSA	NULL
``	NULL
)	NULL
;	NULL
10	NULL
)	NULL
and	NULL
11	NULL
)	NULL
cells	NULL
treated	NULL
with	NULL
15	NULL
ug	NULL
of	NULL
an	NULL
ald	NULL
Ab	NULL
plus	NULL
3	NULL
ug	NULL
of	NULL
the	NULL
cross-linking	NULL
Ab	NULL
(	NULL
``	NULL
+aIgM+X-L	NULL
``	NULL
)	NULL
or	NULL
15	NULL
pg	NULL
of	NULL
a	NULL
control	NULL
Ab	NULL
plus	NULL
3	NULL
pg	NULL
of	NULL
its	NULL
appropriate	NULL
cross-linking	NULL
Ab	NULL
(	NULL
``	NULL
+ald+X-L	NULL
``	NULL
)	NULL
.	NULL

After	NULL
incubation	NULL
,	NULL
monocytes	NULL
were	NULL
harvested	NULL
and	NULL
the	NULL
extract	NULL
was	NULL
run	NULL
on	NULL
an	NULL
SDS-PAGE	NULL
gel	NULL
and	NULL
analyzed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
Santa	NULL
Cruz	NULL
anti-IxBa	NULL
and	NULL
IBB	NULL
anti-sera	NULL
.	NULL

A	NULL
,	NULL
Western	NULL
blot	NULL
of	NULL
IxBa	NULL
levels	NULL
.	NULL

B	NULL
,	NULL
Densitometry	NULL
analysis	NULL
of	NULL
the	NULL
blot	NULL
shown	NULL
in	NULL
A	NULL
.	NULL

C	NULL
,	NULL
Western	NULL
blot	NULL
of	NULL
IBB	NULL
levels	NULL
.	NULL

D	NULL
,	NULL
Densitometry	NULL
analysis	NULL
of	NULL
the	NULL
blot	NULL
shown	NULL
in	NULL
C.	NULL
A	NULL
representative	NULL
experiment	NULL
is	NULL
shown	NULL
.	NULL

(	NULL
lane	NULL
3	NULL
)	NULL
also	NULL
up-regulated	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
viral-mediated	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
could	NULL
be	NULL
blocked	NULL
by	NULL
neutralizing	NULL
Abs	NULL
to	NULL
gB	NULL
and	NULL
gH	NULL
(	NULL
the	NULL
control	NULL
Ab	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
compare	NULL
lanes	NULL
6	NULL
,	NULL
8	NULL
,	NULL
and	NULL
9	NULL
)	NULL
)	NULL
.	NULL

Lastly	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
an	NULL
ald	NULL
Ab	NULL
(	NULL
which	NULL
mimics	NULL
gH	NULL
)	NULL
also	NULL
stimulated	NULL
NF-KB	NULL
activity	NULL
in	NULL
monocytes	NULL
(	NULL
compare	NULL
lanes	NULL
6	NULL
,	NULL
10	NULL
,	NULL
and	NULL
11	NULL
)	NULL
.	NULL

These	NULL
results	NULL
support	NULL
our	NULL
work	NULL
using	NULL
fibroblasts	NULL
in	NULL
which	NULL
we	NULL
reported	NULL
an	NULL
increase	NULL
in	NULL
nuclear	NULL
NF-KB	NULL
activity	NULL
following	NULL
the	NULL
engagement	NULL
of	NULL
the	NULL
HCMV	NULL
glycoproteins	NULL
gB	NULL
and	NULL
gH	NULL
with	NULL
their	NULL
cellular	NULL
receptors	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
also	NULL
examined	NULL
in	NULL
the	NULL
same	NULL
nuclear	NULL
extracts	NULL
the	NULL
induction	NULL
of	NULL
ATE/CREB	NULL
DNA	NULL
binding	NULL
activity	NULL
,	NULL
which	NULL
only	NULL
was	NULL
reported	NULL
to	NULL
be	NULL
increased	NULL
at	NULL
late	NULL
times	NULL
of	NULL
infection	NULL
(	NULL
62	NULL
)	NULL
,	NULL
to	NULL
demonstrate	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
these	NULL
experiments	NULL
showed	NULL
that	NULL
ATFE/CREB	NULL
binding	NULL
activity	NULL
was	NULL
not	NULL
induced	NULL
during	NULL
IE	NULL
times	NULL
of	NULL
infection	NULL
in	NULL
monocytes	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
supershifting	NULL
Abs	NULL
showed	NULL
that	NULL
the	NULL
shifted	NULL
bands	NULL
from	NULL
Fig	NULL
.	NULL

6A	NULL
were	NULL
``	NULL
classic	NULL
``	NULL
NF-KB	NULL
(	NULL
p50/p65	NULL
)	NULL
heterodimers	NULL
and	NULL
p50/p50	NULL
homodimers	NULL
(	NULL
supershifted	NULL
bands	NULL
marked	NULL
with	NULL
an	NULL
asterisk	NULL
)	NULL
.	NULL

We	NULL
also	NULL
used	NULL
appropriate	NULL
blocking	NULL
peptides	NULL
and	NULL
preimmune	NULL
serum	NULL
to	NULL
show	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
supershifting	NULL
Abs	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
rapid	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
HCMV	NULL
fits	NULL
our	NULL
model	NULL
of	NULL
the	NULL
viral-ligand/cellular-receptor-me-diated	NULL
process	NULL
being	NULL
responsible	NULL
for	NULL
an	NULL
early	NULL
step	NULL
of	NULL
cellular	NULL
acti-	NULL
HCMV	NULL
ACTIVATES	NULL
MONOCYTES	NULL
0	NULL
&	NULL
«	NULL
®	NULL
¥	NULL
wo	NULL
.	NULL

@	NULL
-	NULL
&	NULL
C	NULL
._	NULL
``	NULL
>	NULL
»	NULL
FIGURE	NULL
8	NULL
.	NULL

-	NULL
p38	NULL
kinase	NULL
activity	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
the	NULL
viral-mediated	NULL
induction	NULL
of	NULL
IL-1	NULL
6	NULL
message	NULL
expression	NULL
.	NULL

A	NULL
Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
on	NULL
total	NULL
RNA	NULL
harvested	NULL
from	NULL
NAD	NULL
monocytes	NULL
pretreated	NULL
with	NULL
the	NULL
kinase	NULL
inhibitors	NULL
,	NULL
$	NULL
B203580	NULL
and	NULL
PD98059	NULL
.	NULL

A	NULL
representative	NULL
experiment	NULL
is	NULL
shown	NULL
.	NULL

Monocytes	NULL
were	NULL
pretreated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
20	NULL
uM	NULL
$	NULL
B203580	NULL
(	NULL
``	NULL
+8B203580	NULL
``	NULL
)	NULL
,	NULL
20	NULL
uM	NULL
PD98059	NULL
(	NULL
``	NULL
+PD98059	NULL
``	NULL
)	NULL
,	NULL
or	NULL
0.1	NULL
%	NULL
DMSO	NULL
as	NULL
a	NULL
control	NULL
.	NULL

NAD	NULL
monocytes	NULL
(	NULL
``	NULL
NAD	NULL
``	NULL
)	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
gradient-purified	NULL
HCMV	NULL
(	NULL
``	NULL
+HCMV	NULL
``	NULL
,	NULL
M.O.I	NULL
=	NULL
2-3	NULL
)	NULL
for	NULL
1	NULL
h	NULL
and	NULL
then	NULL
harvested	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
probed	NULL
with	NULL
a	NULL
*2P-labeled	NULL
cDNA	NULL
probe	NULL
specific	NULL
for	NULL
IL-1	NULL
3	NULL
.	NULL

288	NULL
ribosome	NULL
levels	NULL
are	NULL
shown	NULL
as	NULL
a	NULL
control	NULL
.	NULL

IL-18	NULL
vation	NULL
,	NULL
as	NULL
well	NULL
as	NULL
confirms	NULL
the	NULL
results	NULL
of	NULL
the	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B-inducible	NULL
genes	NULL
.	NULL

I	NULL
«	NULL
B	NULL
regulation	NULL
correlates	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
in	NULL
activated	NULL
monocytes	NULL
To	NULL
further	NULL
correlate	NULL
the	NULL
increase	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
that	NULL
was	NULL
seen	NULL
above	NULL
,	NULL
we	NULL
also	NULL
examined	NULL
the	NULL
cytosolic	NULL
lysates	NULL
for	NULL
IxBa	NULL
and	NULL
IxBB	NULL
expression	NULL
following	NULL
various	NULL
treatments	NULL
of	NULL
monocytes	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

7A	NULL
showing	NULL
a	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
IxBa	NULL
protein	NULL
levels	NULL
,	NULL
there	NULL
was	NULL
a	NULL
significant	NULL
decrease	NULL
in	NULL
IxBa	NULL
levels	NULL
following	NULL
cellular	NULL
activation	NULL
(	NULL
compare	NULL
lanes	NULL
2	NULL
,	NULL
3	NULL
,	NULL
4	NULL
,	NULL
7	NULL
,	NULL
9	NULL
,	NULL
and	NULL
10	NULL
)	NULL
,	NULL
while	NULL
there	NULL
was	NULL
no	NULL
change	NULL
in	NULL
IxBa	NULL
levels	NULL
in	NULL
the	NULL
control-treated	NULL
cells	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
5	NULL
,	NULL
6	NULL
,	NULL
8	NULL
,	NULL
and	NULL
11	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

7B	NULL
shows	NULL
a	NULL
graph	NULL
of	NULL
the	NULL
levels	NULL
of	NULL
IxBa	NULL
as	NULL
measured	NULL
by	NULL
densitometry	NULL
.	NULL

We	NULL
also	NULL
examined	NULL
changes	NULL
in	NULL
IBB	NULL
levels	NULL
under	NULL
the	NULL
various	NULL
activating	NULL
conditions	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Figs	NULL
.	NULL

7	NULL
,	NULL
C	NULL
and	NULL
D	NULL
(	NULL
Western	NULL
blot	NULL
and	NULL
densitometry	NULL
analyses	NULL
)	NULL
,	NULL
there	NULL
was	NULL
no	NULL
detectable	NULL
change	NULL
in	NULL
IBB	NULL
levels	NULL
.	NULL

These	NULL
results	NULL
are	NULL
thus	NULL
consistent	NULL
with	NULL
the	NULL
virus	NULL
acting	NULL
as	NULL
an	NULL
acute	NULL
activating	NULL
signal	NULL
because	NULL
previously	NULL
described	NULL
agents	NULL
that	NULL
act	NULL
as	NULL
acute	NULL
activating	NULL
signals	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
only	NULL
down-regulate	NULL
IxBa	NULL
,	NULL
not	NULL
IBB	NULL
(	NULL
39	NULL
,	NULL
63	NULL
,	NULL
64	NULL
)	NULL
.	NULL

Blocking	NULL
p38	NULL
function	NULL
prevents	NULL
viral-mediated	NULL
induction	NULL
of	NULL
IL-1B	NULL
message	NULL
expression	NULL
To	NULL
further	NULL
characterize	NULL
the	NULL
viral-mediated	NULL
signal	NULL
transduction	NULL
cascade	NULL
in	NULL
monocytes	NULL
,	NULL
we	NULL
next	NULL
wanted	NULL
to	NULL
focus	NULL
on	NULL
the	NULL
role	NULL
of	NULL
the	NULL
MAPK	NULL
family	NULL
member	NULL
p38	NULL
(	NULL
40	NULL
)	NULL
.	NULL

To	NULL
initially	NULL
examine	NULL
the	NULL
role	NULL
of	NULL
*	NULL
-	NULL
0	NULL
st	NULL
C	NULL
a	NULL
J	NULL
&	NULL
«	NULL
sme	NULL
«	NULL
--	NULL
-	NULL
|	NULL
p38	NULL
FIGURE	NULL
9.	NULL
p38	NULL
is	NULL
rapidly	NULL
up-regulated	NULL
following	NULL
viral	NULL
binding	NULL
.	NULL

A	NULL
Western	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
on	NULL
whole	NULL
cell	NULL
lysate	NULL
from	NULL
harvested	NULL
NAD	NULL
monocytes	NULL
treated	NULL
with	NULL
gradient-purified	NULL
virus	NULL
(	NULL
M.O.I	NULL
.	NULL

=	NULL
2-3	NULL
)	NULL
.	NULL

Monocytes	NULL
were	NULL
either	NULL
harvested	NULL
immediately	NULL
after	NULL
purifying	NULL
(	NULL
TO	NULL
'	NULL
)	NULL
,	NULL
15	NULL
min	NULL
postinfection	NULL
with	NULL
the	NULL
corresponding	NULL
mock-treated	NULL
control	NULL
,	NULL
or	NULL
1	NULL
h	NULL
postinfection	NULL
with	NULL
the	NULL
corresponding	NULL
mock-treated	NULL
control	NULL
.	NULL

Harvested	NULL
monocyte	NULL
extracts	NULL
were	NULL
run	NULL
on	NULL
an	NULL
SDS-PAGE	NULL
gel	NULL
and	NULL
analyzed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
New	NULL
England	NULL
Biolabs	NULL
anti-phospho-specific	NULL
p38	NULL
anti-sera	NULL
.	NULL

A	NULL
representative	NULL
experiment	NULL
is	NULL
shown	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
p38	NULL
,	NULL
we	NULL
used	NULL
an	NULL
inhibitor	NULL
of	NULL
p38	NULL
activity	NULL
and	NULL
then	NULL
looked	NULL
at	NULL
monocyte	NULL
IL-1B	NULL
message	NULL
expression	NULL
.	NULL

Monocytes	NULL
were	NULL
pretreated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
the	NULL
inhibitors	NULL
(	NULL
20	NULL
uM	NULL
$	NULL
B203580	NULL
,	NULL
a	NULL
p38	NULL
inhibitor	NULL
(	NULL
a	NULL
dose	NULL
we	NULL
have	NULL
shown	NULL
inhibits	NULL
HCMV	NULL
replication	NULL
(	NULL
41	NULL
)	NULL
and	NULL
Shapiro	NULL
et	NULL
al	NULL
.	NULL

showed	NULL
blocks	NULL
HIV	NULL
replication	NULL
(	NULL
43	NULL
)	NULL
)	NULL
,	NULL
and	NULL
20	NULL
uM	NULL
PD98059	NULL
,	NULL
a	NULL
MEK	NULL
inhibitor	NULL
(	NULL
44	NULL
)	NULL
)	NULL
before	NULL
their	NULL
1-h	NULL
incubation	NULL
with	NULL
gradient-purified	NULL
virus	NULL
.	NULL

Because	NULL
the	NULL
inhibitors	NULL
were	NULL
dissolved	NULL
in	NULL
DMSO	NULL
and	NULL
were	NULL
used	NULL
such	NULL
that	NULL
the	NULL
final	NULL
concentration	NULL
of	NULL
DMSO	NULL
was	NULL
0.1	NULL
%	NULL
,	NULL
an	NULL
equivalent	NULL
amount	NULL
of	NULL
DMSO	NULL
was	NULL
added	NULL
to	NULL
the	NULL
control	NULL
groups	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
in	NULL
none	NULL
of	NULL
the	NULL
samples	NULL
did	NULL
DMSO	NULL
or	NULL
the	NULL
various	NULL
inhibitors	NULL
affect	NULL
cell	NULL
viability	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Following	NULL
incubation	NULL
with	NULL
the	NULL
inhibitors	NULL
and	NULL
the	NULL
virus	NULL
,	NULL
monocytes	NULL
were	NULL
harvested	NULL
and	NULL
Northern	NULL
blots	NULL
performed	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
,	NULL
only	NULL
the	NULL
blocking	NULL
of	NULL
p38	NULL
function	NULL
had	NULL
a	NULL
major	NULL
effect	NULL
on	NULL
IL-1B	NULL
expression	NULL
(	NULL
>	NULL
95	NULL
%	NULL
in-hibition	NULL
)	NULL
.	NULL

The	NULL
MEK	NULL
inhibitor	NULL
only	NULL
slightly	NULL
blocked	NULL
the	NULL
IL-1B	NULL
signal	NULL
(	NULL
5-15	NULL
%	NULL
decrease	NULL
)	NULL
.	NULL

We	NULL
also	NULL
performed	NULL
titrations	NULL
and	NULL
showed	NULL
that	NULL
higher	NULL
doses	NULL
had	NULL
no	NULL
additional	NULL
effects	NULL
and	NULL
that	NULL
the	NULL
drugs	NULL
effects	NULL
were	NULL
titratable	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
also	NULL
examined	NULL
these	NULL
drugs	NULL
in	NULL
fibroblasts	NULL
at	NULL
a	NULL
number	NULL
of	NULL
different	NULL
concentrations	NULL
for	NULL
toxicity	NULL
and	NULL
none	NULL
of	NULL
the	NULL
doses	NULL
used	NULL
in	NULL
our	NULL
experiments	NULL
were	NULL
toxic	NULL
to	NULL
these	NULL
cells	NULL
in	NULL
long-term	NULL
studies	NULL
.	NULL

Our	NULL
finding	NULL
on	NULL
the	NULL
role	NULL
of	NULL
p38	NULL
in	NULL
viral-mediated	NULL
signaling	NULL
in	NULL
monocytes	NULL
is	NULL
apparently	NULL
uniquely	NULL
monocytic	NULL
in	NULL
nature	NULL
as	NULL
parallel	NULL
experiments	NULL
in	NULL
fibroblasts	NULL
showed	NULL
no	NULL
effect	NULL
(	NULL
our	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

Phosphorylated	NULL
p38	NULL
is	NULL
rapidly	NULL
induced	NULL
following	NULL
viral	NULL
binding	NULL
Lastly	NULL
,	NULL
because	NULL
the	NULL
above	NULL
mentioned	NULL
data	NULL
suggested	NULL
a	NULL
role	NULL
for	NULL
p38	NULL
in	NULL
viral-mediated	NULL
signaling	NULL
,	NULL
we	NULL
next	NULL
wanted	NULL
to	NULL
examine	NULL
if	NULL
HCMV	NULL
infection	NULL
up-regulated	NULL
p38	NULL
activity	NULL
.	NULL

Because	NULL
it	NULL
is	NULL
well	NULL
documented	NULL
that	NULL
phosphorylated	NULL
p38	NULL
correlates	NULL
with	NULL
kinase	NULL
activity	NULL
(	NULL
65	NULL
)	NULL
,	NULL
we	NULL
performed	NULL
Western	NULL
blot	NULL
analyses	NULL
of	NULL
whole	NULL
cell	NULL
extracts	NULL
using	NULL
a	NULL
phospho-specific	NULL
Ab	NULL
(	NULL
recognizes	NULL
phosphorylated	NULL
Thr	NULL
'	NULL
``	NULL
``	NULL
and	NULL
Tyr'*	NULL
``	NULL
)	NULL
.	NULL

The	NULL
results	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

9	NULL
demonstrate	NULL
that	NULL
p38	NULL
is	NULL
phosphorylated	NULL
very	NULL
rapidly	NULL
(	NULL
within	NULL
15	NULL
min	NULL
)	NULL
.	NULL

Following	NULL
induction	NULL
,	NULL
phosphorylated	NULL
p38	NULL
levels	NULL
begin	NULL
to	NULL
decrease	NULL
,	NULL
and	NULL
by	NULL
4-8	NULL
h	NULL
levels	NULL
return	NULL
to	NULL
mock	NULL
levels	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
time	NULL
frame	NULL
of	NULL
p38	NULL
phosphorylation	NULL
(	NULL
15	NULL
min	NULL
to	NULL
1	NULL
h	NULL
)	NULL
correlates	NULL
with	NULL
our	NULL
data	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
in	NULL
which	NULL
the	NULL
rapid	NULL
viral-mediated	NULL
induction	NULL
of	NULL
IL-1B	NULL
(	NULL
within	NULL
1	NULL
h	NULL
)	NULL
was	NULL
blocked	NULL
by	NULL
a	NULL
p38	NULL
inhibitor	NULL
.	NULL

Interestingly	NULL
,	NULL
in	NULL
human	NULL
fibroblasts	NULL
,	NULL
p38	NULL
is	NULL
not	NULL
induced	NULL
during	NULL
this	NULL
early	NULL
time	NULL
frame	NULL
(	NULL
41	NULL
)	NULL
,	NULL
suggesting	NULL
a	NULL
possible	NULL
difference	NULL
in	NULL
the	NULL
mechanisms	NULL
of	NULL
viral	NULL
signaling	NULL
in	NULL
nonpermissive	NULL
(	NULL
monocytes	NULL
)	NULL
and	NULL
permissive	NULL
(	NULL
fibro-blasts	NULL
)	NULL
cell	NULL
types	NULL
.	NULL

Discussion	NULL
Our	NULL
data	NULL
demonstrate	NULL
that	NULL
viral	NULL
binding	NULL
itself	NULL
can	NULL
dramatically	NULL
influence	NULL
the	NULL
state	NULL
of	NULL
the	NULL
cell	NULL
.	NULL

Specifically	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
viral	NULL
binding	NULL
through	NULL
at	NULL
least	NULL
the	NULL
gB	NULL
and	NULL
gH	NULL
glycoproteins	NULL
can	NULL
up-regulate	NULL
the	NULL
signal	NULL
transduction	NULL
pathway	NULL
in	NULL
a	NULL
biologically	NULL
relevant	NULL
cell	NULL
type-the	NULL
human	NULL
peripheral	NULL
blood	NULL
monocyte-which	NULL
ultimately	NULL
results	NULL
in	NULL
an	NULL
altered	NULL
pattern	NULL
of	NULL
cytokine	NULL
and	NULL
other	NULL
immune	NULL
mediator	NULL
expression	NULL
.	NULL

These	NULL
results	NULL
correlate	NULL
with	NULL
our	NULL
previous	NULL
study	NULL
in	NULL
which	NULL
we	NULL
showed	NULL
that	NULL
viral	NULL
binding	NULL
alone	NULL
could	NULL
up-regulate	NULL
NF-KB	NULL
and	NULL
Sp1	NULL
levels	NULL
in	NULL
human	NULL
fibroblasts	NULL
(	NULL
32	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
this	NULL
work	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
many	NULL
studies	NULL
that	NULL
have	NULL
shown	NULL
that	NULL
vi-ruses	NULL
,	NULL
including	NULL
other	NULL
members	NULL
of	NULL
the	NULL
herpesvirus	NULL
family	NULL
,	NULL
bind	NULL
to	NULL
known	NULL
``	NULL
activational	NULL
``	NULL
receptors	NULL
(	NULL
66-70	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
our	NULL
current	NULL
results	NULL
plus	NULL
the	NULL
work	NULL
from	NULL
these	NULL
previous	NULL
studies	NULL
support	NULL
our	NULL
hypothesis	NULL
that	NULL
viruses	NULL
have	NULL
evolved	NULL
a	NULL
common	NULL
strategy	NULL
in	NULL
which	NULL
activational	NULL
molecules/receptors	NULL
are	NULL
used	NULL
for	NULL
not	NULL
only	NULL
viral	NULL
entry	NULL
,	NULL
but	NULL
also	NULL
cellular	NULL
activation	NULL
and	NULL
presumably	NULL
viral	NULL
survival	NULL
.	NULL

We	NULL
showed	NULL
that	NULL
there	NULL
was	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
number	NULL
of	NULL
monocyte	NULL
mediators	NULL
(	NULL
IL-1	NULL
3	NULL
,	NULL
A20	NULL
,	NULL
p105/p50	NULL
,	NULL
and	NULL
IxBa	NULL
)	NULL
4813	NULL
as	NULL
measured	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
following	NULL
viral	NULL
binding	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
results	NULL
showed	NULL
that	NULL
HCMV	NULL
induced	NULL
the	NULL
message	NULL
for	NULL
both	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
subunit	NULL
,	NULL
p105/p50	NULL
,	NULL
and	NULL
its	NULL
inhibitor	NULL
,	NULL
IxBa	NULL
.	NULL

Because	NULL
both	NULL
gene	NULL
products	NULL
are	NULL
NF-	NULL
«	NULL
B	NULL
inducible	NULL
,	NULL
these	NULL
results	NULL
are	NULL
not	NULL
surprising	NULL
.	NULL

However	NULL
,	NULL
one	NULL
should	NULL
keep	NULL
in	NULL
mind	NULL
that	NULL
message	NULL
induction	NULL
does	NULL
not	NULL
mean	NULL
the	NULL
protein	NULL
is	NULL
induced	NULL
or	NULL
up-regulated	NULL
,	NULL
which	NULL
under	NULL
our	NULL
conditions	NULL
examined	NULL
seem	NULL
to	NULL
be	NULL
the	NULL
case	NULL
,	NULL
as	NULL
IxBa	NULL
levels	NULL
do	NULL
not	NULL
return	NULL
to	NULL
untreated	NULL
levels	NULL
even	NULL
by	NULL
4	NULL
h	NULL
poststimu-lation	NULL
,	NULL
suggesting	NULL
that	NULL
a	NULL
potential	NULL
viral-mediated	NULL
translational	NULL
or	NULL
posttranslational	NULL
control	NULL
exists	NULL
(	NULL
perhaps	NULL
as	NULL
seen	NULL
with	NULL
the	NULL
hepatitis	NULL
B	NULL
virus	NULL
HBx	NULL
protein	NULL
(	NULL
71	NULL
)	NULL
,	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
Tat	NULL
protein	NULL
(	NULL
72	NULL
)	NULL
,	NULL
or	NULL
the	NULL
human	NULL
T	NULL
lymphotropic	NULL
virus	NULL
I	NULL
Tax	NULL
,	NULL
protein	NULL
(	NULL
73	NULL
)	NULL
)	NULL
.	NULL

We	NULL
showed	NULL
that	NULL
HCMV	NULL
binding	NULL
induced	NULL
A20	NULL
expression	NULL
(	NULL
orig-inally	NULL
described	NULL
by	NULL
Dixit	NULL
et	NULL
al	NULL
.	NULL

(	NULL
74	NULL
)	NULL
,	NULL
although	NULL
we	NULL
originally	NULL
called	NULL
this	NULL
gene	NULL
product	NULL
MAD-6	NULL
(	NULL
60	NULL
)	NULL
)	NULL
,	NULL
an	NULL
anti-apoptotic	NULL
factor	NULL
(	NULL
75	NULL
)	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
this	NULL
gene	NULL
product	NULL
was	NULL
up-regulated	NULL
in	NULL
monocytes	NULL
activated	NULL
via	NULL
their	NULL
adhesion	NULL
receptors	NULL
(	NULL
42	NULL
)	NULL
or	NULL
adhesion	NULL
itself	NULL
(	NULL
60	NULL
)	NULL
.	NULL

A20	NULL
can	NULL
block	NULL
p53-mediated	NULL
apoptosis	NULL
(	NULL
75	NULL
)	NULL
and	NULL
with	NULL
the	NULL
extended	NULL
life	NULL
cycle	NULL
of	NULL
HCMV	NULL
in	NULL
human	NULL
monocytes	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
and	NULL
the	NULL
reported	NULL
induction	NULL
of	NULL
p53	NULL
(	NULL
76	NULL
)	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
an	NULL
anti-apoptotic	NULL
factor	NULL
might	NULL
be	NULL
necessary	NULL
for	NULL
viral	NULL
survival	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
EBV	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
induces	NULL
A20	NULL
and	NULL
this	NULL
protects	NULL
these	NULL
cells	NULL
from	NULL
p53-mediated	NULL
apoptosis	NULL
(	NULL
77	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
herpesviruses	NULL
in	NULL
general	NULL
might	NULL
use	NULL
the	NULL
anti-apoptotic	NULL
properties	NULL
of	NULL
this	NULL
gene	NULL
product	NULL
for	NULL
their	NULL
own	NULL
survival	NULL
.	NULL

It	NULL
was	NULL
also	NULL
shown	NULL
that	NULL
viral	NULL
binding	NULL
could	NULL
enhance	NULL
gene	NULL
expression	NULL
in	NULL
simultaneously	NULL
adherently	NULL
activated	NULL
monocytes	NULL
.	NULL

Adherence	NULL
is	NULL
a	NULL
known	NULL
physiologic	NULL
signal	NULL
responsible	NULL
for	NULL
monocyte	NULL
and	NULL
mac-rophage	NULL
activation	NULL
(	NULL
42	NULL
,	NULL
51	NULL
,	NULL
60	NULL
,	NULL
61	NULL
,	NULL
78	NULL
,	NULL
79	NULL
)	NULL
.	NULL

This	NULL
HCMV-induced	NULL
message	NULL
expression	NULL
was	NULL
mediated	NULL
by	NULL
viral	NULL
binding	NULL
as	NULL
neutralizing	NULL
Abs	NULL
to	NULL
the	NULL
major	NULL
HCMV	NULL
glycoproteins	NULL
(	NULL
gB	NULL
and	NULL
gH	NULL
)	NULL
blocked	NULL
this	NULL
expression	NULL
,	NULL
even	NULL
in	NULL
adherent	NULL
activated	NULL
monocytes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
also	NULL
showed	NULL
that	NULL
UV-irradiated	NULL
virus	NULL
also	NULL
up-regulated	NULL
message	NULL
expression	NULL
,	NULL
demonstrating	NULL
that	NULL
newly	NULL
synthesized	NULL
viral	NULL
gene	NULL
products	NULL
were	NULL
not	NULL
required	NULL
for	NULL
the	NULL
signal	NULL
.	NULL

This	NULL
UV-irradiated	NULL
virus-mediated	NULL
signaling	NULL
could	NULL
also	NULL
be	NULL
blocked	NULL
by	NULL
neutralizing	NULL
Abs	NULL
.	NULL

To	NULL
show	NULL
that	NULL
viral	NULL
binding	NULL
truly	NULL
was	NULL
inducing	NULL
mediator	NULL
mRNA	NULL
expression	NULL
,	NULL
we	NULL
examined	NULL
directly	NULL
the	NULL
regulation	NULL
of	NULL
monocyte	NULL
activation	NULL
by	NULL
using	NULL
purified	NULL
HCMV	NULL
gB	NULL
(	NULL
described	NULL
previously	NULL
(	NULL
32	NULL
)	NULL
)	NULL
as	NULL
a	NULL
stimulus	NULL
.	NULL

The	NULL
results	NULL
of	NULL
these	NULL
studies	NULL
demonstrated	NULL
that	NULL
there	NULL
was	NULL
indeed	NULL
a	NULL
viral	NULL
glycoprotein-mediated	NULL
signaling	NULL
event	NULL
occurring	NULL
in	NULL
monocytes	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
well-characterized	NULL
ald	NULL
Ab	NULL
(	NULL
32	NULL
,	NULL
38	NULL
,	NULL
47-50	NULL
)	NULL
,	NULL
which	NULL
mimics	NULL
gH	NULL
and	NULL
has	NULL
previously	NULL
been	NULL
documented	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
fibroblast	NULL
signaling	NULL
(	NULL
38	NULL
,	NULL
50	NULL
)	NULL
,	NULL
also	NULL
up-regulated	NULL
monocyte	NULL
message	NULL
expression	NULL
.	NULL

These	NULL
combined	NULL
results	NULL
again	NULL
support	NULL
our	NULL
hypothesis	NULL
of	NULL
a	NULL
novel	NULL
viral	NULL
binding-mediated	NULL
signaling	NULL
event	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
wanted	NULL
to	NULL
examine	NULL
the	NULL
effects	NULL
of	NULL
our	NULL
activating	NULL
conditions	NULL
on	NULL
monocyte	NULL
cytokine	NULL
secretion	NULL
,	NULL
because	NULL
ultimately	NULL
monocyte	NULL
function	NULL
in	NULL
many	NULL
cases	NULL
is	NULL
measured	NULL
by	NULL
its	NULL
cytokine	NULL
secretion	NULL
.	NULL

As	NULL
the	NULL
results	NULL
showed	NULL
,	NULL
HCMV	NULL
binding	NULL
,	NULL
as	NULL
well	NULL
as	NULL
gB-	NULL
and	NULL
gH-mediated	NULL
signaling	NULL
,	NULL
all	NULL
up-regulated	NULL
the	NULL
secretion	NULL
of	NULL
IL-1	NULL
protein	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
HCMV	NULL
binding	NULL
also	NULL
induced	NULL
IL-1	NULL
$	NULL
secretion	NULL
in	NULL
adherently	NULL
activated	NULL
monocytes	NULL
when	NULL
added	NULL
at	NULL
the	NULL
initial	NULL
time	NULL
of	NULL
adherence	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
IL-1	NULL
$	NULL
secretion	NULL
in	NULL
only	NULL
adherent	NULL
activated	NULL
monocytes	NULL
(	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
virus	NULL
or	NULL
other	NULL
activating	NULL
stimuli	NULL
)	NULL
is	NULL
not	NULL
surprising	NULL
as	NULL
it	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
by	NULL
Haskill	NULL
et	NULL
al	NULL
.	NULL

(	NULL
51	NULL
)	NULL
that	NULL
adherent	NULL
monocytes	NULL
need	NULL
two	NULL
signals	NULL
to	NULL
generate	NULL
the	NULL
secretion	NULL
of	NULL
IL-1B	NULL
protein	NULL
.	NULL

Adherence	NULL
only	NULL
up-regulates	NULL
message	NULL
expression	NULL
,	NULL
while	NULL
a	NULL
second	NULL
signal	NULL
such	NULL
as	NULL
that	NULL
provided	NULL
by	NULL
a	NULL
mitogen	NULL
or	NULL
cytokine	NULL
is	NULL
needed	NULL
to	NULL
get	NULL
the	NULL
translational	NULL
up-regulation	NULL
of	NULL
IL-1	NULL
$	NULL
protein	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
virus	NULL
might	NULL
provide	NULL
the	NULL
second	NULL
signal	NULL
,	NULL
much	NULL
as	NULL
a	NULL
cytokine	NULL
normally	NULL
would	NULL
do	NULL
,	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
4814	NULL
and	NULL
thus	NULL
might	NULL
point	NULL
to	NULL
at	NULL
least	NULL
one	NULL
of	NULL
the	NULL
reasons	NULL
behind	NULL
the	NULL
immune	NULL
dysregulation	NULL
seen	NULL
in	NULL
HCMV	NULL
individuals	NULL
.	NULL

Interestingly	NULL
,	NULL
we	NULL
previously	NULL
showed	NULL
that	NULL
integrin	NULL
engagement	NULL
in	NULL
nonadherent	NULL
monocytes	NULL
only	NULL
needed	NULL
one	NULL
signal	NULL
to	NULL
generate	NULL
IL-1	NULL
secretion	NULL
(	NULL
42	NULL
)	NULL
,	NULL
a	NULL
fact	NULL
that	NULL
also	NULL
seems	NULL
to	NULL
occur	NULL
in	NULL
our	NULL
system	NULL
following	NULL
viral	NULL
binding	NULL
.	NULL

The	NULL
gene	NULL
products	NULL
described	NULL
above	NULL
that	NULL
were	NULL
significantly	NULL
up-regulated	NULL
during	NULL
viral	NULL
binding	NULL
or	NULL
gB	NULL
or	NULL
gH-mediated	NULL
signaling	NULL
are	NULL
all	NULL
NF-	NULL
«	NULL
B-inducible	NULL
gene	NULL
products	NULL
.	NULL

Therefore	NULL
,	NULL
to	NULL
continue	NULL
our	NULL
investigation	NULL
of	NULL
the	NULL
signaling	NULL
process	NULL
we	NULL
next	NULL
focused	NULL
on	NULL
the	NULL
regulation	NULL
of	NULL
NF-KB	NULL
in	NULL
monocytes	NULL
following	NULL
the	NULL
various	NULL
described	NULL
treatments	NULL
.	NULL

We	NULL
showed	NULL
that	NULL
there	NULL
was	NULL
a	NULL
rapid	NULL
increase	NULL
in	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
levels	NULL
following	NULL
viral	NULL
binding	NULL
or	NULL
gB-	NULL
or	NULL
gH-mediated	NULL
binding	NULL
in	NULL
monocytes	NULL
,	NULL
which	NULL
confirmed	NULL
the	NULL
results	NULL
of	NULL
previous	NULL
studies	NULL
in	NULL
fibroblasts	NULL
(	NULL
26	NULL
,	NULL
27	NULL
,	NULL
29	NULL
,	NULL
30	NULL
,	NULL
33	NULL
)	NULL
.	NULL

The	NULL
data	NULL
demonstrated	NULL
that	NULL
the	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
EMSA	NULL
activity	NULL
was	NULL
specific	NULL
,	NULL
because	NULL
ATF/	NULL
CREB	NULL
EMSA	NULL
activity	NULL
was	NULL
not	NULL
induced	NULL
supporting	NULL
the	NULL
results	NULL
of	NULL
Kerry	NULL
et	NULL
al	NULL
.	NULL

who	NULL
showed	NULL
that	NULL
ATF	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
only	NULL
up-regulated	NULL
at	NULL
late	NULL
times	NULL
of	NULL
infection	NULL
(	NULL
62	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
IxBa	NULL
protein	NULL
levels	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
changes	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
levels	NULL
;	NULL
that	NULL
is	NULL
as	NULL
NF-B	NULL
activity	NULL
increases	NULL
,	NULL
levels	NULL
decrease	NULL
.	NULL

Interestingly	NULL
,	NULL
even	NULL
at	NULL
1-4	NULL
h	NULL
poststimulation	NULL
(	NULL
either	NULL
``	NULL
live	NULL
``	NULL
or	NULL
UV-inactivated	NULL
virus	NULL
or	NULL
purified	NULL
ligands	NULL
)	NULL
,	NULL
IxBa	NULL
levels	NULL
were	NULL
still	NULL
significantly	NULL
reduced	NULL
,	NULL
suggesting	NULL
that	NULL
in	NULL
our	NULL
system	NULL
there	NULL
are	NULL
viral	NULL
mechanisms	NULL
operating	NULL
to	NULL
inhibit	NULL
IxBa	NULL
protein	NULL
levels	NULL
.	NULL

In	NULL
other	NULL
reported	NULL
systems	NULL
,	NULL
IxBa	NULL
levels	NULL
usually	NULL
return	NULL
to	NULL
unstimulated	NULL
levels	NULL
within	NULL
1	NULL
h	NULL
(	NULL
39	NULL
)	NULL
.	NULL

There	NULL
were	NULL
no	NULL
changes	NULL
detected	NULL
in	NULL
IBB	NULL
levels	NULL
under	NULL
any	NULL
of	NULL
the	NULL
conditions	NULL
used	NULL
in	NULL
our	NULL
experiments	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
there	NULL
might	NULL
be	NULL
changes	NULL
in	NULL
IBB	NULL
levels	NULL
at	NULL
later	NULL
times	NULL
of	NULL
infection	NULL
or	NULL
that	NULL
IxBB	NULL
could	NULL
be	NULL
acting	NULL
as	NULL
a	NULL
chaperone	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
protecting	NULL
it	NULL
from	NULL
IxBa	NULL
,	NULL
as	NULL
Suyang	NULL
et	NULL
al	NULL
.	NULL

have	NULL
shown	NULL
for	NULL
some	NULL
forms	NULL
of	NULL
IxBB	NULL
(	NULL
63	NULL
)	NULL
.	NULL

These	NULL
results	NULL
thus	NULL
suggest	NULL
that	NULL
the	NULL
virus	NULL
is	NULL
acting	NULL
like	NULL
an	NULL
acute	NULL
stimuli	NULL
(	NULL
39	NULL
,	NULL
63	NULL
,	NULL
64	NULL
)	NULL
,	NULL
at	NULL
least	NULL
under	NULL
our	NULL
laboratory	NULL
conditions	NULL
.	NULL

Lastly	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
there	NULL
was	NULL
a	NULL
rapid	NULL
increase	NULL
in	NULL
p38	NULL
phosphorylation	NULL
(	NULL
within	NULL
15	NULL
min	NULL
)	NULL
,	NULL
which	NULL
has	NULL
been	NULL
well	NULL
documented	NULL
to	NULL
be	NULL
correlated	NULL
to	NULL
p38	NULL
function	NULL
(	NULL
65	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
viral-mediated	NULL
signaling	NULL
(	NULL
at	NULL
least	NULL
IL-1	NULL
B	NULL
production	NULL
)	NULL
was	NULL
dependent	NULL
on	NULL
p38	NULL
activity	NULL
as	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
p38	NULL
(	NULL
SB203580	NULL
)	NULL
nearly	NULL
completely	NULL
blocked	NULL
IL-1B	NULL
message	NULL
expression	NULL
(	NULL
>	NULL
95	NULL
%	NULL
decrease	NULL
)	NULL
in	NULL
all	NULL
the	NULL
doses	NULL
we	NULL
tested	NULL
(	NULL
1-50	NULL
M	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
thus	NULL
begin	NULL
to	NULL
map	NULL
the	NULL
signaling	NULL
events	NULL
associated	NULL
with	NULL
viral	NULL
glycoprotein-cellu-lar	NULL
receptor	NULL
engagement	NULL
in	NULL
monocytes	NULL
.	NULL

Excitingly	NULL
,	NULL
this	NULL
event	NULL
appears	NULL
to	NULL
be	NULL
unique	NULL
to	NULL
monocytes	NULL
because	NULL
in	NULL
permissively	NULL
infected	NULL
human	NULL
fibroblasts	NULL
p38	NULL
activity	NULL
has	NULL
no	NULL
function	NULL
at	NULL
IE	NULL
or	NULL
early	NULL
times	NULL
after	NULL
infection	NULL
(	NULL
15	NULL
min	NULL
to	NULL
8	NULL
h	NULL
postinfection	NULL
;	NULL
(	NULL
41	NULL
)	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
in	NULL
fibroblasts	NULL
the	NULL
signaling	NULL
cascade	NULL
through	NULL
these	NULL
same	NULL
glycoproteins	NULL
(	NULL
gB	NULL
and	NULL
gH	NULL
)	NULL
diverges	NULL
following	NULL
viral	NULL
binding	NULL
.	NULL

These	NULL
differences	NULL
may	NULL
point	NULL
to	NULL
the	NULL
unique	NULL
and	NULL
important	NULL
biological	NULL
signaling	NULL
consequences	NULL
of	NULL
viral	NULL
infection	NULL
in	NULL
nonpermissive	NULL
vs	NULL
permissive	NULL
cell	NULL
types	NULL
.	NULL

Our	NULL
on	NULL
going	NULL
studies	NULL
are	NULL
now	NULL
addressing	NULL
these	NULL
potential	NULL
differences	NULL
in	NULL
more	NULL
detail	NULL
.	NULL

It	NULL
is	NULL
important	NULL
to	NULL
point	NULL
out	NULL
that	NULL
it	NULL
is	NULL
unlikely	NULL
in	NULL
any	NULL
of	NULL
the	NULL
cases	NULL
presented	NULL
above	NULL
that	NULL
the	NULL
monocyte	NULL
activation	NULL
seen	NULL
was	NULL
due	NULL
to	NULL
some	NULL
mitogenic	NULL
factor	NULL
in	NULL
the	NULL
viral	NULL
supernatant	NULL
or	NULL
in	NULL
the	NULL
soluble	NULL
activating	NULL
agents	NULL
(	NULL
gB	NULL
or	NULL
the	NULL
gH	NULL
anti-idiotypic	NULL
Ab	NULL
)	NULL
because	NULL
1	NULL
)	NULL
in	NULL
the	NULL
viral	NULL
binding	NULL
studies	NULL
we	NULL
used	NULL
density	NULL
gradient-purified	NULL
virus	NULL
;	NULL
2	NULL
)	NULL
in	NULL
the	NULL
gB-mediated	NULL
studies	NULL
we	NULL
used	NULL
a	NULL
control	NULL
protein	NULL
lysate	NULL
isolated	NULL
in	NULL
the	NULL
same	NULL
manner	NULL
as	NULL
the	NULL
purified	NULL
gB	NULL
;	NULL
and	NULL
3	NULL
)	NULL
in	NULL
the	NULL
gH-mediated	NULL
studies	NULL
we	NULL
used	NULL
the	NULL
appropriate	NULL
control	NULL
Abs	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
Ab	NULL
blocking	NULL
studies	NULL
from	NULL
these	NULL
various	NULL
experiments	NULL
supported	NULL
this	NULL
fact	NULL
.	NULL

If	NULL
a	NULL
soluble	NULL
mitogenic	NULL
factor	NULL
was	NULL
copurified	NULL
with	NULL
the	NULL
virus	NULL
or	NULL
the	NULL
gB	NULL
,	NULL
its	NULL
effect	NULL
would	NULL
not	NULL
have	NULL
been	NULL
specifically	NULL
inhibited	NULL
by	NULL
the	NULL
anti-HCMV	NULL
Abs	NULL
.	NULL

The	NULL
UV-inactivated	NULL
virus	NULL
studies	NULL
,	NULL
which	NULL
also	NULL
HCMV	NULL
ACTIVATES	NULL
MONOCYTES	NULL
resulted	NULL
in	NULL
activated	NULL
gene	NULL
expression	NULL
and	NULL
transcription	NULL
factors	NULL
,	NULL
further	NULL
supports	NULL
these	NULL
points	NULL
because	NULL
the	NULL
studies	NULL
are	NULL
similar	NULL
to	NULL
the	NULL
work	NULL
by	NULL
Boldogh	NULL
et	NULL
al	NULL
.	NULL

in	NULL
which	NULL
they	NULL
showed	NULL
that	NULL
density-purified	NULL
virus	NULL
and	NULL
inactivated	NULL
virus	NULL
had	NULL
identical	NULL
effects	NULL
on	NULL
protooncogene	NULL
mRNA	NULL
levels	NULL
(	NULL
31	NULL
)	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
there	NULL
is	NULL
a	NULL
bona	NULL
fide	NULL
signal	NULL
transduction	NULL
event	NULL
that	NULL
takes	NULL
place	NULL
following	NULL
HCMV	NULL
binding	NULL
to	NULL
monocytes	NULL
through	NULL
the	NULL
interaction	NULL
of	NULL
the	NULL
surface	NULL
glycoproteins	NULL
,	NULL
gB	NULL
and	NULL
gH	NULL
,	NULL
on	NULL
the	NULL
viral	NULL
membrane	NULL
.	NULL

We	NULL
have	NULL
documented	NULL
a	NULL
rapid	NULL
increase	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
following	NULL
the	NULL
incubation	NULL
of	NULL
HCMV	NULL
with	NULL
monocytes	NULL
that	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
degradation	NULL
of	NULL
IxBa	NULL
.	NULL

This	NULL
transcription	NULL
factor	NULL
induction	NULL
is	NULL
then	NULL
probably	NULL
responsible	NULL
for	NULL
the	NULL
observed	NULL
increase	NULL
in	NULL
monocyte	NULL
mediators	NULL
(	NULL
IL-1B	NULL
,	NULL
A20	NULL
,	NULL
p105/p50	NULL
,	NULL
and	NULL
IxBa	NULL
)	NULL
and	NULL
then	NULL
ultimately	NULL
in	NULL
the	NULL
increased	NULL
cytokine	NULL
production	NULL
and	NULL
secretion	NULL
(	NULL
as	NULL
shown	NULL
for	NULL
IL-1	NULL
)	NULL
.	NULL

This	NULL
dysregulation	NULL
of	NULL
monocyte	NULL
function	NULL
by	NULL
HCMV	NULL
would	NULL
have	NULL
serious	NULL
consequences	NULL
for	NULL
the	NULL
infected	NULL
host	NULL
because	NULL
at	NULL
the	NULL
very	NULL
least	NULL
an	NULL
increased	NULL
cytokine	NULL
production	NULL
would	NULL
profoundly	NULL
affect	NULL
the	NULL
way	NULL
cells	NULL
behave	NULL
in	NULL
their	NULL
natural	NULL
environment	NULL
.	NULL

This	NULL
aberrant	NULL
HCMV-mediated	NULL
activation	NULL
of	NULL
monocytes	NULL
could	NULL
be	NULL
some	NULL
of	NULL
the	NULL
molecular	NULL
events	NULL
behind	NULL
HCMV	NULL
s	NULL
link	NULL
to	NULL
chronic	NULL
inflammatory	NULL
diseases	NULL
such	NULL
as	NULL
coronary	NULL
restenosis	NULL
,	NULL
atherosclerosis	NULL
,	NULL
arthritis	NULL
,	NULL
and	NULL
other	NULL
HCMV-associated	NULL
diseases	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Dr.	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
for	NULL
his	NULL
gift	NULL
of	NULL
the	NULL
anti-p50	NULL
and	NULL
-p65	NULL
anti-sera	NULL
,	NULL
Dr.	NULL
L.	NULL
Rasmussen	NULL
for	NULL
her	NULL
generous	NULL
gift	NULL
of	NULL
the	NULL
anti-gB	NULL
and	NULL
-gH	NULL
anti-sera	NULL
,	NULL
and	NULL
Dr.	NULL
S.	NULL
Keay	NULL
for	NULL
her	NULL
generous	NULL
gift	NULL
of	NULL
the	NULL
ald	NULL
and	NULL
control	NULL
anti-sera	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
S.-M.	NULL
Huong	NULL
for	NULL
her	NULL
valuable	NULL
technical	NULL
assistance	NULL
and	NULL
R.	NULL
Johnson	NULL
,	NULL
Dr.	NULL
R.	NULL
Scott	NULL
,	NULL
Dr.	NULL
L.	NULL
Su	NULL
,	NULL
and	NULL
B	NULL
.	NULL

Faith	NULL
for	NULL
their	NULL
critical	NULL
review	NULL
of	NULL
the	NULL
manuscript	NULL
and	NULL
helpful	NULL
discussions	NULL
.	NULL

Lastly	NULL
,	NULL
we	NULL
thank	NULL
Drs	NULL
.	NULL

H.-Y	NULL
.	NULL

Fu	NULL
and	NULL
Jennifer	NULL
Webster-Cyriaque	NULL
for	NULL
drawing	NULL
blood	NULL
and	NULL
our	NULL
valuable	NULL
blood	NULL
donors	NULL
for	NULL
their	NULL
invaluable	NULL
contributions	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Pike	NULL
,	NULL
M.	NULL
C.	NULL
1997	NULL
.	NULL

Structure	NULL
and	NULL
function	NULL
of	NULL
monocytes	NULL
and	NULL
macrophages	NULL
.	NULL

In	NULL
Arthritis	NULL
and	NULL
Allied	NULL
Conditions	NULL
:	NULL
A	NULL
Textbook	NULL
of	NULL
Rheumatology	NULL
.	NULL

W.	NULL
J.	NULL
Koopman	NULL
,	NULL
ed	NULL
.	NULL

Williams	NULL
and	NULL
Wilkins	NULL
,	NULL
Baltimore	NULL
,	NULL
p.	NULL
339	NULL
.	NULL

2	NULL
.	NULL

Inman	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
A.	NULL
Perl	NULL
,	NULL
and	NULL
P.	NULL
E.	NULL
Phillips	NULL
.	NULL

1997	NULL
.	NULL

Infectious	NULL
agents	NULL
in	NULL
chronic	NULL
rheumatic	NULL
diseases	NULL
.	NULL

In	NULL
Arthritis	NULL
and	NULL
Allied	NULL
Conditions	NULL
:	NULL
A	NULL
Textbook	NULL
of	NULL
Rheumatology	NULL
.	NULL

W.	NULL
J.	NULL
Koopman	NULL
,	NULL
ed	NULL
.	NULL

Williams	NULL
and	NULL
Wilkins	NULL
,	NULL
Baltimore	NULL
,	NULL
p.	NULL
585	NULL
.	NULL

3	NULL
.	NULL

Sher	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
G.	NULL
Colley	NULL
.	NULL

1989	NULL
.	NULL

Immunoparasitology	NULL
.	NULL

In	NULL
Fundamental	NULL
Immunology	NULL
.	NULL

W.	NULL
E.	NULL
Paul	NULL
,	NULL
ed	NULL
.	NULL

Raven	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
,	NULL
p.	NULL
957	NULL
.	NULL

4	NULL
.	NULL

Huang	NULL
,	NULL
E.-S.	NULL
,	NULL
and	NULL
T.	NULL
F.	NULL
Kowalik	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
pathogenicity	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
:	NULL
an	NULL
overview	NULL
.	NULL

In	NULL
Molecular	NULL
Aspects	NULL
of	NULL
Human	NULL
Cytomegalovirus	NULL
Diseases	NULL
.	NULL

Y.	NULL
Becker	NULL
,	NULL
G.	NULL
Darai	NULL
,	NULL
and	NULL
E.	NULL
S.	NULL
Huang	NULL
,	NULL
eds	NULL
.	NULL

Springer-Verlag	NULL
,	NULL
Berlin	NULL
,	NULL
p.	NULL
1	NULL
.	NULL

5	NULL
.	NULL

Yarchoan	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
S.	NULL
Broder	NULL
.	NULL

1989	NULL
.	NULL

Immunology	NULL
of	NULL
HIV	NULL
Infection	NULL
.	NULL

In	NULL
Fundamental	NULL
Immunology	NULL
.	NULL

W.	NULL
E.	NULL
Paul	NULL
,	NULL
ed	NULL
.	NULL

Raven	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
,	NULL
p.	NULL
957	NULL
.	NULL

6	NULL
.	NULL

Dudding	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
Haskill	NULL
,	NULL
B.	NULL
D.	NULL
Clark	NULL
,	NULL
P.	NULL
E.	NULL
Auron	NULL
,	NULL
S.	NULL
Sporn	NULL
,	NULL
and	NULL
E.	NULL
S.	NULL
Huang	NULL
.	NULL

1989	NULL
.	NULL

Cytomegalovirus	NULL
infection	NULL
stimulates	NULL
expression	NULL
of	NULL
monocyte-associated	NULL
mediator	NULL
genes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

143:3343	NULL
.	NULL

7	NULL
.	NULL

Fish	NULL
,	NULL
K.	NULL
N.	NULL
,	NULL
A.	NULL
S.	NULL
Depto	NULL
,	NULL
A.	NULL
V.	NULL
Moses	NULL
,	NULL
W.	NULL
Britt	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Nelson	NULL
.	NULL

1995	NULL
.	NULL

Growth	NULL
kinetics	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
are	NULL
altered	NULL
in	NULL
monocyte-derived	NULL
macrophages	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:3737	NULL
.	NULL

8	NULL
.	NULL

Fish	NULL
,	NULL
K.	NULL
N.	NULL
,	NULL
W.	NULL
Britt	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Nelson	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
novel	NULL
mechanism	NULL
for	NULL
persistence	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
in	NULL
macrophages	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:1855	NULL
.	NULL

9	NULL
.	NULL

Ibanez	NULL
,	NULL
C.	NULL
E.	NULL
,	NULL
R.	NULL
Schrier	NULL
,	NULL
P.	NULL
Ghazal	NULL
,	NULL
C.	NULL
Wiley	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Nelson	NULL
.	NULL

1991	NULL
.	NULL

Human	NULL
cytomegalovirus	NULL
productively	NULL
infects	NULL
primary	NULL
differentiated	NULL
macrophages	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:6581	NULL
.	NULL

10	NULL
.	NULL

Rice	NULL
,	NULL
G.	NULL
P.	NULL
A.	NULL
,	NULL
R.	NULL
D.	NULL
Schrier	NULL
,	NULL
and	NULL
M.	NULL
B	NULL
.	NULL

A.	NULL
Oldstone	NULL
.	NULL

1984	NULL
.	NULL

Cytomegalovirus	NULL
infects	NULL
human	NULL
lymphocytes	NULL
and	NULL
monocytes	NULL
:	NULL
virus	NULL
expression	NULL
is	NULL
restricted	NULL
to	NULL
IE	NULL
gene	NULL
products	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
81:6134	NULL
.	NULL

11	NULL
.	NULL

Soderberg-Naucler	NULL
,	NULL
C.	NULL
,	NULL
K.	NULL
N.	NULL
Fish	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Nelson	NULL
.	NULL

1997	NULL
.	NULL

Reactivation	NULL
of	NULL
latent	NULL
human	NULL
cytomegalovirus	NULL
by	NULL
allogeneic	NULL
stimulation	NULL
of	NULL
blood	NULL
cells	NULL
from	NULL
healthy	NULL
donors	NULL
.	NULL

Cell	NULL
91:119	NULL
.	NULL

12	NULL
.	NULL

Taylor-Wiedman	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
Sissons	NULL
,	NULL
and	NULL
J.	NULL
Sinclair	NULL
.	NULL

1994	NULL
.	NULL

Induction	NULL
of	NULL
endogenous	NULL
human	NULL
cytomegalovirus	NULL
gene	NULL
expression	NULL
after	NULL
differentiation	NULL
of	NULL
monocytes	NULL
from	NULL
health	NULL
carriers	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:1597	NULL
.	NULL

13	NULL
.	NULL

Kondo	NULL
,	NULL
K.	NULL
,	NULL
H.	NULL
Kaneshima	NULL
,	NULL
and	NULL
E.	NULL
S.	NULL
Mocarski	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
cytomegalovirus	NULL
latent	NULL
infection	NULL
of	NULL
granulocyte-macrophage	NULL
progenitors	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:11879	NULL
.	NULL

14	NULL
.	NULL

Haskill	NULL
,	NULL
S.	NULL
,	NULL
L.	NULL
Dudding	NULL
,	NULL
and	NULL
E.-S.	NULL
Huang	NULL
.	NULL

1993	NULL
.	NULL

Cytomegalovirus	NULL
and	NULL
macro-phage	NULL
interactions	NULL
.	NULL

In	NULL
Molecular	NULL
Aspects	NULL
of	NULL
Human	NULL
Cytomegalovirus	NULL
Diseases	NULL
.	NULL

Y.	NULL
Becker	NULL
,	NULL
G.	NULL
Darai	NULL
,	NULL
and	NULL
E.	NULL
S.	NULL
Huang	NULL
,	NULL
eds	NULL
.	NULL

Springer-Verlag	NULL
,	NULL
Berlin	NULL
,	NULL
p.	NULL
101	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

Gura	NULL
,	NULL
T.	NULL
1998	NULL
.	NULL

Infections	NULL
:	NULL
a	NULL
cause	NULL
of	NULL
artery-clogging	NULL
plaques	NULL
?	NULL

Science	NULL
281:35	NULL
.	NULL

Murayama	NULL
,	NULL
T.	NULL
,	NULL
N.	NULL
Mukaida	NULL
,	NULL
K.	NULL
S.	NULL
A.	NULL
Khabar	NULL
,	NULL
and	NULL
K.	NULL
Matsushima	NULL
.	NULL

1998	NULL
.	NULL

Potential	NULL
involvement	NULL
of	NULL
IL-8	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
infection	NULL
.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

64:62	NULL
.	NULL

Kline	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
L.	NULL
J.	NULL
Geist	NULL
,	NULL
M.	NULL
M.	NULL
Monick	NULL
,	NULL
M.	NULL
F.	NULL
Stinski	NULL
,	NULL
and	NULL
G.	NULL
W.	NULL
Hunninghake	NULL
.	NULL

1994	NULL
.	NULL

Regulation	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
IL-1	NULL
receptor	NULL
antagonist	NULL
(	NULL
IL-Ira	NULL
)	NULL
gene	NULL
by	NULL
products	NULL
of	NULL
the	NULL
human	NULL
cytomegalovirus	NULL
immediate	NULL
early	NULL
genes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

152	NULL
;	NULL
2351	NULL
.	NULL

Smith	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
S.	NULL
S.	NULL
Saini	NULL
,	NULL
M.	NULL
Raffeld	NULL
,	NULL
M.	NULL
Manischewitz	NULL
,	NULL
and	NULL
S.	NULL
M.	NULL
Wahl	NULL
.	NULL

1992	NULL
.	NULL

Cytomegalovirus	NULL
induction	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
by	NULL
human	NULL
monocytes	NULL
and	NULL
mucosal	NULL
macrophages	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

90:1642	NULL
.	NULL

Turtinen	NULL
,	NULL
L.	NULL
W.	NULL
,	NULL
A.	NULL
Assimacopoulos	NULL
,	NULL
and	NULL
A.	NULL
T.	NULL
Haase	NULL
.	NULL

1989	NULL
.	NULL

Increased	NULL
monokines	NULL
in	NULL
cytomegalovirus	NULL
infected	NULL
myelomonocytic	NULL
cell	NULL
cultures	NULL
.	NULL

Microb	NULL
.	NULL

Pathog	NULL
.	NULL

7:135	NULL
.	NULL

Clouse	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
P.	NULL
B.	NULL
Robbins	NULL
,	NULL
B.	NULL
Fernie	NULL
,	NULL
J.	NULL
M.	NULL
Ostrove	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1989	NULL
.	NULL

Viral	NULL
antigen	NULL
stimulation	NULL
of	NULL
the	NULL
production	NULL
of	NULL
human	NULL
monokines	NULL
capable	NULL
of	NULL
regulating	NULL
HIV1	NULL
expression	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

143:470	NULL
.	NULL

Geist	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
M.	NULL
M.	NULL
Monick	NULL
,	NULL
M.	NULL
F.	NULL
Stinski	NULL
,	NULL
and	NULL
G.	NULL
W.	NULL
Hunninghake	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
immediate	NULL
early	NULL
genes	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
upregulate	NULL
tumor	NULL
necrosis	NULL
fac-gene	NULL
expression	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

93:474	NULL
.	NULL

Iwamoto	NULL
,	NULL
G.	NULL
K.	NULL
,	NULL
M.	NULL
M.	NULL
Monick	NULL
,	NULL
B.	NULL
D.	NULL
Clark	NULL
,	NULL
P.	NULL
E.	NULL
Auron	NULL
,	NULL
M.	NULL
F.	NULL
Stinski	NULL
,	NULL
and	NULL
G.	NULL
W.	NULL
Hunninghake	NULL
.	NULL

1990	NULL
.	NULL

Modulation	NULL
of	NULL
interleukin	NULL
13	NULL
gene	NULL
expression	NULL
by	NULL
the	NULL
immediate	NULL
early	NULL
genes	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

85:1853	NULL
.	NULL

Simmons	NULL
,	NULL
P.	NULL
,	NULL
K.	NULL
Kaushansky	NULL
,	NULL
and	NULL
B.	NULL
Torok-Storb	NULL
.	NULL

1990	NULL
.	NULL

Mechanisms	NULL
of	NULL
cyto-megalovirus-mediated	NULL
myelosuppression	NULL
:	NULL
perturbation	NULL
of	NULL
stromal	NULL
cell	NULL
function	NULL
versus	NULL
direct	NULL
infection	NULL
of	NULL
myeloid	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:1386	NULL
.	NULL

Wahren	NULL
,	NULL
B.	NULL
,	NULL
P.	NULL
Ljungman	NULL
,	NULL
T.	NULL
Paulin	NULL
,	NULL
and	NULL
O.	NULL
Ringden	NULL
.	NULL

1986	NULL
.	NULL

Enhancive	NULL
and	NULL
sup-pressive	NULL
effects	NULL
of	NULL
cytomegalovirus	NULL
on	NULL
human	NULL
lymphocyte	NULL
responses	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

58:909	NULL
.	NULL

Carny	NULL
,	NULL
W.	NULL
P.	NULL
,	NULL
and	NULL
M.	NULL
S.	NULL
Hirsch	NULL
.	NULL

1981	NULL
.	NULL

Mechanisms	NULL
of	NULL
immunosuppression	NULL
in	NULL
cytomegalovirus	NULL
mononucleosis	NULL
.	NULL

II	NULL
.	NULL

Virus-monocyte	NULL
interactions	NULL
.	NULL

J.	NULL
Infect	NULL
.	NULL

Dis	NULL
.	NULL

144:47	NULL
.	NULL

Yurochko	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
M.	NULL
W.	NULL
Mayo	NULL
,	NULL
E.	NULL
E.	NULL
Poma	NULL
,	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
E.-S.	NULL
Huang	NULL
.	NULL

1997	NULL
.	NULL

Induction	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
Sp1	NULL
during	NULL
human	NULL
cytomegalovirus	NULL
infection	NULL
mediates	NULL
upregulation	NULL
of	NULL
the	NULL
p65	NULL
and	NULL
p105/p50	NULL
NF-	NULL
«	NULL
B	NULL
promoters	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:4638	NULL
.	NULL

Yurochko	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
T.	NULL
F.	NULL
Kowalik	NULL
,	NULL
S.-M.	NULL
Huong	NULL
,	NULL
and	NULL
E.-S.	NULL
Huang	NULL
.	NULL

1995	NULL
.	NULL

HCMV	NULL
upregulates	NULL
NF-KB	NULL
activity	NULL
by	NULL
transactivating	NULL
the	NULL
NF-KB	NULL
p105/p50-	NULL
and	NULL
p65-promoters	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:5391	NULL
.	NULL

Albrecht	NULL
,	NULL
T.	NULL
,	NULL
I.	NULL
Boldogh	NULL
,	NULL
M.	NULL
P.	NULL
Fons	NULL
,	NULL
and	NULL
T.	NULL
Valyi-Nagy	NULL
.	NULL

1993	NULL
.	NULL

Activation	NULL
of	NULL
proto-oncogenes	NULL
and	NULL
cell	NULL
activation	NULL
signals	NULL
in	NULL
the	NULL
initiation	NULL
and	NULL
progression	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
infection	NULL
.	NULL

In	NULL
Molecular	NULL
Aspects	NULL
of	NULL
Human	NULL
Cytomegalovirus	NULL
Diseases	NULL
.	NULL

Y.	NULL
Becker	NULL
,	NULL
G.	NULL
Darai	NULL
,	NULL
and	NULL
B.	NULL
S.	NULL
Huang	NULL
,	NULL
eds	NULL
.	NULL

Springer-Verlag	NULL
,	NULL
Berlin	NULL
,	NULL
p.	NULL
384	NULL
.	NULL

Boldogh	NULL
,	NULL
I.	NULL
,	NULL
M.	NULL
P.	NULL
Fons	NULL
,	NULL
and	NULL
T.	NULL
Albrecht	NULL
.	NULL

1993	NULL
.	NULL

Increased	NULL
levels	NULL
of	NULL
sequence-specific	NULL
DNA-binding	NULL
proteins	NULL
in	NULL
human	NULL
cytomegalovirus-infected	NULL
cells	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

197:1505	NULL
.	NULL

Sambucetti	NULL
,	NULL
L.	NULL
C.	NULL
,	NULL
J.	NULL
M.	NULL
Cherrington	NULL
,	NULL
G.	NULL
W.	NULL
Wilkinson	NULL
,	NULL
and	NULL
E.	NULL
S.	NULL
Mocarski	NULL
.	NULL

1989	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
activation	NULL
of	NULL
the	NULL
cytomegalovirus	NULL
enhancer	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
viral	NULL
trans-activator	NULL
and	NULL
by	NULL
T	NULL
cell	NULL
stimulation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:4251	NULL
.	NULL

Boldogh	NULL
,	NULL
I.	NULL
,	NULL
S.	NULL
AbuBakar	NULL
,	NULL
and	NULL
T.	NULL
Albrecht	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
of	NULL
proto-oncogenes	NULL
:	NULL
an	NULL
immediate	NULL
carly	NULL
event	NULL
in	NULL
human	NULL
cytomegalovirus	NULL
.	NULL

Science	NULL
247:561	NULL
.	NULL

Yurochko	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
E.-S.	NULL
Hwang	NULL
,	NULL
L.	NULL
Rasmussen	NULL
,	NULL
S.	NULL
Keay	NULL
,	NULL
L.	NULL
Pereira	NULL
,	NULL
and	NULL
E.-S.	NULL
Huang	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
human	NULL
cytomegalovirus	NULL
ULS55	NULL
(	NULL
gB	NULL
)	NULL
and	NULL
UL75	NULL
(	NULL
gH	NULL
)	NULL
glycoprotein	NULL
ligands	NULL
initiate	NULL
the	NULL
rapid	NULL
activation	NULL
of	NULL
Sp1	NULL
and	NULL
NF-KB	NULL
during	NULL
infection	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:5051	NULL
.	NULL

Kowalik	NULL
,	NULL
T.	NULL
F.	NULL
,	NULL
B	NULL
.	NULL

Wing	NULL
,	NULL
J.	NULL
S.	NULL
Haskill	NULL
,	NULL
J.	NULL
C.	NULL
Azizkhan	NULL
,	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
E.-S.	NULL
Huang	NULL
.	NULL

1993	NULL
.	NULL

Multiple	NULL
mechanisms	NULL
are	NULL
implicated	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
during	NULL
human	NULL
cytomegalovirus	NULL
infection	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:1107	NULL
.	NULL

Stenberg	NULL
,	NULL
R.	NULL
M.	NULL
1993	NULL
.	NULL

Immediate-early	NULL
genes	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
:	NULL
organization	NULL
and	NULL
function	NULL
.	NULL

In	NULL
Molecular	NULL
Aspects	NULL
of	NULL
Human	NULL
Cytomegalovirus	NULL
Diseases	NULL
.	NULL

Y.	NULL
Becker	NULL
,	NULL
G.	NULL
Darai	NULL
,	NULL
and	NULL
E.	NULL
S.	NULL
Huang	NULL
,	NULL
eds	NULL
.	NULL

Springer-Verlag	NULL
,	NULL
Berlin	NULL
,	NULL
p.	NULL
330	NULL
.	NULL

Cherrington	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
E.	NULL
S.	NULL
Mocarski	NULL
.	NULL

1989	NULL
.	NULL

Human	NULL
cytomegalovirus	NULL
ic1	NULL
trans-activates	NULL
the	NULL
«	NULL
@	NULL
promoter-enhancer	NULL
via	NULL
an	NULL
18-base-pair	NULL
repeat	NULL
clement	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:1435	NULL
.	NULL

Albrecht	NULL
,	NULL
T.	NULL
,	NULL
M.	NULL
P.	NULL
Fons	NULL
,	NULL
I.	NULL
Boldogh	NULL
,	NULL
S.	NULL
AbuBakar	NULL
,	NULL
C.	NULL
Z.	NULL
Deng	NULL
,	NULL
and	NULL
D.	NULL
Millinoff	NULL
.	NULL

1991	NULL
.	NULL

Metabolic	NULL
and	NULL
cellular	NULL
effects	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
infection	NULL
.	NULL

Trans-plant	NULL
.	NULL

Proc	NULL
.	NULL

23:48	NULL
.	NULL

Yurochko	NULL
,	NULL
A.	NULL
D.	NULL
1997	NULL
.	NULL

Adhesion	NULL
molecules	NULL
as	NULL
signal	NULL
transduction	NULL
molecules	NULL
.	NULL

In	NULL
Targeting	NULL
-	NULL
Cell	NULL
-	NULL
Adhesion	NULL
-	NULL
Molecules	NULL
-	NULL
for	NULL
-	NULL
Therapeutic	NULL
-	NULL
Application	NULL
.	NULL

L.	NULL
C.	NULL
Paul	NULL
and	NULL
T.	NULL
Issekutz	NULL
,	NULL
eds	NULL
.	NULL

Marcel	NULL
Dekker	NULL
,	NULL
New	NULL
York	NULL
,	NULL
p.	NULL
155	NULL
.	NULL

Keay	NULL
,	NULL
S.	NULL
,	NULL
B.	NULL
Baldwin	NULL
,	NULL
M.	NULL
W.	NULL
Smith	NULL
,	NULL
S.	NULL
S.	NULL
Wasserman	NULL
,	NULL
and	NULL
W.	NULL
F.	NULL
Goldman	NULL
.	NULL

1995	NULL
.	NULL

Increases	NULL
in	NULL
[	NULL
Ca	NULL
``	NULL
*	NULL
]	NULL
;	NULL
mediated	NULL
by	NULL
the	NULL
92.5-kDa	NULL
putative	NULL
cell	NULL
membrane	NULL
receptor	NULL
for	NULL
HCMV	NULL
gp86	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

269	NULL
:	NULL
C11	NULL
.	NULL

Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
1996	NULL
.	NULL

The	NULL
NF-kB	NULL
and	NULL
IB	NULL
proteins	NULL
:	NULL
new	NULL
discoveries	NULL
and	NULL
insights	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:649	NULL
.	NULL

Kumar	NULL
,	NULL
S.	NULL
,	NULL
P.	NULL
C.	NULL
McDonnell	NULL
,	NULL
R.	NULL
J.	NULL
Gum	NULL
,	NULL
A.	NULL
T.	NULL
Hand	NULL
,	NULL
J.	NULL
C.	NULL
Lee	NULL
,	NULL
and	NULL
P.	NULL
R.	NULL
Young	NULL
.	NULL

1997	NULL
.	NULL

Novel	NULL
homologues	NULL
of	NULL
CSBP/p38	NULL
MAP	NULL
kinase	NULL
:	NULL
activation	NULL
,	NULL
substrate	NULL
specificity	NULL
and	NULL
sensitivity	NULL
to	NULL
inhibition	NULL
by	NULL
pyridinyl	NULL
imidazoles	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

235:533	NULL
.	NULL

Johnson	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
S.-M.	NULL
Huong	NULL
,	NULL
and	NULL
E.-S.	NULL
Huang	NULL
.	NULL

1999	NULL
.	NULL

Inhibitory	NULL
effect	NULL
of	NULL
[	NULL
4-	NULL
(	NULL
4-fluo-ropheny1	NULL
)	NULL
-2-	NULL
(	NULL
4-hydroxypheny1	NULL
)	NULL
-5-	NULL
(	NULL
4-pyridy1	NULL
)	NULL
1H-imidazole	NULL
}	NULL
(	NULL
FHPT	NULL
)	NULL
on	NULL
HCMV	NULL
DNA	NULL
replication	NULL
and	NULL
permissive	NULL
infection	NULL
.	NULL

Antiviral	NULL
Res	NULL
.	NULL

In	NULL
press	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

4815	NULL
Yurochko	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
D.	NULL
Y.	NULL
Liu	NULL
,	NULL
D.	NULL
Eierman	NULL
,	NULL
and	NULL
S.	NULL
Haskill	NULL
.	NULL

1992	NULL
.	NULL

Integrins	NULL
as	NULL
a	NULL
primary	NULL
signal	NULL
transduction	NULL
molecule	NULL
regulating	NULL
monocyte	NULL
immediate-early	NULL
gene	NULL
induction	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:9034	NULL
.	NULL

Shapiro	NULL
,	NULL
L.	NULL
,	NULL
K.	NULL
A.	NULL
Heidenreich	NULL
,	NULL
M.	NULL
K.	NULL
Meintzer	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Dinarello	NULL
.	NULL

1998	NULL
.	NULL

Role	NULL
of	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
HIV	NULL
type	NULL
1	NULL
production	NULL
in	NULL
vitro	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95:7422	NULL
.	NULL

Dudley	NULL
,	NULL
D.	NULL
T.	NULL
,	NULL
L.	NULL
Pang	NULL
,	NULL
S.	NULL
J.	NULL
Decker	NULL
,	NULL
A.	NULL
J.	NULL
Bridges	NULL
,	NULL
and	NULL
A.	NULL
R.	NULL
Saltiel	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
synthetic	NULL
inhibitor	NULL
of	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
cascade	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:7686	NULL
.	NULL

Rasmussen	NULL
,	NULL
L.	NULL
,	NULL
J.	NULL
Mullenax	NULL
,	NULL
R.	NULL
Nelson	NULL
,	NULL
and	NULL
T.	NULL
C.	NULL
Merigan	NULL
.	NULL

1985	NULL
.	NULL

Viral	NULL
polypep-tides	NULL
detected	NULL
by	NULL
a	NULL
complement-dependent	NULL
neutralizing	NULL
murine	NULL
monoclonal	NULL
antibody	NULL
to	NULL
human	NULL
cytomegalovirus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

55:274	NULL
.	NULL

Rasmussen	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
R.	NULL
M.	NULL
Nelson	NULL
,	NULL
D.	NULL
C.	NULL
Kelsall	NULL
,	NULL
and	NULL
T.	NULL
C.	NULL
Merigan	NULL
.	NULL

1984	NULL
.	NULL

Murine	NULL
monoclonal	NULL
antibody	NULL
to	NULL
a	NULL
single	NULL
protein	NULL
neutralizes	NULL
the	NULL
infectivity	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
81:876	NULL
.	NULL

Keay	NULL
,	NULL
S.	NULL
,	NULL
L.	NULL
Rasmussen	NULL
,	NULL
and	NULL
L.	NULL
Merigan	NULL
.	NULL

1988	NULL
.	NULL

Syngeneic	NULL
monoclonal	NULL
anti-idiotypic	NULL
antibodies	NULL
that	NULL
bear	NULL
the	NULL
internal	NULL
image	NULL
of	NULL
a	NULL
human	NULL
cytomegalovirus	NULL
neutralization	NULL
epitope	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

140:944	NULL
.	NULL

Keay	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
B.	NULL
Baldwin	NULL
.	NULL

1991	NULL
.	NULL

Anti-idiotypic	NULL
antibodies	NULL
that	NULL
mimic	NULL
gp86	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
inhibit	NULL
viral	NULL
fusion	NULL
but	NULL
not	NULL
attachment	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:5124	NULL
.	NULL

Keay	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
C.	NULL
Merigan	NULL
,	NULL
and	NULL
L.	NULL
Rasmussen	NULL
.	NULL

1989	NULL
.	NULL

Identification	NULL
of	NULL
cell	NULL
surface	NULL
receptors	NULL
for	NULL
the	NULL
86-kilodalton	NULL
glycoprotein	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:10100	NULL
.	NULL

Keay	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
B.	NULL
R.	NULL
Baldwin	NULL
.	NULL

1996	NULL
.	NULL

Evidence	NULL
for	NULL
the	NULL
role	NULL
of	NULL
cell	NULL
phosphorylation	NULL
in	NULL
human	NULL
cytomegalovirus/host	NULL
cell	NULL
fusion	NULL
.	NULL

J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

77:2597	NULL
.	NULL

Haskill	NULL
,	NULL
S.	NULL
,	NULL
C.	NULL
Johnson	NULL
,	NULL
D.	NULL
Eierman	NULL
,	NULL
S.	NULL
Becker	NULL
,	NULL
and	NULL
K.	NULL
Warren	NULL
.	NULL

1988	NULL
.	NULL

Adherence	NULL
induces	NULL
selective	NULL
mRNA	NULL
expression	NULL
of	NULL
monocyte	NULL
mediators	NULL
and	NULL
proto-onco-genes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

140:1690	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
V.	NULL
Blank	NULL
,	NULL
F.	NULL
Legeat	NULL
,	NULL
J.	NULL
Vandkerckhove	NULL
,	NULL
F.	NULL
Lottseich	NULL
,	NULL
O	NULL
.	NULL

Le	NULL
Bail	NULL
,	NULL
M.	NULL
B	NULL
.	NULL

Urban	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-KB	NULL
is	NULL
identical	NULL
to	NULL
factor	NULL
KBF1	NULL
and	NULL
homologous	NULL
to	NULL
the	NULL
ref	NULL
oncogene	NULL
product	NULL
.	NULL

Cell	NULL
62:1007	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
P.	NULL
J.	NULL
Dillon	NULL
,	NULL
R.	NULL
Schreck	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
C.	NULL
H.	NULL
Chen	NULL
,	NULL
M.	NULL
Maher	NULL
,	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1991	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
re-related	NULL
human	NULL
cDNA	NULL
that	NULL
potentially	NULL
encodes	NULL
the	NULL
65-kD	NULL
subunit	NULL
of	NULL
NF-kB	NULL
.	NULL

Science	NULL
251:1490	NULL
,	NULL
Haskill	NULL
,	NULL
S.	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Beg	NULL
,	NULL
S.	NULL
M.	NULL
Tompkins	NULL
,	NULL
J.	NULL
S.	NULL
Morris	NULL
,	NULL
A.	NULL
D.	NULL
Yurochko	NULL
,	NULL
A.	NULL
Sampson-Johannes	NULL
,	NULL
K.	NULL
Mondal	NULL
,	NULL
P.	NULL
Ralph	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1991	NULL
.	NULL

Characterization	NULL
of	NULL
an	NULL
immediate-early	NULL
gene	NULL
induced	NULL
in	NULL
adherent	NULL
monocytes	NULL
that	NULL
encodes	NULL
IxB-like	NULL
activity	NULL
.	NULL

Cell	NULL
65:1281	NULL
.	NULL

Albelda	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Buck	NULL
.	NULL

1990	NULL
.	NULL

Integrins	NULL
and	NULL
other	NULL
cell	NULL
adhesion	NULL
molecule	NULL
.	NULL

FASEB	NULL
J	NULL
.	NULL

4:2868	NULL
.	NULL

Osborn	NULL
,	NULL
L.	NULL
1990	NULL
.	NULL

Leukocyte	NULL
adhesion	NULL
to	NULL
endothelium	NULL
in	NULL
inflammation	NULL
.	NULL

Cell	NULL
62:3	NULL
.	NULL

Span	NULL
,	NULL
A.	NULL
H.	NULL
M.	NULL
,	NULL
M.	NULL
C.	NULL
E.	NULL
Van	NULL
Dam-Micras	NULL
,	NULL
W.	NULL
Mullers	NULL
,	NULL
J.	NULL
Endert	NULL
,	NULL
A.	NULL
D.	NULL
Muller	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Bruggeman	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
virus	NULL
infection	NULL
on	NULL
the	NULL
adherence	NULL
of	NULL
leukocytes	NULL
or	NULL
platelets	NULL
to	NULL
endothelial	NULL
cells	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

21:331	NULL
.	NULL

Waldman	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
D.	NULL
A.	NULL
Knight	NULL
,	NULL
E.	NULL
H.	NULL
Huang	NULL
,	NULL
and	NULL
D.	NULL
D.	NULL
Sedmak	NULL
.	NULL

1995	NULL
.	NULL

Bidirectional	NULL
transmission	NULL
of	NULL
infectious	NULL
cytomegalovirus	NULL
between	NULL
monocytes	NULL
and	NULL
vascular	NULL
endothelial	NULL
cells	NULL
:	NULL
an	NULL
in	NULL
vitro	NULL
model	NULL
.	NULL

J.	NULL
Infect	NULL
.	NULL

Dis	NULL
.	NULL

171:263	NULL
.	NULL

Guetta	NULL
,	NULL
E.	NULL
,	NULL
V.	NULL
Guetta	NULL
,	NULL
T.	NULL
Shibutani	NULL
,	NULL
and	NULL
S.	NULL
E.	NULL
Epstein	NULL
.	NULL

1997	NULL
.	NULL

Monocytes	NULL
harboring	NULL
cytomegalovirus	NULL
:	NULL
interactions	NULL
with	NULL
endothelial	NULL
cells	NULL
,	NULL
smooth	NULL
muscle	NULL
cells	NULL
,	NULL
and	NULL
oxidized	NULL
low-density	NULL
lipoprotein	NULL
.	NULL

Circ	NULL
.	NULL

Res	NULL
.	NULL

81:8	NULL
.	NULL

Sporn	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
D.	NULL
F.	NULL
Bierman	NULL
,	NULL
C.	NULL
E.	NULL
Johnson	NULL
,	NULL
J.	NULL
Morris	NULL
,	NULL
G.	NULL
Martin	NULL
,	NULL
M.	NULL
Ladner	NULL
,	NULL
and	NULL
S.	NULL
Haskill	NULL
.	NULL

1990	NULL
.	NULL

Monocyte	NULL
adherence	NULL
results	NULL
in	NULL
selective	NULL
induction	NULL
of	NULL
novel	NULL
genes	NULL
sharing	NULL
homology	NULL
with	NULL
mediators	NULL
of	NULL
inflammation	NULL
and	NULL
tissue	NULL
repair	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144:4434	NULL
.	NULL

Eierman	NULL
,	NULL
D.	NULL
F.	NULL
,	NULL
C.	NULL
E.	NULL
Johnson	NULL
,	NULL
and	NULL
J.	NULL
S.	NULL
Haskill	NULL
.	NULL

1989	NULL
.	NULL

Human	NULL
monocyte	NULL
inflammatory	NULL
mediator	NULL
gene	NULL
expression	NULL
is	NULL
selectively	NULL
regulated	NULL
by	NULL
adherence	NULL
substrates	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

140:1690	NULL
.	NULL

Kerry	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
M.	NULL
A.	NULL
Priddy	NULL
,	NULL
T.	NULL
L.	NULL
Staley	NULL
,	NULL
T.	NULL
R.	NULL
Jones	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Stenberg	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
role	NULL
of	NULL
ATF	NULL
in	NULL
regulating	NULL
the	NULL
human	NULL
cytomegalovirus	NULL
DNA	NULL
polymerase	NULL
(	NULL
UL54	NULL
)	NULL
promoter	NULL
during	NULL
viral	NULL
infection	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

77:2120	NULL
.	NULL

Suyang	NULL
,	NULL
H.	NULL
,	NULL
R.	NULL
Phillips	NULL
,	NULL
I.	NULL
Douglas	NULL
,	NULL
and	NULL
S.	NULL
Ghosh	NULL
.	NULL

1996	NULL
.	NULL

Role	NULL
of	NULL
unphosphory-lated	NULL
,	NULL
newly	NULL
synthesized	NULL
IBB	NULL
in	NULL
persistent	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:5444	NULL
.	NULL

Thompson	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
R.	NULL
J.	NULL
Phillips	NULL
,	NULL
H.	NULL
Erdjument-Bromage	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
and	NULL
S.	NULL
Ghosh	NULL
.	NULL

1995	NULL
.	NULL

IxB-	NULL
$	NULL
regulates	NULL
the	NULL
persistent	NULL
response	NULL
in	NULL
a	NULL
biphasic	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Cell	NULL
80:573	NULL
.	NULL

Raingeaud	NULL
,	NULL
J.	NULL
,	NULL
S.	NULL
Gupta	NULL
,	NULL
J.	NULL
S.	NULL
Rogers	NULL
,	NULL
M.	NULL
Dickens	NULL
,	NULL
M.	NULL
Han	NULL
,	NULL
R.	NULL
J.	NULL
Ulevitch	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Davis	NULL
.	NULL

1995	NULL
.	NULL

Pro-inflammatory	NULL
cytokines	NULL
and	NULL
environmental	NULL
stress	NULL
cause	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
activation	NULL
by	NULL
dual	NULL
phosphorylation	NULL
on	NULL
ty-rosine	NULL
and	NULL
threonine	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:7420	NULL
.	NULL

Bergelson	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
R.	NULL
W.	NULL
Finberg	NULL
.	NULL

1993	NULL
.	NULL

Integrins	NULL
as	NULL
receptors	NULL
for	NULL
virus	NULL
attachment	NULL
and	NULL
cell	NULL
entry	NULL
.	NULL

Trends	NULL
Microbiol	NULL
.	NULL

1:287	NULL
.	NULL

Montgomery	NULL
,	NULL
R.	NULL
I.	NULL
,	NULL
M.	NULL
S.	NULL
Warmer	NULL
,	NULL
B.	NULL
J.	NULL
Lum	NULL
,	NULL
and	NULL
P.	NULL
G.	NULL
Spear	NULL
.	NULL

1996	NULL
.	NULL

Herpes	NULL
simplex	NULL
virus-1	NULL
entry	NULL
into	NULL
cells	NULL
mediated	NULL
by	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
TNE/NGF	NULL
receptor	NULL
family	NULL
.	NULL

Cell	NULL
87:427	NULL
.	NULL

Dalgliesh	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
P.	NULL
C.	NULL
L.	NULL
Beverley	NULL
,	NULL
P.	NULL
R.	NULL
Clapham	NULL
,	NULL
D.	NULL
H.	NULL
Crawford	NULL
,	NULL
M.	NULL
F.	NULL
Greaves	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Weiss	NULL
.	NULL

1984	NULL
.	NULL

The	NULL
CD4	NULL
(	NULL
T4	NULL
)	NULL
antigen	NULL
is	NULL
an	NULL
essential	NULL
component	NULL
of	NULL
the	NULL
receptor	NULL
for	NULL
the	NULL
AIDS	NULL
retrovirus	NULL
.	NULL

Nature	NULL
312:763	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
4816	NULL
69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

Tanner	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
C.	NULL
Alfieri	NULL
,	NULL
T.	NULL
A.	NULL
Chatila	NULL
,	NULL
and	NULL
F.	NULL
Diaz-Mitoma	NULL
.	NULL

1996	NULL
.	NULL

Induction	NULL
of	NULL
interleukin-6	NULL
after	NULL
stimulation	NULL
of	NULL
human	NULL
B-cell	NULL
CD21	NULL
by	NULL
Epstein-Barr	NULL
virus	NULL
glycoproteins	NULL
gp350	NULL
and	NULL
gp220	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:570	NULL
.	NULL

Marsters	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
T.	NULL
M.	NULL
Ayres	NULL
,	NULL
M.	NULL
Skubatch	NULL
,	NULL
C.	NULL
L.	NULL
Gray	NULL
,	NULL
M.	NULL
Rothe	NULL
,	NULL
and	NULL
A.	NULL
Ashkenazi	NULL
.	NULL

1997	NULL
.	NULL

Herpesvirus	NULL
entry	NULL
mediator	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
(	NULL
TNFR	NULL
)	NULL
family	NULL
,	NULL
interacts	NULL
with	NULL
members	NULL
of	NULL
the	NULL
TNFR-associated	NULL
factor	NULL
family	NULL
and	NULL
activates	NULL
the	NULL
transcription	NULL
factors	NULL
NF-KB	NULL
and	NULL
AP-1	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:14029	NULL
.	NULL

Su	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Schneider	NULL
.	NULL

1996	NULL
.	NULL

Hepatitis	NULL
B	NULL
virus	NULL
HBx	NULL
protein	NULL
activates	NULL
transcription	NULL
factor	NULL
NF-KB	NULL
by	NULL
acting	NULL
on	NULL
multiple	NULL
cytoplasmic	NULL
inhibitors	NULL
of	NULL
rel-related	NULL
proteins	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:4558	NULL
.	NULL

Demarchi	NULL
,	NULL
F.	NULL
,	NULL
F.	NULL
d	NULL
'	NULL
Adda	NULL
di	NULL
Fagagna	NULL
,	NULL
A.	NULL
Falaschi	NULL
,	NULL
and	NULL
M.	NULL
Giacca	NULL
.	NULL

1996	NULL
.	NULL

Activation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-KB	NULL
by	NULL
the	NULL
Tat	NULL
protein	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:4427	NULL
.	NULL

Lindholm	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
M.	NULL
Tamami	NULL
,	NULL
J.	NULL
Makowski	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Brady	NULL
.	NULL

1996	NULL
.	NULL

Human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
1	NULL
Tax	NULL
;	NULL
activation	NULL
of	NULL
NF-KB	NULL
:	NULL
Involvement	NULL
of	NULL
the	NULL
protein	NULL
kinase	NULL
C	NULL
pathway	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:2525	NULL
.	NULL

Dixit	NULL
,	NULL
V.	NULL
M.	NULL
,	NULL
S.	NULL
Green	NULL
,	NULL
V.	NULL
Sarma	NULL
,	NULL
L.	NULL
B.	NULL
Holzman	NULL
,	NULL
F.	NULL
W.	NULL
Wolf	NULL
,	NULL
K.	NULL
O'Rourke	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

Ward	NULL
,	NULL
E.	NULL
V.	NULL
Prochownik	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Marks	NULL
.	NULL

1990	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor-a	NULL
75	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

78	NULL
.	NULL

79	NULL
.	NULL

HCMV	NULL
ACTIVATES	NULL
MONOCYTES	NULL
induction	NULL
of	NULL
novel	NULL
gene	NULL
products	NULL
in	NULL
human	NULL
endothelial	NULL
cells	NULL
including	NULL
a	NULL
macro-phage-specific	NULL
chemotaxin	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265:2973	NULL
.	NULL

Opipari	NULL
,	NULL
A.	NULL
W.	NULL
,	NULL
H.	NULL
M.	NULL
Hu	NULL
,	NULL
R.	NULL
Yabkowitz	NULL
,	NULL
and	NULL
V.	NULL
M.	NULL
Dixit	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
A20	NULL
zinc	NULL
finger	NULL
protein	NULL
protects	NULL
cells	NULL
from	NULL
tumor	NULL
necrosis	NULL
factor	NULL
cytotoxicity	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:4572	NULL
.	NULL

Muganda	NULL
,	NULL
P.	NULL
,	NULL
O	NULL
.	NULL

Mendoza	NULL
.	NULL

,	NULL
J.	NULL
Hernandez	NULL
,	NULL
and	NULL
Q.	NULL
Qian	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
cytomegalovirus	NULL
elevates	NULL
levels	NULL
of	NULL
the	NULL
cellular	NULL
protein	NULL
p53	NULL
in	NULL
infected	NULL
fibroblasts	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:8028	NULL
.	NULL

Fries	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
W.	NULL
E.	NULL
Miller	NULL
,	NULL
and	NULL
N.	NULL
Raab-Traub	NULL
.	NULL

1996	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
blocks	NULL
p53-mediated	NULL
apoptosis	NULL
through	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
A20	NULL
gene	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:8653	NULL
.	NULL

Fublbrigge	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
D.	NULL
D.	NULL
Chaplin	NULL
,	NULL
J.	NULL
M.	NULL
Kiely	NULL
,	NULL
and	NULL
E.	NULL
R.	NULL
Unanue	NULL
.	NULL

1987	NULL
.	NULL

Regulation	NULL
of	NULL
interleukin	NULL
1	NULL
gene	NULL
expression	NULL
by	NULL
adherence	NULL
and	NULL
lipopolysaccharide	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

138:3799	NULL
.	NULL

Thorens	NULL
,	NULL
B.	NULL
,	NULL
J.	NULL
J.	NULL
Mermod	NULL
,	NULL
and	NULL
P.	NULL
Vassalli	NULL
.	NULL

1987	NULL
.	NULL

Phagocytosis	NULL
and	NULL
inflammatory	NULL
stimuli	NULL
induce	NULL
GM-CSF	NULL
mRNA	NULL
in	NULL
macrophages	NULL
through	NULL
posttranscriptional	NULL
reg-ulation	NULL
.	NULL

Cell	NULL
48:671	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL

